id,label
GAPDH,Entity
chronic intestinal failure,Entity
Small intestinal polyposis,Entity
hepatitis E virus infection,Entity
RPL24,Entity
duodenal somatostatinoma,Entity
Isopropamide,Entity
Ceftizoxime,Entity
RB1,Entity
Dutasteride,Entity
THADA,Entity
rectal neoplasm,Entity
ATF3,Entity
PLCB1,Entity
mucinous adenocarcinoma of the appendix,Entity
PTPRJ,Entity
ABCC4,Entity
CFHR5,Entity
Rectal polyposis,Entity
Narrow chest,Entity
carcinoma in situ of cecum,Entity
SLC10A1,Entity
anal canal adenocarcinoma (disease),Entity
Low plasma citrulline,Entity
Fidaxomicin,Entity
EP300,Entity
anus lymphoma,Entity
adenoid cystic carcinoma of oropharynx,Entity
IgG4-related retroperitoneal fibrosis,Entity
Tamsulosin,Entity
Bifid sacrum,Entity
Dependency on intravenous nutrition,Entity
intestinal disease due to fat malabsorption,Entity
CC2D2A,Entity
gastroesophageal reflux disease,Entity
Dexfenfluramine,Entity
mucin-producing carcinoma,Entity
NTRK3,Entity
EML2,Entity
aflatoxin-related hepatocellular carcinoma,Entity
SLC6A14,Entity
Extrahepatic biliary duct atresia,Entity
lysine malabsorption syndrome,Entity
CYP19A1,Entity
Acetophenazine,Entity
MKI67,Entity
MYB,Entity
Impaired glucose tolerance,Entity
Abnormal oral glucose tolerance,Entity
Aplasia cutis congenita over the scalp vertex,Entity
UMPS,Entity
lipoma of colon,Entity
CNTN1,Entity
PA2G4,Entity
NAXD,Entity
Vocal cord paresis,Entity
syndromic intestinal malformation,Entity
paranasal sinus adenoid cystic carcinoma,Entity
Salmeterol,Entity
FCN2,Entity
AGPAT2,Entity
Increased total bilirubin,Entity
radiation proctitis,Entity
tricho-hepato-enteric syndrome,Entity
CTNNA1,Entity
Abnormal cerebral vascular morphology,Entity
CYP2R1,Entity
Ketoacidosis,Entity
Rosiglitazone,Entity
uvula cancer,Entity
solid pseudopapillary neoplasm of the pancreas,Entity
Pulmonary arterial hypertension,Entity
anal canal Paget disease,Entity
Vascular dilatation,Entity
HK3,Entity
CELA3B,Entity
Abnormal respiratory system morphology,Entity
Nabumetone,Entity
F5,Entity
anorectal stricture,Entity
Salicylic acid,Entity
Calvarial skull defect,Entity
Thick eyebrow,Entity
MAGEA1,Entity
Bromine,Entity
Cabergoline,Entity
Neuroblastoma,Entity
cap polyposis,Entity
Furosemide,Entity
TPX2,Entity
SOCS3,Entity
Respiratory insufficiency due to muscle weakness,Entity
adenomatoid odontogenic tumor,Entity
ALAD,Entity
OXT,Entity
colorectal squamous cell carcinoma,Entity
infantile diarrhea,Entity
Oxybutynin,Entity
CLIC1,Entity
TAGAP,Entity
Aplastic/hypoplastic toenail,Entity
EPO,Entity
Riboflavin,Entity
bile duct adenocarcinoma,Entity
endometriosis (disease),Entity
alveolar echinococcosis,Entity
pediatric collagenous gastritis,Entity
Intestinal carcinoid,Entity
BRINP1,Entity
WASL,Entity
Phenol,Entity
cystadenocarcinoma,Entity
HAO2,Entity
ATOX1,Entity
RGN,Entity
Interstitial pneumonitis,Entity
Golimumab,Entity
Immune dysregulation,Entity
Rubidium,Entity
MIR3591,Entity
peptic ulcer perforation,Entity
Epigastric pain,Entity
SYT9,Entity
HNF1A,Entity
CBX5,Entity
Levetiracetam,Entity
Synthetic camphor,Entity
colon signet ring cell adenocarcinoma,Entity
genetic nervous system disorder,Entity
GRID1,Entity
colon serrated polyposis,Entity
CALR,Entity
congenital sucrase-isomaltase deficiency without sucrose intolerance,Entity
Anti-thyroid peroxidase antibody positivity,Entity
CCNB1,Entity
epithelial tumor of anal canal,Entity
Abnormality of skin pigmentation,Entity
Hypoplasia of the uterus,Entity
FGFR3,Entity
NFXL1,Entity
Small nail,Entity
Gastrointestinal atresia,Entity
partial monosomy of the short arm of chromosome 20,Entity
MIR625,Entity
Neck pain,Entity
PLS3,Entity
Abnormal pineal melatonin secretion,Entity
CLSTN2,Entity
MFF,Entity
Ixabepilone,Entity
PDILT,Entity
familial pancreatic carcinoma,Entity
MLC1,Entity
TCOF1,Entity
Brittle hair,Entity
CEP131,Entity
pouchitis,Entity
Hepatomegaly,Entity
ACSL1,Entity
childhood malignant neoplasm,Entity
Magnesium trisilicate,Entity
FOXP3,Entity
MRO,Entity
TCTN1,Entity
Schwannoma,Entity
Athetosis,Entity
diarrhea 9,Entity
Alagille syndrome due to a NOTCH2 point mutation,Entity
PTPRS,Entity
Intermittent jaundice,Entity
bile duct neoplasm,Entity
Nausea,Entity
Brimonidine,Entity
Abnormality of the pancreatic islet cells,Entity
Tobramycin,Entity
CSRNP3,Entity
Abnormal rectum morphology,Entity
Hypoalbuminemia,Entity
Crohn disease,Entity
hepatobiliary disease,Entity
cefuroxime axetil,Entity
Polyuria,Entity
Laryngeal stridor,Entity
DNAH8,Entity
LRP5,Entity
Elevated alkaline phosphatase of hepatic origin,Entity
PLCE1,Entity
Trichlorfon,Entity
"hepatitis, viral, animal",Entity
MBTPS2,Entity
"Sodium phosphate, dibasic",Entity
genetic cardiac rhythm disease,Entity
Renal Fanconi syndrome,Entity
MIR1271,Entity
Arterial occlusion,Entity
ESM1,Entity
Hyperchloremic metabolic acidosis,Entity
Mebeverine,Entity
large intestine disease,Entity
Oxymorphone,Entity
pediatric hepatocellular carcinoma,Entity
primary desmosis coli,Entity
Anagrelide,Entity
VIPoma,Entity
Pitavastatin,Entity
Hyperbilirubinemia,Entity
Unilateral renal agenesis,Entity
Sulfabenzamide,Entity
Levonorgestrel,Entity
CPE,Entity
Verteporfin,Entity
IL12A,Entity
SLC66A2,Entity
Peginterferon alfa-2a,Entity
FBLN2,Entity
AGTPBP1,Entity
Fosinopril,Entity
ATF4,Entity
LOXL2,Entity
SLC2A4,Entity
esophagitis (disease),Entity
hyperinsulinism due to HNF4A deficiency,Entity
tumor of salivary gland,Entity
Doxazosin,Entity
ZDHHC2,Entity
PARP1,Entity
Prominent nasal bridge,Entity
Anteverted nares,Entity
DNASE1L3,Entity
IFNL3,Entity
ICAM5,Entity
Amaurosis fugax,Entity
immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,Entity
Increased urinary porphobilinogen,Entity
LDHA,Entity
COL15A1,Entity
pancreatic acinar cell cystadenocarcinoma,Entity
MIR206,Entity
constipation disorder,Entity
Multiple small medullary renal cysts,Entity
ORC1,Entity
Inflammatory cap polyp,Entity
PDZK1,Entity
Hypogeusia,Entity
MIR100,Entity
Propranolol,Entity
DLAT,Entity
IL10,Entity
FOLR1,Entity
PDZRN4,Entity
CTRC,Entity
ARID4B,Entity
C4orf19,Entity
GNB3,Entity
Abnormal circulating apolipoprotein concentration,Entity
CLCN3,Entity
CCR2,Entity
"digestive system neuroendocrine tumor, grade 1/2",Entity
Ozone,Entity
Articaine,Entity
Low levels of vitamin B1,Entity
HAS3,Entity
PALB2,Entity
FANCD2,Entity
ME1,Entity
Mercury,Entity
C12orf76,Entity
Aztreonam,Entity
pancreatic cystadenocarcinoma,Entity
cardia cancer,Entity
Tinidazole,Entity
RAB23,Entity
DGAT2,Entity
POLR2G,Entity
congenital anemia,Entity
bis(4-hydroxyphenyl)sulfone,Entity
"Hydrocarbons, Chlorinated",Entity
Miconazole,Entity
GSN,Entity
P4HB,Entity
Demeclocycline,Entity
Abnormal circulating eicosanoid concentration,Entity
TALDO1,Entity
CSPG4,Entity
Hepatic vein thrombosis,Entity
RRM2B,Entity
tumor of duodenum,Entity
Blue sclerae,Entity
MALAT1,Entity
necrotizing gastritis,Entity
FBXW7,Entity
MIR185,Entity
RBBP8,Entity
genetic systemic or rheumatologic disease,Entity
Riluzole,Entity
Hepatoblastoma,Entity
vestibule of mouth cancer,Entity
IL21,Entity
TXNRD1,Entity
SH3TC1,Entity
esophageal lipoma,Entity
KLF14,Entity
respiratory system cancer,Entity
Muscular hypotonia of the trunk,Entity
MIR328,Entity
TM6SF2,Entity
Diethylpropion,Entity
MYBL1,Entity
PEMT,Entity
Neutropenia,Entity
NKX2-1,Entity
congenital sucrase-isomaltase deficiency,Entity
Disopyramide,Entity
Racepinephrine,Entity
GPC3,Entity
Flaviviridae infectious disease,Entity
CEBPA,Entity
CCDC93,Entity
SRSF6,Entity
NEAT1,Entity
Hydrochloric Acid,Entity
Simvastatin,Entity
GATA1,Entity
MECP2,Entity
NR1D1,Entity
rectal traditional serrated adenoma,Entity
Neoplasm of the skin,Entity
Hypotonia,Entity
DNAJB9,Entity
Extension of hair growth on temples to lateral eyebrow,Entity
Ileal atresia,Entity
colon leiomyoma,Entity
eosinophilic gastritis,Entity
ZNF471,Entity
Irritability,Entity
Sarcoma,Entity
FOXL2,Entity
Carmofur,Entity
Ardeparin,Entity
ADRA1A,Entity
GPX3,Entity
MIR1247,Entity
biliary tract disease,Entity
Vinyl Chloride,Entity
Decreased prealbumin level,Entity
Retinal degeneration,Entity
TATDN1,Entity
"colorectal cancer, hereditary nonpolyposis,",Entity
Anti-glutamic acid decarboxylase antibody positivity,Entity
Methylergometrine,Entity
Adefovir dipivoxil,Entity
Buformin,Entity
genetic biliary tract disease,Entity
Misoprostol,Entity
Papillary cystadenoma of the epididymis,Entity
Pentostatin,Entity
CYBA,Entity
Succinylcholine,Entity
Anal canal neoplasm,Entity
CDCA3,Entity
appendix leiomyoma,Entity
GNMT,Entity
ABCB6,Entity
Bilateral single transverse palmar creases,Entity
Downturned corners of mouth,Entity
esophageal neuroendocrine tumor,Entity
Zinc oxide,Entity
RPS6KB1,Entity
head and neck carcinoma,Entity
ZNF257,Entity
anal Paget disease,Entity
Intestinal obstruction,Entity
Hirschsprung disease-type D brachydactyly syndrome,Entity
EIF3H,Entity
HSPA8,Entity
HTR3C,Entity
Abnormal form of the vertebral bodies,Entity
MAPK8,Entity
MT1F,Entity
MIR338,Entity
small intestinal enteropathy-associated T-cell lymphoma,Entity
YBX1,Entity
extrahepatic bile duct lipoma,Entity
MIR301A,Entity
Iocetamic acid,Entity
gastrointestinal stromal tumor,Entity
"pancreatic lymphoma, familial",Entity
Methimazole,Entity
microcephalic primordial dwarfism-insulin resistance syndrome,Entity
Choline magnesium trisalicylate,Entity
butylate,Entity
rectal tubular adenoma,Entity
Ursodeoxycholic acid,Entity
Minocycline,Entity
AGT,Entity
Saquinavir,Entity
PTPN1,Entity
fungal esophagitis,Entity
major salivary gland carcinoma,Entity
Medetomidine,Entity
Aplasia/Hypoplasia of the pancreas,Entity
Metyrosine,Entity
CACNB1,Entity
KDM6A,Entity
SMAD2,Entity
Caroli disease,Entity
FAM92B,Entity
Sodium citrate,Entity
STC2,Entity
necrotizing enterocolitis,Entity
Bendamustine,Entity
WEE2,Entity
ampullary signet ring cell adenocarcinoma,Entity
Melena,Entity
MIR92B,Entity
skull cancer,Entity
hamartoma (disease),Entity
duodenal obstruction,Entity
Delayed skeletal maturation,Entity
SLC30A8,Entity
IRAK1,Entity
Narrow mouth,Entity
Dichlorvos,Entity
Meconium stained amniotic fluid,Entity
rectosigmoid junction cancer,Entity
Malabsorption,Entity
bromodichloromethane,Entity
adenoma of small intestine,Entity
IFI27,Entity
pancreatic non-invasive mucinous cystadenocarcinoma,Entity
syndromic intellectual disability,Entity
B2M,Entity
IL13RA1,Entity
cholecystitis,Entity
MIR1343,Entity
CYP2A6,Entity
adenomatous colon polyp,Entity
BID,Entity
Biliary tract obstruction,Entity
CCNH,Entity
malignant tumor of extrahepatic bile duct,Entity
SETBP1,Entity
SMTN,Entity
DNALI1,Entity
GPX1,Entity
metastasis from malignant tumor of colon,Entity
SAMHD1,Entity
Asthenia,Entity
Docetaxel,Entity
Elevated carcinoembryonic antigen level,Entity
WFS1,Entity
Donepezil,Entity
CTBP1,Entity
TCIM,Entity
colon neuroendocrine tumor G1,Entity
TEX14,Entity
Allantoin,Entity
Hypercholesterolemia,Entity
FOLR2,Entity
EIF2AK3,Entity
Ipratropium,Entity
Tesamorelin,Entity
Bupivacaine,Entity
rectal medullary carcinoma,Entity
oral cavity mucoepidermoid carcinoma,Entity
Aminoglutethimide,Entity
"jejunal neuroendocrine tumor, well differentiated, low or intermediate grade",Entity
MBD3L2,Entity
Chloroprocaine,Entity
ATG5,Entity
CDKL5,Entity
Carbamazepine,Entity
GRM1,Entity
Duodenal stenosis,Entity
APPL1,Entity
Increased body weight,Entity
Recurrent skin infections,Entity
FPR2,Entity
SNX8,Entity
Iloperidone,Entity
RPS15,Entity
Crohn jejunoileitis,Entity
rectal adenosquamous carcinoma,Entity
Clinodactyly of the 5th finger,Entity
CRHBP,Entity
urinary bladder disease,Entity
DBT,Entity
HHEX,Entity
intestinal schistosomiasis,Entity
Glucosamine,Entity
Ademetionine,Entity
hilar cholangiocarcinoma,Entity
MIR1285-1,Entity
Cefradine,Entity
Prostate neoplasm,Entity
Round face,Entity
cholesterolosis of gallbladder,Entity
oral candidiasis,Entity
PLG,Entity
LGALS3BP,Entity
Carbutamide,Entity
Calcium acetate,Entity
MAT1A,Entity
Anemic pallor,Entity
Ferrous gluconate,Entity
ING4,Entity
Palmoplantar cutis laxa,Entity
HGF,Entity
CTNNA2,Entity
glucose transport disorder,Entity
SLC11A2,Entity
CADPS2,Entity
pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia,Entity
Mirex,Entity
Meckel diverticulum neoplasm,Entity
peritonitis,Entity
leather-bottle stomach,Entity
Hypolipidemia,Entity
NIBAN1,Entity
Hexachlorocyclohexane,Entity
MIR335,Entity
ITGAM,Entity
MLXIPL,Entity
gastric mucosal hypertrophy,Entity
Sparse or absent eyelashes,Entity
autosomal dominant polycystic liver disease,Entity
Renal tubular acidosis,Entity
Rheumatoid arthritis,Entity
hepatic tuberculosis,Entity
tubular adenocarcinoma,Entity
pancreatic mucinous cystadenoma,Entity
Metacycline,Entity
duodenal villous adenoma,Entity
MST1,Entity
Benzphetamine,Entity
Dimercaprol,Entity
oropharynx squamous cell carcinoma,Entity
AJUBA,Entity
hepatopulmonary syndrome,Entity
Hyperventilation,Entity
PNP,Entity
Gallium,Entity
porphyria cutanea tarda,Entity
MBOAT1,Entity
Hepatocellular carcinoma,Entity
displacement of cardia through esophageal hiatus,Entity
Hamartomatous polyposis,Entity
Echothiophate,Entity
POLB,Entity
Short neck,Entity
Sotalol,Entity
SNX5,Entity
Gliclazide,Entity
Sulfadiazine,Entity
SERPINA4,Entity
Butabarbital,Entity
Methenamine,Entity
Almotriptan,Entity
CD46,Entity
Ureteropelvic junction obstruction,Entity
ATP6V1E1,Entity
gastroparesis (disease),Entity
Congestive heart failure,Entity
cystadenoma,Entity
goblet cell carcinoma,Entity
choledocholithiasis,Entity
Pneumonia,Entity
BCAR1,Entity
"diabetes mellitus, noninsulin-dependent",Entity
MICA,Entity
MMP2,Entity
Azithromycin,Entity
Abnormal sacrum morphology,Entity
Cyclosporine,Entity
"neuronal intestinal dysplasia, type B",Entity
Cilastatin,Entity
Rifabutin,Entity
MIR190A,Entity
FILIP1,Entity
pharynx cancer,Entity
Ceftriaxone,Entity
DACT1,Entity
SLC26A6,Entity
rectal signet ring cell adenocarcinoma,Entity
SULT1E1,Entity
invasive carcinoma,Entity
"Fatty Acids, Omega-3",Entity
GSR,Entity
Secretin human,Entity
Histrelin,Entity
LGR5,Entity
PRKCD,Entity
OPRM1,Entity
ZIC4,Entity
congenital generalized lipodystrophy,Entity
Sertraline,Entity
Rifaximin,Entity
oropharyngeal carcinoma,Entity
MIR320A,Entity
MIR1304,Entity
Recurrent upper respiratory tract infections,Entity
SMAD3,Entity
accessory pancreas,Entity
DMKN,Entity
fenoprop,Entity
EXOC4,Entity
ADRA2B,Entity
KRT5,Entity
Fragile skin,Entity
MIR497,Entity
duodenal gastrin-producing neuroendocrine tumor,Entity
Agitation,Entity
salivary gland adenoid cystic carcinoma,Entity
CCR5,Entity
HRH4,Entity
anus disease,Entity
rectum mucinous adenocarcinoma,Entity
GALK1,Entity
Methylprednisolone,Entity
MIR99A,Entity
GABRD,Entity
TUBA1A,Entity
SULT2B1,Entity
Mexiletine,Entity
GSTO1,Entity
rectum sarcoma,Entity
liver sarcoma,Entity
SLC30A10,Entity
Boceprevir,Entity
RPS6,Entity
DEPDC1B,Entity
Aliskiren,Entity
cascade stomach,Entity
MTNR1B,Entity
CFAP77,Entity
TRNE,Entity
ABCC13,Entity
Pentobarbital,Entity
GDNF,Entity
Abnormality of the pylorus,Entity
Cytarabine,Entity
duodenitis,Entity
Air Pollutants,Entity
DAPK1,Entity
Flutamide,Entity
Sensory impairment,Entity
Dehydrocholic acid,Entity
esophageal atresia (disease),Entity
TSC1,Entity
classic or attenuated familial adenomatous polyposis,Entity
pneumatosis cystoides intestinalis,Entity
NRG1,Entity
TTLL3,Entity
Triflupromazine,Entity
MIR6852,Entity
DPEP1,Entity
IQUB,Entity
PTGS2,Entity
CPA1,Entity
maturity-onset diabetes of the young,Entity
PGAM1,Entity
SLC9A1,Entity
Acetaminophen,Entity
Coarse facial features,Entity
ampulla of vater mucinous adenocarcinoma,Entity
AKAP6,Entity
MIR205,Entity
SLC29A1,Entity
ADH7,Entity
Bosentan,Entity
Capsaicin,Entity
ARID5B,Entity
DMRTA1,Entity
hyperbiliverdinemia,Entity
C3,Entity
Nitrogen Dioxide,Entity
Potassium citrate,Entity
MIR302C,Entity
Phenytoin,Entity
CYP8B1,Entity
MAP2K4,Entity
FATE1,Entity
PTMA,Entity
Transitional cell carcinoma of the bladder,Entity
TTK,Entity
Dyskinesia,Entity
Spontaneous esophageal perforation,Entity
IKZF1,Entity
MYCN,Entity
rectal cancer,Entity
ampulla of vater cancer,Entity
Babinski sign,Entity
immune dysregulation disease with immunodeficiency,Entity
ABCA6,Entity
SYDE1,Entity
Mandibular prognathia,Entity
appendix L-cell glucagon-like peptide-producing neuroendocrine tumor,Entity
non-alcoholic steatohepatitis,Entity
MAP2K2,Entity
Aagenaes syndrome,Entity
Benazepril,Entity
PRDX6,Entity
Carious teeth,Entity
Developmental cataract,Entity
Decreased fetal movement,Entity
ANXA7,Entity
inherited neuroendocrine tumor,Entity
diffuse large B-cell lymphoma,Entity
PPP1R3A,Entity
Dyspnea,Entity
GSTA4,Entity
Hydroxyzine,Entity
neoplastic syndrome,Entity
Guaiacol,Entity
PTTG1,Entity
IFT172,Entity
Erythematous plaque,Entity
Adrenal insufficiency,Entity
CDH7,Entity
Childhood onset,Entity
neurofibroma,Entity
KANSL1,Entity
gallbladder squamous cell carcinoma,Entity
Telaprevir,Entity
colon leiomyosarcoma,Entity
ANKS6,Entity
colorectal cancer,Entity
INPP4B,Entity
SLC51A,Entity
oropharynx cancer,Entity
CD53,Entity
CCDC92,Entity
Carvedilol,Entity
CHD1,Entity
AREG,Entity
ZEB2,Entity
MIR483,Entity
HSPA9,Entity
Pancreatic adenocarcinoma,Entity
Recurrent respiratory infections,Entity
WIPI1,Entity
PLAG1,Entity
Malathion,Entity
MIR455,Entity
HLA-A,Entity
chronic enteropathy associated with SLCO2A1 gene,Entity
MIR6881,Entity
Mitoxantrone,Entity
sessile serrated polyposis cancer syndrome,Entity
Portal hypertension,Entity
Pleural effusion,Entity
HIPK1,Entity
CDCA5,Entity
developmental anomaly of metabolic origin,Entity
MIR29B2,Entity
Mydriasis,Entity
genetic otorhinolaryngological malformation,Entity
neuroendocrine carcinoma,Entity
Cefaclor,Entity
Flavoxate,Entity
Heparin,Entity
SLC13A4,Entity
Fosaprepitant,Entity
KIF18A,Entity
MSLN,Entity
Pituitary null cell adenoma,Entity
Ectopic anus,Entity
GSTP1,Entity
Salsalate,Entity
Tiopronin,Entity
Bronchospasm,Entity
KDM8,Entity
familial melanoma,Entity
PTPRG,Entity
ALDH1A1,Entity
Multiple glomerular cysts,Entity
Impaired platelet aggregation,Entity
lipoma,Entity
MIR542,Entity
diffuse gastric adenocarcinoma,Entity
mucocele of appendix,Entity
malignant neoplasm of thoracic esophagus,Entity
Abnormality of blood and blood-forming tissues,Entity
Polygenic inheritance,Entity
SHH,Entity
GDI1,Entity
perinatal jaundice due to hepatocellular damage,Entity
Abnormal platelet morphology,Entity
HSD11B2,Entity
ACE,Entity
tongue neoplasm,Entity
autoimmune disease,Entity
GNB4,Entity
NME2,Entity
PAK3,Entity
perihilar intrahepatic cholangiocarcinoma,Entity
Crohn ileitis and jejunitis,Entity
Halogenated Diphenyl Ethers,Entity
MC4R,Entity
MSR1,Entity
GUCY2C,Entity
neoplasm of esophagus,Entity
CBFA2T3,Entity
NFKBIZ,Entity
CD300E,Entity
digestive system infectious disease,Entity
Calcium,Entity
SEMA3C,Entity
DIDO1,Entity
Phenyltoloxamine,Entity
CAMSAP2,Entity
CSRNP1,Entity
ACHE,Entity
tongue cancer,Entity
Indomethacin,Entity
CD274,Entity
Peritonitis,Entity
PDK4,Entity
F2R,Entity
RAG2,Entity
colloid carcinoma of the pancreas,Entity
MIR30C2,Entity
OGG1,Entity
Cefazolin,Entity
IAPP,Entity
KCNK16,Entity
MIR1260A,Entity
Hematuria,Entity
large cell carcinoma,Entity
Ondansetron,Entity
Elevated hemoglobin A1c,Entity
Vitamin A,Entity
Haloperidol,Entity
ICAM2,Entity
hydrops of gallbladder,Entity
GREM1,Entity
CAVIN2,Entity
Doxycycline,Entity
Intrahepatic cholestasis with episodic jaundice,Entity
Brain abscess,Entity
ARL6IP5,Entity
Sorafenib,Entity
liposarcoma,Entity
GRB14,Entity
Rokitansky-Aschoff sinuses of the gallbladder,Entity
gastroesophageal disease,Entity
XAF1,Entity
TROAP,Entity
MEP1A,Entity
Crusting erythematous dermatitis,Entity
Cognitive impairment,Entity
Acute hepatic failure,Entity
MIR873,Entity
IHH,Entity
spleen cancer,Entity
familial partial lipodystrophy,Entity
syndromic nail anomaly,Entity
"Defoliants, Chemical",Entity
Felbamate,Entity
TCF19,Entity
CYP26A1,Entity
PCNA,Entity
squamous cell carcinoma of floor of mouth,Entity
MTBP,Entity
TIMD4,Entity
Incoordination,Entity
PTPRD,Entity
lip neoplasm,Entity
BAK1,Entity
Enoxaparin,Entity
sarcomatous intrahepatic cholangiocarcinoma,Entity
SRC,Entity
NFATC1,Entity
non-syndromic intestinal malformation,Entity
Cholecystitis,Entity
SLC5A8,Entity
pancreatic insufficiency-anemia-hyperostosis syndrome,Entity
CYTB,Entity
DAP,Entity
MIR4433B,Entity
Vonoprazan,Entity
ZNF217,Entity
C2CD4A,Entity
tyrosinemia,Entity
septic peritonitis,Entity
MYO5B,Entity
RNF157,Entity
Neoplasm of the adrenal gland,Entity
NKX6-1,Entity
FBN1,Entity
Maprotiline,Entity
Thrombocytosis,Entity
hemorrhagic duodenitis,Entity
FPGS,Entity
FGF3,Entity
Sacrosidase,Entity
MAP1LC3B,Entity
Fenofibrate,Entity
Epinephrine,Entity
small intestinal vasoactive intestinal peptide producing tumor,Entity
L-Glutamine,Entity
Intestinal fistula,Entity
VPS18,Entity
MIR10A,Entity
extrahepatic bile duct cystadenoma,Entity
growth retardation-mild developmental delay-chronic hepatitis syndrome,Entity
CAPN10,Entity
Lymphedema,Entity
Secundum atrial septal defect,Entity
NR1I2,Entity
Guanfacine,Entity
inflammatory bowel disease,Entity
PEX11A,Entity
Desonide,Entity
NFE2L2,Entity
SORD,Entity
Xylenes,Entity
visceral myopathy,Entity
RASSF2,Entity
PITPNM3,Entity
eosinophilic colitis,Entity
BRD2,Entity
Death in early adulthood,Entity
Broad thumb,Entity
Neoplasm of the nervous system,Entity
Elevated urinary delta-aminolevulinic acid,Entity
SLC11A1,Entity
Abnormal circulating protein concentration,Entity
esophageal squamous cell carcinoma,Entity
Biperiden,Entity
ATR,Entity
ROBO2,Entity
gallbladder lymphoma,Entity
Large forehead,Entity
methyl bromide,Entity
GPC1,Entity
Neoplasm of the thymus,Entity
Osteoporosis,Entity
Methylene Chloride,Entity
neuroendocrine tumor of the anal canal,Entity
pancreatic hypoplasia-diabetes-congenital heart disease syndrome,Entity
MAP2,Entity
Decreased HDL cholesterol concentration,Entity
SUOX,Entity
CDC6,Entity
EPHA3,Entity
carcinoma in situ of oropharynx,Entity
IKZF3,Entity
Bromocriptine,Entity
Tranylcypromine,Entity
MIR1179,Entity
Posterior embryotoxon,Entity
AURKA,Entity
AR,Entity
Cholic Acid,Entity
Nyctalopia,Entity
esophageal atresia/tracheoesophageal fistula,Entity
Dyphylline,Entity
colorectal diffuse large B-cell lymphoma,Entity
MIR125B1,Entity
ACAD8,Entity
Reticulocytosis,Entity
Anti-liver cytosolic antigen type 1 antibody positivity,Entity
Protruding ear,Entity
HACL1,Entity
LRRC4,Entity
SERPINH1,Entity
jejunal cancer,Entity
Jejunal diverticula,Entity
Fosamprenavir,Entity
Osteolytic defects of the phalanges of the hand,Entity
Neoplasm of the gallbladder,Entity
Naloxone,Entity
Back pain,Entity
ZNF560,Entity
Tridihexethyl,Entity
extrahepatic bile duct mucinous adenocarcinoma,Entity
Erythroderma,Entity
soft tissue sarcoma,Entity
MTTP,Entity
Epstein-Barr virus-associated gastric carcinoma,Entity
ABCB4,Entity
Dexmedetomidine,Entity
intestinal obstruction,Entity
FST,Entity
LINGO2,Entity
Stanozolol,Entity
tonsillar squamous cell carcinoma,Entity
MRPL13,Entity
MIR499A,Entity
ABCB11,Entity
ETFDH,Entity
STX3,Entity
Gemfibrozil,Entity
RPL18,Entity
CISD2,Entity
Normochromic anemia,Entity
Nelarabine,Entity
Tetraparesis,Entity
CDH1,Entity
Lincomycin,Entity
Tenofovir disoproxil,Entity
small intestinal fibrosarcoma,Entity
primary ovarian failure,Entity
Squamous cell carcinoma,Entity
High palate,Entity
Etonogestrel,Entity
EIF4EBP2,Entity
ELF3,Entity
Abnormality of the ovary,Entity
Melphalan,Entity
HOXD9,Entity
IL2RA,Entity
ANXA10,Entity
Food allergy,Entity
FBXO30,Entity
HEY1,Entity
inflammatory diarrhea,Entity
SMAD5,Entity
Mannitol,Entity
UCP2,Entity
HSPA2,Entity
Arginine,Entity
malignant endocrine neoplasm,Entity
esophageal small cell neuroendocrine carcinoma,Entity
GJB1,Entity
TFPI2,Entity
gastrointestinal hamartoma,Entity
JAKMIP2,Entity
gallbladder papillary neoplasm with an associated invasive carcinoma,Entity
PCK1,Entity
UHRF1,Entity
Esophageal neoplasm,Entity
Alphaprodine,Entity
Vardenafil,Entity
MADCAM1,Entity
RBFOX2,Entity
Polymicrogyria,Entity
tonsillar lymphoma,Entity
SLC4A2,Entity
DHFR,Entity
MAD2L1,Entity
Gastrointestinal obstruction,Entity
White eyebrow,Entity
hyperinsulinism due to HNF1A deficiency,Entity
DEFA6,Entity
SLC22A15,Entity
polyp,Entity
Meckel diverticulitis,Entity
TMEM127,Entity
extrahepatic biliary atresia,Entity
cecum adenocarcinoma,Entity
BMI1,Entity
Perphenazine,Entity
cysticercosis,Entity
HNF4A,Entity
autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,Entity
Abnormal joint morphology,Entity
Chilaiditi syndrome,Entity
Laryngeal carcinoma,Entity
BTG3,Entity
intrahepatic cholangiocarcinoma,Entity
STK40,Entity
Dysmenorrhea,Entity
Phenylmercuric nitrate,Entity
PRKAA1,Entity
Generalized-onset seizure,Entity
Kanamycin,Entity
pancreatic foamy gland adenocarcinoma,Entity
Color vision defect,Entity
IL1A,Entity
CCNY,Entity
Methylene blue,Entity
pyloric gland adenoma,Entity
rhabdomyosarcoma (disease),Entity
gastrointestinal tuberculosis,Entity
AP3S2,Entity
disorder of glycolysis,Entity
rectum leiomyoma,Entity
Mefloquine,Entity
salivary gland large cell carcinoma,Entity
Idarubicin,Entity
Abnormal intestine morphology,Entity
esophageal malformation,Entity
Lymphadenopathy,Entity
Abnormality of the pancreas,Entity
SLCO2A1,Entity
MIR141,Entity
pancreatic insulinoma,Entity
Penbutolol,Entity
CCDC80,Entity
Afamelanotide,Entity
ATP2A2,Entity
Neonatal hypotonia,Entity
TULP3,Entity
TMEM132D,Entity
MAP3K5,Entity
Late onset,Entity
BAP1,Entity
noma,Entity
Hyperplastic colonic polyposis,Entity
ulcer disease,Entity
Abnormality of the neck,Entity
Milia,Entity
BAAT,Entity
autosomal semi-dominant severe lipodystrophic laminopathy,Entity
TNS4,Entity
constitutional megaloblastic anemia due to folate metabolism disorder,Entity
CA2,Entity
ERBIN,Entity
CCN2,Entity
"diarrhea 10, protein-losing enteropathy type",Entity
YTHDF2,Entity
undifferentiated carcinoma of stomach,Entity
Hypopituitarism,Entity
ECHS1,Entity
chronic duodenal ileus,Entity
TTLL9,Entity
Intestinal perforation,Entity
COQ9,Entity
SLC30A7,Entity
NREP,Entity
PRR5-ARHGAP8,Entity
Profenamine,Entity
NKILA,Entity
LMNB2,Entity
PLAGL1,Entity
ALDOB,Entity
NFKBIA,Entity
ulcer of anus and rectum,Entity
Insulin resistance,Entity
Abnormal aortic morphology,Entity
PUM1,Entity
Tetrachlorodibenzodioxin,Entity
Levosalbutamol,Entity
Bloody diarrhea,Entity
CSTA,Entity
TP53,Entity
Alvimopan,Entity
KISS1R,Entity
stomach polyp,Entity
SACS,Entity
TJP2,Entity
BACH2,Entity
Pulmonary hemorrhage,Entity
intestinal disease due to vitamin absorption anomaly,Entity
Bile duct proliferation,Entity
Racecadotril,Entity
acute intermittent porphyria,Entity
Chlorphentermine,Entity
KDM1A,Entity
Genu valgum,Entity
Clonidine,Entity
PTGER1,Entity
BRAF,Entity
IL1R2,Entity
VTI1A,Entity
CDK12,Entity
Focal segmental glomerulosclerosis,Entity
GLI2,Entity
Pituitary prolactin cell adenoma,Entity
aplasia cutis congenita-intestinal lymphangiectasia syndrome,Entity
NFKB1,Entity
PREP,Entity
Histamine,Entity
hyperinsulinemic hypoglycemia,Entity
Chlorthalidone,Entity
Pravastatin,Entity
ERICH1,Entity
MYO1B,Entity
PDHA1,Entity
large cell neuroendocrine carcinoma,Entity
TP53TG1,Entity
PIK3R5,Entity
FAT2,Entity
"cleft larynx, posterior",Entity
Right ventricular failure,Entity
digestive system cancer,Entity
SCRN1,Entity
acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome,Entity
Dystrophic toenail,Entity
"celiac disease, susceptibility to",Entity
Calcium carbonate,Entity
hepatic veno-occlusive disease-immunodeficiency syndrome,Entity
Fentanyl,Entity
SF3A1,Entity
EDN1,Entity
TPM4,Entity
IFT88,Entity
bile duct disease,Entity
HIC1,Entity
Low-grade fever,Entity
BIRC5,Entity
MIR27B,Entity
viral hepatitis,Entity
THRA,Entity
Fesoterodine,Entity
UROD,Entity
ADAM29,Entity
disease by anatomical system,Entity
mesenchymal hamartoma,Entity
NDUFA1,Entity
CASP10,Entity
palatal neoplasm,Entity
Fenofibric acid,Entity
Megestrol acetate,Entity
Clinodactyly of the 4th finger,Entity
FXYD3,Entity
AKAP13,Entity
ZNF43,Entity
TNNI3K,Entity
nutmeg liver,Entity
Abnormal myocardium morphology,Entity
VENTX,Entity
PNPLA3,Entity
Phorate,Entity
undifferentiated carcinoma of esophagus,Entity
Gold,Entity
SLC44A4,Entity
IRF1,Entity
GLUD1,Entity
Teniposide,Entity
PCLAF,Entity
Impaired proprioception,Entity
TNFRSF10B,Entity
KRT73,Entity
Short metatarsal,Entity
follicular cholangitis and pancreatitis,Entity
Potassium Iodide,Entity
MLH1,Entity
undifferentiated pancreatic carcinoma,Entity
Neoplasm of the pancreas,Entity
Overlapping fingers,Entity
CD55,Entity
DEFA4,Entity
Spironolactone,Entity
BOP1,Entity
PPoma,Entity
HBEGF,Entity
Muscle weakness,Entity
AMBP,Entity
mono-isobutyl phthalate,Entity
MAP1B,Entity
Sparse body hair,Entity
Docosahexaenoic Acids,Entity
Iopodic acid,Entity
PROS1,Entity
esophagus carcinoma in situ,Entity
MT1E,Entity
SPTBN2,Entity
TMEM231,Entity
Ergometrine,Entity
FOXP2,Entity
low phospholipid associated cholelithiasis,Entity
Abnormal hair morphology,Entity
MMP9,Entity
duodenal atresia (disease),Entity
NUDT7,Entity
Reduced subcutaneous adipose tissue,Entity
Pancreatic islet cell adenoma,Entity
liver leiomyoma,Entity
Ascorbic acid,Entity
Acebutolol,Entity
TYK2,Entity
MIR142,Entity
Tripelennamine,Entity
Broad-based gait,Entity
ZNF480,Entity
teratoma,Entity
SNAI2,Entity
Paresthesia,Entity
Porphyrinuria,Entity
Clinodactyly of the 5th toe,Entity
Lymphoproliferative disorder,Entity
Levobunolol,Entity
intestinal impaction,Entity
Highly arched eyebrow,Entity
TMEM38B,Entity
Cevimeline,Entity
Citalopram,Entity
duodenum cancer,Entity
"Spontaneous, recurrent epistaxis",Entity
CXCL10,Entity
GRK6,Entity
Ropivacaine,Entity
Anasarca,Entity
Increased glucagon level,Entity
malignant tumor of nasopharynx,Entity
pancreatic carcinoma with mixed differentiation,Entity
tonsillar pillar cancer,Entity
syndrome with combined immunodeficiency,Entity
submandibular gland cancer,Entity
BRCA2,Entity
"2,2,4-trimethylpentane",Entity
APLN,Entity
Severe failure to thrive,Entity
oral tuberculosis,Entity
amebiasis,Entity
ABL1,Entity
benign neoplasm of anus,Entity
SDHD,Entity
Prochlorperazine,Entity
TIMP1,Entity
GPX2,Entity
PTEN,Entity
Glucagonoma,Entity
oropharyngeal anthrax,Entity
anus rhabdomyosarcoma,Entity
Visceral angiomatosis,Entity
Ethynodiol diacetate,Entity
pharyngeal adenoid cystic carcinoma,Entity
ADAMTSL3,Entity
Tretinoin,Entity
RAD21,Entity
WNT8B,Entity
CASP12,Entity
Topotecan,Entity
ABO,Entity
CYP7A1,Entity
congenital nervous system disorder,Entity
SNAI1,Entity
GAP43,Entity
Achlorhydria,Entity
Butacaine,Entity
BRCA1,Entity
squamous cell carcinoma of lip,Entity
papillary epithelial neoplasm,Entity
ARPC2,Entity
Moyamoya disease,Entity
parotid gland carcinoma ex pleomorphic adenoma,Entity
FAM72B,Entity
gastric papillary adenocarcinoma,Entity
CELSR1,Entity
FSD1,Entity
INSRR,Entity
Diiodohydroxyquinoline,Entity
CDCA2,Entity
malignant colon neoplasm,Entity
extrahepatic biliary papillomatosis,Entity
Cefdinir,Entity
Progressive,Entity
DNASE2,Entity
COX4I2,Entity
adenosquamous colon carcinoma,Entity
Laryngeal cleft,Entity
familial intrahepatic cholestasis,Entity
CLSTN3,Entity
Hypsarrhythmia,Entity
NELL1,Entity
ELP4,Entity
colon sarcoma,Entity
EIF3I,Entity
IQGAP3,Entity
Prolonged QT interval,Entity
Sodium fluoride,Entity
SLC16A1,Entity
Aeromonas hydrophila intestinal disease,Entity
coenurosis,Entity
CAMK2B,Entity
TOP1,Entity
isolated neonatal sclerosing cholangitis,Entity
Temozolomide,Entity
vein disease,Entity
POLD3,Entity
TMEM140,Entity
hereditary mixed polyposis syndrome,Entity
MED12,Entity
aggressive insulitis,Entity
Fatigue,Entity
Oxycodone,Entity
Methohexital,Entity
Dopamine,Entity
Pramocaine,Entity
hepatitis D virus infection,Entity
Lisinopril,Entity
Refractory anemia,Entity
FCGR3B,Entity
Jejunoileal diverticula,Entity
Lynch syndrome 1,Entity
CGREF1,Entity
ATAD1,Entity
Diplopia,Entity
CDH13,Entity
ADCYAP1,Entity
Ileal adenocarcinoma,Entity
PRICKLE2,Entity
intrahepatic cholestasis,Entity
Isometheptene,Entity
ALDH1B1,Entity
CCT3,Entity
SOX10,Entity
autoimmune primary ovarian failure,Entity
GLI1,Entity
Betaxolol,Entity
Coarctation of aorta,Entity
epithelial tumor of colon,Entity
extragonadal nonseminomatous germ cell tumor,Entity
IDH2,Entity
Felodipine,Entity
rectum Kaposi sarcoma,Entity
acalculous cholecystitis,Entity
PRPS1,Entity
ACSL4,Entity
Renal steatosis,Entity
cryptosporidiosis,Entity
Abnormal pulmonary valve cusp morphology,Entity
intestinal polyposis syndrome,Entity
FKBP1A,Entity
Nifedipine,Entity
LIFR,Entity
gallbladder adenocarcinoma,Entity
pancreatic tubular adenocarcinoma,Entity
NID1,Entity
CASR,Entity
MIR26B,Entity
distal biliary tract carcinoma,Entity
Formaldehyde,Entity
hyperinsulinism due to INSR deficiency,Entity
DNMT3B,Entity
sigmoid colon cancer,Entity
"inherited bleeding disorder, platelet-type",Entity
TFEC,Entity
KIF2C,Entity
PPTC7,Entity
Cerebral calcification,Entity
Portal fibrosis,Entity
Paritaprevir,Entity
colonic lymphangioma,Entity
autoimmune enteropathy,Entity
PSME1,Entity
ADAMTS13,Entity
Leukopenia,Entity
Distal muscle weakness,Entity
rectal neuroendocrine tumor G1,Entity
SLC2A1,Entity
PSME2,Entity
splenic manifestation of hairy cell leukemia,Entity
HPD,Entity
Butterfly vertebral arch,Entity
RUNX3,Entity
Lindane,Entity
Magnesium salicylate,Entity
FAM83D,Entity
Ethinylestradiol,Entity
MIR22,Entity
NEIL1,Entity
hepatic veno-occlusive disease,Entity
Quetiapine,Entity
Peripheral edema,Entity
Strabismus,Entity
Hypouricemia,Entity
CNR1,Entity
Lamotrigine,Entity
Rifampicin,Entity
CCR1,Entity
AXIN2,Entity
SYMPK,Entity
cecal disease,Entity
immune system disease,Entity
EDA,Entity
Rod-cone dystrophy,Entity
malignant tumor of neck,Entity
"o,p'-DDT",Entity
NR0B2,Entity
XAGE1B,Entity
Decreased urine output,Entity
cholelithiasis,Entity
diarrheal disease secondary to altered bowel motility,Entity
permanent neonatal diabetes mellitus,Entity
ADAMTS18,Entity
HRAS,Entity
TTLL10,Entity
Adenocarcinoma of the large intestine,Entity
Myoclonus,Entity
Meclofenamic acid,Entity
Cerivastatin,Entity
CLMP,Entity
benign neoplasm of gallbladder,Entity
CLEC16A,Entity
Arsenicals,Entity
primary short bowel syndrome,Entity
SH2B3,Entity
ALDH7A1,Entity
Gallbladder dyskinesia,Entity
Procarbazine,Entity
Specific learning disability,Entity
Procaine,Entity
DICER1,Entity
pharyngeal squamous cell carcinoma,Entity
exocrine pancreatic carcinoma,Entity
disorder of carbohydrate absorption and transport,Entity
STAT4,Entity
Cobalamin,Entity
NCF4,Entity
CD9,Entity
PrP systemic amyloidosis,Entity
bile duct cancer,Entity
ODAM,Entity
Abnormality of the voice,Entity
RACGAP1,Entity
eosinophilic gastrointestinal disease,Entity
Arthritis,Entity
Valproic acid,Entity
splenic manifestation of leukemia,Entity
carcinoma in situ of epiglottis,Entity
Paromomycin,Entity
RANBP10,Entity
Finasteride,Entity
combined hepatocellular carcinoma and cholangiocarcinoma,Entity
IQGAP1,Entity
Neoplasm of the lung,Entity
Visual impairment,Entity
C1QB,Entity
HAPLN1,Entity
ischemic disease,Entity
Depressivity,Entity
Oxacillin,Entity
AMER2,Entity
GRK4,Entity
E2F1,Entity
UNG,Entity
Phentermine,Entity
Duloxetine,Entity
POLR3K,Entity
spleen neoplasm,Entity
Ziprasidone,Entity
gallbladder cancer,Entity
Permethrin,Entity
RPRM,Entity
small intestinal neuroendocrine tumor G1,Entity
pyloric antrum cancer,Entity
SPNS3,Entity
anorectal malformation,Entity
TYMS,Entity
MSH2,Entity
FKBP2,Entity
Recurrent aspiration pneumonia,Entity
ITIH1,Entity
Linezolid,Entity
tropical sprue,Entity
Levomefolic acid,Entity
Triethylenetetramine,Entity
rectal tubulovillous adenoma,Entity
Cinacalcet,Entity
MAP3K15,Entity
HDAC2,Entity
cutaneous Paget disease,Entity
ACOX3,Entity
CDKN1C,Entity
Fingolimod,Entity
NOS1,Entity
Increased urine alpha-ketoglutarate concentration,Entity
PRC1,Entity
Decreased circulating 12-HETE,Entity
KALRN,Entity
minor salivary gland adenocarcinoma,Entity
Feeding difficulties,Entity
upper gum cancer,Entity
Rosuvastatin,Entity
CDK4,Entity
cholera,Entity
Atopic dermatitis,Entity
CYP17A1,Entity
somatostatinoma,Entity
Gastrointestinal inflammation,Entity
Alkalosis,Entity
gastrointestinal polyp,Entity
PIWIL2,Entity
Ileus,Entity
hepatitis,Entity
ZNF540,Entity
ERGIC3,Entity
Waldeyer's ring cancer,Entity
Bicuspid aortic valve,Entity
PCB 180,Entity
SKA3,Entity
Meloxicam,Entity
autoimmune gastritis,Entity
HIKESHI,Entity
APC,Entity
Abnormal pattern of respiration,Entity
EYA4,Entity
PEX5L,Entity
Abnormality of higher mental function,Entity
Biliary cirrhosis,Entity
intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome,Entity
DAPK3,Entity
duodenal adenocarcinoma,Entity
ERCC1,Entity
Chronic kidney disease,Entity
hereditary leiomyomatosis and renal cell cancer,Entity
carcinoma of parotid gland,Entity
"cholangiocarcinoma, susceptibility to",Entity
renal or urinary tract malformation,Entity
Butobarbital,Entity
microscopic colitis,Entity
Hearing impairment,Entity
CYP1B1,Entity
PUS10,Entity
Pigmentary retinopathy,Entity
IFNA5,Entity
Smooth philtrum,Entity
hyperinsulinism (disease),Entity
extrahepatic bile duct carcinoma,Entity
intrahepatic bile duct cystadenoma,Entity
KL,Entity
Entacapone,Entity
TERT,Entity
benign neoplasm of oropharynx,Entity
ADGRG7,Entity
Aortic regurgitation,Entity
Aplasia/Hypoplasia of the abdominal wall musculature,Entity
Methapyrilene,Entity
IL4,Entity
MIR23A,Entity
MIR1273H,Entity
EPTC,Entity
PTER,Entity
Aripiprazole,Entity
polymalformative genetic syndrome with increased risk of developing cancer,Entity
MED1,Entity
ANP32A,Entity
Neoplasm of the small intestine,Entity
Tegaserod,Entity
Docusate,Entity
hexabrominated diphenyl ether 153,Entity
GSTT1,Entity
MT2A,Entity
propylene dichloride,Entity
GPR65,Entity
MIRLET7G,Entity
Fluvoxamine,Entity
colon juvenile polyp,Entity
Romidepsin,Entity
marginal zone lymphoma,Entity
CPSF1,Entity
digestive system melanoma,Entity
S100A4,Entity
LAMA1,Entity
Sulfadoxine,Entity
TNFAIP8,Entity
AKR1D1,Entity
Lorazepam,Entity
SCAP,Entity
pancreatic intraductal papillary-mucinous neoplasm with high grade dysplasia,Entity
KAT6A,Entity
RAB38,Entity
Abnormality of the vertebral column,Entity
small intestine lymphoma,Entity
gastroduodenal Crohn disease,Entity
Abnormal nervous system morphology,Entity
Hypocapnia,Entity
epilepsy syndrome,Entity
Nateglinide,Entity
Caspofungin,Entity
CDK1,Entity
"Metals, Heavy",Entity
Immunodeficiency,Entity
Tolcapone,Entity
emphysematous cholecystitis,Entity
enterochromaffin cell serotonin-producing pancreatic neuroendocrine tumor,Entity
Hypovolemic shock,Entity
Emtricitabine,Entity
IL17RD,Entity
BUB1,Entity
RFX6,Entity
NR2F2,Entity
ARFGEF1,Entity
MIR132,Entity
Carbaryl,Entity
liver lipoma,Entity
Abnormality of the eye,Entity
CCND2,Entity
ABCC2,Entity
MIR219A1,Entity
Nicotine,Entity
gastric neuroendocrine neoplasm,Entity
extrahepatic bile duct adenosquamous carcinoma,Entity
Abnormality of exocrine pancreas physiology,Entity
enteropathy-associated T-cell lymphoma,Entity
RPS6KA3,Entity
constitutional hemolytic anemia due to acanthocytosis,Entity
appendix neuroendocrine tumor G1,Entity
peritonsillar abscess,Entity
vascular insufficiency disorder,Entity
Reduced bone mineral density,Entity
ARNT,Entity
QKI,Entity
liver solitary fibrous tumor,Entity
transient infantile hypertriglyceridemia and hepatosteatosis,Entity
ALG8,Entity
Procaine benzylpenicillin,Entity
PSMC5,Entity
Mood changes,Entity
chronic hepatitis B virus infection,Entity
familial visceral myopathy,Entity
BCL11A,Entity
Ovarian neoplasm,Entity
Nadolol,Entity
RARB,Entity
UGT1A1,Entity
VGF,Entity
MAPK13,Entity
Eplerenone,Entity
FCN3,Entity
ABCC1,Entity
Seizure,Entity
ECM1,Entity
Bloody mucoid diarrhea,Entity
Azacitidine,Entity
congenital pancreatic cyst,Entity
Captopril,Entity
extrahepatic bile duct squamous cell carcinoma,Entity
squamous cell carcinoma of the small intestine,Entity
PRSS1,Entity
duodenal disease,Entity
Beclomethasone dipropionate,Entity
Tranexamic acid,Entity
gastric non-hodgkin lymphoma,Entity
colon inflammatory polyp,Entity
Acute colitis,Entity
serous cystadenocarcinoma,Entity
osmotic diarrheal disease,Entity
Calcification of muscles,Entity
CLDN3,Entity
OCLN,Entity
Methyl salicylate,Entity
KIT,Entity
MAGEC2,Entity
Hepatocellular adenoma,Entity
BRDT,Entity
anal polyp,Entity
ACSL5,Entity
Gastrointestinal hemorrhage,Entity
anisakiasis,Entity
HJV,Entity
Ribavirin,Entity
autosomal erythropoietic protoporphyria,Entity
TCF4,Entity
Poor appetite,Entity
LOX,Entity
Quinethazone,Entity
gastric carcinoma,Entity
pancreatic mucinous-cystic neoplasm,Entity
Dry skin,Entity
Hereditary nonpolyposis colorectal carcinoma,Entity
small intestine leiomyosarcoma,Entity
Megacystis,Entity
familial cystic renal disease,Entity
ameloblastic carcinoma,Entity
IL12B,Entity
Vehicle Emissions,Entity
FASLG,Entity
DCAF4L2,Entity
Hepatic periportal necrosis,Entity
intestinal disease,Entity
URM1,Entity
IL24,Entity
Clemastine,Entity
TBX1,Entity
Ticagrelor,Entity
Zinc sulfate,Entity
MSH3,Entity
oral cavity cancer,Entity
GATA5,Entity
Nimodipine,Entity
carcinoma of esophagus,Entity
gastric neuroendocrine tumor,Entity
Fenfluramine,Entity
MIR432,Entity
NOTCH4,Entity
Epididymal cyst,Entity
Uranium,Entity
Gastrointestinal stroma tumor,Entity
Sudden cardiac death,Entity
hyperplastic polyp,Entity
anal canal neuroendocrine neoplasm,Entity
LMO7,Entity
Anoperineal fistula,Entity
Sodium fluorophosphate,Entity
squamous cell carcinoma of colon,Entity
pancreatic mucinous cystadenocarcinoma,Entity
maternally-inherited diabetes and deafness,Entity
gastrojejunal ulcer,Entity
FLT1,Entity
gastric adenocarcinoma,Entity
Cysteamine,Entity
CPS1,Entity
acinar cell carcinoma,Entity
Desvenlafaxine,Entity
Tenofovir,Entity
glucagonoma,Entity
Elevated serum creatinine,Entity
Methadyl acetate,Entity
Pituitary adenoma,Entity
inflammatory myofibroblastic tumor,Entity
LAS1L,Entity
GPD1,Entity
MIR452,Entity
Bacampicillin,Entity
CDON,Entity
Waste Water,Entity
colon carcinoma in situ,Entity
Abnormality of gastrointestinal vasculature,Entity
Glycine,Entity
Atorvastatin,Entity
Fluctuations in consciousness,Entity
ESR2,Entity
Hypoplastic toenails,Entity
Deserpidine,Entity
SOX11,Entity
CRP,Entity
Short stature,Entity
SLC39A6,Entity
WT1,Entity
pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma,Entity
fatty liver disease,Entity
cecum carcinoma,Entity
Povidone-iodine,Entity
embryonal rhabdomyosarcoma,Entity
RDX,Entity
Oligomenorrhea,Entity
sclerosing hepatic carcinoma,Entity
HSPA1B,Entity
bone cancer,Entity
Doxylamine,Entity
Insulin glargine,Entity
CCBE1,Entity
oculogastrointestinal muscular dystrophy,Entity
Abnormal circulating polysaccharide concentration,Entity
Urinary bladder inflammation,Entity
carcinoma in situ of nasopharynx,Entity
GPD2,Entity
FGF13,Entity
Pituitary corticotropic cell adenoma,Entity
ABCC8,Entity
Promazine,Entity
Meropenem,Entity
Estrone,Entity
WDR46,Entity
IL6,Entity
acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,Entity
C9,Entity
Tegafur,Entity
MX1,Entity
SLC1A7,Entity
PPM1F,Entity
THEM4,Entity
liver adenosquamous carcinoma,Entity
Betamethasone,Entity
Abdominal situs inversus,Entity
permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Entity
gastric teratoma,Entity
Renal cyst,Entity
PRF1,Entity
TRAIP,Entity
familial hyperinsulinism,Entity
IGF2BP1,Entity
Urinary tract neoplasm,Entity
muscle tissue disease,Entity
Tetryzoline,Entity
Decreased intestinal transit time,Entity
Decreased proportion of CD4-positive helper T cells,Entity
WNT5B,Entity
TSPEAR,Entity
TAF1,Entity
CHL1,Entity
pancreas disease,Entity
Dementia,Entity
ZNRD1,Entity
SULT1C3,Entity
IL3,Entity
Breast carcinoma,Entity
GLUL,Entity
hyperinsulinism-hyperammonemia syndrome,Entity
TLR9,Entity
alpha-Linolenic Acid,Entity
NFATC2,Entity
KRT8,Entity
"cholestasis, intrahepatic, of pregnancy",Entity
GFI1B,Entity
Hydrochlorothiazide,Entity
Memory impairment,Entity
DiGeorge syndrome,Entity
pendimethalin,Entity
MET,Entity
Abnormal eyebrow morphology,Entity
pancreatic neuroendocrine tumor,Entity
BMP2,Entity
Hepatic steatosis,Entity
carcinoma in situ of extrahepatic bile duct,Entity
EGR1,Entity
intractable diarrhea of infancy,Entity
POU2F2,Entity
carcinoid tumor (disease),Entity
Beclabuvir,Entity
Linaclotide,Entity
THEMIS,Entity
TLR2,Entity
STARD8,Entity
Metoprolol,Entity
KIF18B,Entity
Motor delay,Entity
CENPF,Entity
monogenic diabetes,Entity
Guaifenesin,Entity
SFRP1,Entity
Morphological abnormality of the gastrointestinal tract,Entity
GSTM4,Entity
PHKG1,Entity
ZDHHC23,Entity
congenital malabsorptive diarrhea 4,Entity
ileal neuroendocrine tumor G1,Entity
Hypophosphatemic rickets,Entity
Pyrantel,Entity
Dexlansoprazole,Entity
lactose intolerance,Entity
ANK2,Entity
hirudiniasis,Entity
Hypoproteinemia,Entity
ITLN1,Entity
Thiopental,Entity
Dienogest,Entity
MIR370,Entity
HAVCR1,Entity
Sibutramine,Entity
extrahepatic bile duct adenoma,Entity
IL20,Entity
Increased circulating IgE level,Entity
Kyphoscoliosis,Entity
Tetrabenazine,Entity
ABCA10,Entity
Nitrofural,Entity
XRCC4,Entity
Epirubicin,Entity
SERPINA5,Entity
HR,Entity
Clarithromycin,Entity
Small for gestational age,Entity
Microcornea,Entity
lip cancer,Entity
Dexpanthenol,Entity
HULC,Entity
Vaniprevir,Entity
CD24,Entity
Tracheoesophageal fistula,Entity
SERPINF1,Entity
Tigecycline,Entity
APOA1,Entity
Trifluridine,Entity
chronic diarrheal disease,Entity
Dilatation of the cerebral artery,Entity
COL4A6,Entity
Fluticasone propionate,Entity
SREBF2,Entity
TERC,Entity
MRC1,Entity
ABCA4,Entity
TNXB,Entity
liver disease,Entity
lymphangioma,Entity
RPS20,Entity
TLR4,Entity
JAK3,Entity
SUCLG1,Entity
gallbladder mucinous adenocarcinoma,Entity
VWA2,Entity
TPI1,Entity
Budesonide,Entity
MIR4492,Entity
juvenile polyp,Entity
RIPK2,Entity
Folic acid,Entity
F2RL1,Entity
AQP3,Entity
Ibuprofen,Entity
Primary hypercortisolism,Entity
benign neoplasm,Entity
Lanreotide,Entity
viral gastritis,Entity
KCNQ5,Entity
inherited blood coagulation disorder,Entity
KDM2A,Entity
PHGDH,Entity
COL7A1,Entity
Hyporeflexia,Entity
RBP1,Entity
Tetracaine,Entity
EBI3,Entity
anal gland neoplasm,Entity
hypertrophic pyloric stenosis,Entity
hereditary nonpolyposis colon cancer,Entity
GSTM1,Entity
Stiff neck,Entity
Magnesium sulfate,Entity
Disseminated intravascular coagulation,Entity
NUSAP1,Entity
Ferrous fumarate,Entity
Mangafodipir,Entity
Lethargy,Entity
chronic atrophic gastritis,Entity
undifferentiated embryonal sarcoma of the liver,Entity
carcinoma of hard palate,Entity
submandibular gland adenocarcinoma,Entity
ING1,Entity
MLKL,Entity
ADH1B,Entity
Mirizzi syndrome,Entity
juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,Entity
Infliximab,Entity
IDH1,Entity
Parnaparin,Entity
Sevelamer,Entity
ISLR,Entity
Cachexia,Entity
common bile duct neoplasm,Entity
Hypoactive bowel sounds,Entity
"2,4,5-Trichlorophenoxyacetic Acid",Entity
FGG,Entity
PFN1,Entity
Ataxia,Entity
Stercoral ulcer,Entity
MIR6741,Entity
ARG1,Entity
TNFRSF19,Entity
NDUFS1,Entity
Hyperparathyroidism,Entity
Mitotane,Entity
MRPS18B,Entity
TNFSF13,Entity
DUSP21,Entity
Abnormality of the wrist,Entity
LAMC1,Entity
ALDH9A1,Entity
ICOSLG,Entity
Pentoxyverine,Entity
SIRT1,Entity
Protracted diarrhea,Entity
Pancreatic islet-cell hyperplasia,Entity
intestinal neuroendocrine neoplasm,Entity
Lack of bowel sounds,Entity
Drowsiness,Entity
PARP8,Entity
Carbinoxamine,Entity
major salivary gland adenoid cystic carcinoma,Entity
Esomeprazole,Entity
Neoplasm of the large intestine,Entity
CD248,Entity
"cirrhosis, familial",Entity
Quinacrine,Entity
Peutz-Jeghers polyp of the stomach,Entity
Venous thrombosis,Entity
BCAT1,Entity
Thoracolumbar scoliosis,Entity
irritable bowel syndrome,Entity
Magnesium lactate,Entity
esophageal varices with bleeding,Entity
ZNF569,Entity
MRAS,Entity
ATG7,Entity
Premature birth,Entity
Sparse eyelashes,Entity
intraductal tubulopapillary neoplasm of pancreas,Entity
Dehydration,Entity
Aspartic acid,Entity
ZNHIT1,Entity
Camptodactyly of finger,Entity
Dacarbazine,Entity
Dieulafoy lesion,Entity
Abnormal erythrocyte enzyme level,Entity
PALLD,Entity
Molybdenum,Entity
TMEM17,Entity
helminthiasis,Entity
CKAP2L,Entity
Eribulin,Entity
neonatal diabetes mellitus with congenital hypothyroidism,Entity
Etodolac,Entity
CARD9,Entity
Sulbactam,Entity
Halothane,Entity
Oligodontia,Entity
squamous cell carcinoma of pancreas,Entity
ABCA12,Entity
CSF2,Entity
Silver,Entity
colon lymphoma,Entity
XPC,Entity
DSTN,Entity
polyp of gallbladder,Entity
Abnormality of iron homeostasis,Entity
tetrachloroisophthalonitrile,Entity
PDGFB,Entity
hyperplastic polyposis syndrome,Entity
Abnormal enzyme/coenzyme activity,Entity
intrahepatic bile duct adenosquamous carcinoma,Entity
ANXA1,Entity
Quazepam,Entity
CYGB,Entity
Chronic atrophic gastritis,Entity
Abnormal thrombosis,Entity
neoplasm of hypopharynx,Entity
"cirrhosis, familial, with antigenemia",Entity
Peripheral pulmonary artery stenosis,Entity
Large intestinal polyposis,Entity
Testosterone cypionate,Entity
Abnormality of venous physiology,Entity
Abnormality of the lymphatic system,Entity
ileum cancer,Entity
VTN,Entity
digestive system mixed adenoneuroendocrine carcinoma,Entity
respiratory or mediastinal malformation,Entity
CTSE,Entity
anal canal cancer,Entity
Yohimbine,Entity
Abnormality of the hepatic vasculature,Entity
PTHLH,Entity
MECOM,Entity
PTF1A,Entity
ZFP36L2,Entity
KMT2A,Entity
Osteopenia,Entity
Picornaviridae infectious disease,Entity
Interferon alfa-2b,Entity
Short chin,Entity
X-linked inheritance,Entity
Irregular menstruation,Entity
LRRC59,Entity
Amphotericin B,Entity
LAP3,Entity
Hypertonia,Entity
ERBB4,Entity
BRD4,Entity
Hydrocortisone,Entity
ALDH8A1,Entity
colorectal carcinoma,Entity
perfluorooctane sulfonic acid,Entity
H2BC14,Entity
Abnormal nervous system physiology,Entity
tonsillar fossa cancer,Entity
TAGLN,Entity
CCNB3,Entity
MIR629,Entity
Clofarabine,Entity
Glossitis,Entity
Edetic acid,Entity
esophageal ulcer,Entity
TRAF3IP3,Entity
MIER2,Entity
ABCG1,Entity
Decreased proportion of memory B cells,Entity
hepatic flexure cancer,Entity
LGR6,Entity
Dantrolene,Entity
Formoterol,Entity
ROS1,Entity
Immunologic hypersensitivity,Entity
Prazepam,Entity
NRAS,Entity
BTG2,Entity
"Water Pollutants, Chemical",Entity
CCNF,Entity
Hernia,Entity
Sotagliflozin,Entity
LILRB5,Entity
Propantheline,Entity
JADE2,Entity
RHOJ,Entity
Reduced factor VII activity,Entity
ALOX5,Entity
buccal mucosa neoplasm,Entity
EPCAM,Entity
Clobetasol propionate,Entity
ACLY,Entity
villous adenoma of colon,Entity
Oxyphencyclimine,Entity
intestine carcinoma in situ,Entity
CCL14,Entity
RASGRF2,Entity
Hemin,Entity
GP2,Entity
ADAM19,Entity
Abnormal peristalsis,Entity
Developmental glaucoma,Entity
Meticillin,Entity
ADRB1,Entity
Status epilepticus,Entity
ZMYM4,Entity
malakoplakia,Entity
AREDYLD syndrome,Entity
RAD54L,Entity
Crofelemer,Entity
IL23R,Entity
pigmentation disorder with eye involvement,Entity
Gefitinib,Entity
autoimmune disease of endocrine system,Entity
gastroenteric neuroendocrine neoplasm,Entity
Etoposide,Entity
sigmoid neoplasm,Entity
CCK,Entity
Cefotaxime,Entity
ABT1,Entity
extrahepatic bile duct neoplasm,Entity
perinatal intestinal perforation,Entity
CNR2,Entity
CLEC1B,Entity
Succinic acid,Entity
Nickel,Entity
RNF6,Entity
EPC2,Entity
GLA,Entity
FGF2,Entity
NME7,Entity
small intestine adenocarcinoma,Entity
Adomiparin,Entity
Desflurane,Entity
Armodafinil,Entity
NBAS,Entity
genetic vascular tumor,Entity
MIR423,Entity
Pancreatic pseudocyst,Entity
PDGFRL,Entity
Insulin glulisine,Entity
mucoepidermoid esophageal carcinoma,Entity
verrucous carcinoma of oral cavity,Entity
MT1A,Entity
small cell carcinoma,Entity
MARK4,Entity
PPIA,Entity
MIR7977,Entity
ISG15,Entity
liver rhabdomyosarcoma,Entity
OLFML2A,Entity
coccidiosis,Entity
GADD45A,Entity
BBC3,Entity
infectious colitis,Entity
APEX1,Entity
Vinorelbine,Entity
CDC45,Entity
UGT3A2,Entity
TLR5,Entity
Cefprozil,Entity
PPARA,Entity
Cyclopentolate,Entity
Abnormal pyramidal sign,Entity
VEGFA,Entity
GAL,Entity
MASP2,Entity
Hemeralopia,Entity
AUTS2,Entity
Increased erythrocyte protoporphyrin concentration,Entity
Cholecalciferol,Entity
APOB,Entity
Growth delay,Entity
gastric mucosa-associated lymphoid tissue lymphoma,Entity
DTX4,Entity
PCSK1N,Entity
CELSR3,Entity
TRRAP,Entity
Rectal fistula,Entity
Phylloquinone,Entity
Abnormality of renal excretion,Entity
CYB5D2,Entity
Selenium,Entity
carcinoma,Entity
jaw cancer,Entity
Escitalopram,Entity
endocrine pancreas disease,Entity
upper lip cancer,Entity
FOS,Entity
KCNJ11,Entity
Testosterone,Entity
Chronic active hepatitis,Entity
FHL3,Entity
Abscess,Entity
RRM1,Entity
mixed hepatoblastoma,Entity
PPIC,Entity
SLC23A1,Entity
Agent Orange,Entity
MIR409,Entity
Allopurinol,Entity
mucoepidermoid carcinoma of submandibular gland,Entity
FLT4,Entity
infantile liver failure,Entity
IL2RB,Entity
Functional abnormality of the bladder,Entity
MIR1260B,Entity
Triazolam,Entity
SHANK1,Entity
MIR30A,Entity
FHIT,Entity
ZMIZ1,Entity
SERPINA6,Entity
Hemolytic anemia,Entity
EXO1,Entity
PYCARD,Entity
KIFBP,Entity
KNG1,Entity
Peptic ulcer,Entity
proctosigmoiditis,Entity
NEK4,Entity
IL18,Entity
Benzatropine,Entity
Omeprazole,Entity
Colistin,Entity
ARHGEF10L,Entity
Pramlintide,Entity
Intestinal pseudo-obstruction,Entity
ABI1,Entity
Neutropenia in presence of anti-neutropil antibodies,Entity
MIR140,Entity
Dasabuvir,Entity
rectum lymphoma,Entity
Chlorambucil,Entity
intestinal atresia (disease),Entity
esophageal cancer,Entity
isolated mesenteric vein thrombosis,Entity
Benzyl alcohol,Entity
MCC,Entity
pylorus cancer,Entity
ASF1B,Entity
Ticarcillin,Entity
Estradiol,Entity
PTPN22,Entity
HSPD1,Entity
Oxymetholone,Entity
Gimeracil,Entity
Ibandronate,Entity
UBXN1,Entity
MACROD2,Entity
sublingual gland adenoid cystic carcinoma,Entity
JDP2,Entity
FBXL2,Entity
Daptomycin,Entity
Vanadium,Entity
LIG1,Entity
MNX1,Entity
Abnormal onset of bleeding,Entity
PCOLCE,Entity
Dicoumarol,Entity
benign duodenal neoplasm,Entity
Hirschsprung disease-nail hypoplasia-dysmorphism syndrome,Entity
MIR215,Entity
EPHA10,Entity
Increased T cell count,Entity
CHD8,Entity
APOC3,Entity
Clindamycin,Entity
Sildenafil,Entity
varicose disease,Entity
hepatic infarction,Entity
ACTL9,Entity
NDRG1,Entity
IDH3B,Entity
PARP4,Entity
MIR34A,Entity
CXCL8,Entity
RSPO3,Entity
LIPC,Entity
MIR93,Entity
MVK,Entity
Hydralazine,Entity
Aplasia/Hypoplasia of the cerebellum,Entity
Nonketotic hypoglycemia,Entity
submandibular gland neoplasm,Entity
TLK2,Entity
PLAU,Entity
PDX1,Entity
FYN,Entity
Esmolol,Entity
RASAL2,Entity
DPYD,Entity
IL6R,Entity
IGFALS,Entity
USP2,Entity
hepatobiliary neoplasm,Entity
PIK3CA,Entity
splenic tuberculosis,Entity
ALDH2,Entity
MIR5196,Entity
major salivary gland carcinoma ex pleomorphic adenoma,Entity
Sucralfate,Entity
glucose metabolism disease,Entity
Atypical scarring of skin,Entity
Colon cancer,Entity
Excessive salivation,Entity
Constriction of peripheral visual field,Entity
Ombitasvir,Entity
colon Kaposi sarcoma,Entity
Naratriptan,Entity
JUN,Entity
FAM168A,Entity
DCDC2,Entity
hiatus hernia (disease),Entity
VEGFC,Entity
RIPK1,Entity
Chorioretinal atrophy,Entity
KMT2C,Entity
granular cell tumor,Entity
Intrauterine growth retardation,Entity
Nilotinib,Entity
"neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade",Entity
Exocrine pancreatic insufficiency,Entity
Sagittal craniosynostosis,Entity
Decreased circulating antibody level,Entity
Chlorotrianisene,Entity
Galantamine,Entity
Euphoria,Entity
pancreatoblastoma,Entity
CDKN1B,Entity
CXCL2,Entity
IL1RN,Entity
TRPV1,Entity
mucinous neoplasm,Entity
Sulfanilamide,Entity
MIR194-1,Entity
Abnormal bowel sounds,Entity
Focal active colitis,Entity
intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,Entity
MOK,Entity
PRKCH,Entity
MCM3AP,Entity
functional colonic disease,Entity
docosapentaenoic acid,Entity
SCN3B,Entity
Genu varum,Entity
STRAP,Entity
Oxymetazoline,Entity
Weight loss,Entity
Increased urinary cortisol level,Entity
EIF4G1,Entity
NSD1,Entity
mantle cell lymphoma,Entity
esophageal candidiasis,Entity
Behavioral abnormality,Entity
Evogliptin,Entity
ERLEC1,Entity
TNFRSF14,Entity
LRG1,Entity
Desmoid tumors,Entity
ATP2A3,Entity
Urinary hesitancy,Entity
HJURP,Entity
Abnormal macular morphology,Entity
Type II diabetes mellitus,Entity
SOX4,Entity
colonic atresia (disease),Entity
Multifactorial inheritance,Entity
Vincristine,Entity
Minoxidil,Entity
acquired metabolic disease,Entity
PCNT,Entity
HLA-DRB5,Entity
M6PR,Entity
Disulfiram,Entity
"visceral steatosis, congenital",Entity
Almasilate,Entity
LRP2,Entity
POLG,Entity
endocrine system disease,Entity
MIR1303,Entity
Abnormality of brain morphology,Entity
COX2,Entity
polyp of large intestine,Entity
DCD,Entity
IGFBP3,Entity
GRFoma,Entity
Abnormality of dental enamel,Entity
disorder of folate metabolism and transport,Entity
esophagus liposarcoma,Entity
CLDN1,Entity
Abnormal skull morphology,Entity
Displacement of the urethral meatus,Entity
Flumazenil,Entity
"2,4,5,2',4',5'-hexachlorobiphenyl",Entity
cholangiocarcinoma,Entity
hypopharyngeal carcinoma,Entity
NTRK1,Entity
EPHX3,Entity
MMP12,Entity
pancreatic acinar cell carcinoma,Entity
MIR6803,Entity
Proguanil,Entity
BCORL1,Entity
Sodium sulfate,Entity
Olfactory lobe agenesis,Entity
HOXA13,Entity
Carbenicillin,Entity
Rufinamide,Entity
MIR130A,Entity
Natalizumab,Entity
variegate porphyria,Entity
respiratory malformation,Entity
IL19,Entity
IL32,Entity
Elevated circulating parathyroid hormone level,Entity
Salbutamol,Entity
Pleuritis,Entity
Nail dystrophy,Entity
DHRS2,Entity
H2AC16,Entity
Sulfathiazole,Entity
MAPK3,Entity
ABCA1,Entity
Scarring,Entity
APCS,Entity
benign neoplasm of exocrine pancreas,Entity
MIR98,Entity
Portal vein thrombosis,Entity
Etacrynic acid,Entity
DDX58,Entity
Recurrent abscess formation,Entity
CFP,Entity
genetic peripheral neuropathy,Entity
Capreomycin,Entity
Timolol,Entity
juvenile polyposis syndrome,Entity
PTPRU,Entity
primary peritoneal tumor,Entity
Telotristat ethyl,Entity
LARGE1,Entity
candidiasis,Entity
ENO1,Entity
LZTS2,Entity
HOXD1,Entity
EPHA7,Entity
PTPRN2,Entity
Tremor,Entity
Tyramine,Entity
MIR222,Entity
small intestine carcinoma,Entity
Elevated alkaline phosphatase,Entity
MIR152,Entity
Cystic liver disease,Entity
NDUFV1,Entity
GCG,Entity
AFAP1-AS1,Entity
EBF2,Entity
colorectal signet ring cell carcinoma,Entity
LGALS1,Entity
ERBB2,Entity
Orphenadrine,Entity
ABCB5,Entity
Abnormality of the genital system,Entity
ADRB2,Entity
FAM234A,Entity
Insulin receptor antibody positivity,Entity
COMT,Entity
Gastroesophageal reflux,Entity
occlusion of gallbladder,Entity
Slurred speech,Entity
SPC25,Entity
RHEB,Entity
Abnormality of connective tissue,Entity
gallbladder adenosquamous carcinoma,Entity
Desogestrel,Entity
JUND,Entity
ITGA1,Entity
Abnormality of the abdominal wall,Entity
FGF16,Entity
Vildagliptin,Entity
Splenomegaly,Entity
Pimozide,Entity
EHD3,Entity
Axenfeld anomaly,Entity
"duodenal neuroendocrine tumor, well differentiated, low or intermediate grade",Entity
Neoplasm of the colon,Entity
SLC22A1,Entity
pancreatic triacylglycerol lipase deficiency,Entity
Recurrent ear infections,Entity
ADAMTS17,Entity
Phenmetrazine,Entity
DBH,Entity
congenital intestinal disease due to an enzymatic defect,Entity
hemorrhagic disorder due to a platelet anomaly,Entity
liver failure,Entity
MIR378I,Entity
Abnormal C-peptide level,Entity
TP53BP1,Entity
OLFML2B,Entity
PSMD6,Entity
CYP1A2,Entity
MED13,Entity
Thick vermilion border,Entity
heart disease,Entity
Increased intracranial pressure,Entity
PPP1R1A,Entity
HSPA1A,Entity
TSLP,Entity
MIR378A,Entity
FBP1,Entity
Glucose intolerance,Entity
Intestinal hypoplasia,Entity
appendix carcinoma,Entity
gallbladder angiosarcoma,Entity
Abnormal fingernail morphology,Entity
Respiratory distress,Entity
Breathing dysregulation,Entity
Nafarelin,Entity
genetic multiple congenital anomalies/dysmorphic syndrome,Entity
Muscle spasm,Entity
MAGI2,Entity
"neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor",Entity
MIR365A,Entity
infectious disease,Entity
Droperidol,Entity
SI,Entity
herpetic gastritis,Entity
Silodosin,Entity
CXCL14,Entity
CTSL,Entity
leiomyoma,Entity
Ranolazine,Entity
Flurbiprofen,Entity
imazethapyr,Entity
EGLN3,Entity
Methylphenidate,Entity
Autoimmune thrombocytopenia,Entity
small intestine neoplasm,Entity
Abnormality of the peritoneum,Entity
disorder of appendix,Entity
Skin vesicle,Entity
pylorospasm,Entity
fungal infectious disease,Entity
FUT2,Entity
Hearing abnormality,Entity
HOXC9,Entity
Neoplasm of the rectum,Entity
MAP2K3,Entity
Elevated C-reactive protein level,Entity
HES1,Entity
Dactinomycin,Entity
Diflunisal,Entity
CKM,Entity
RNF182,Entity
ZSCAN22,Entity
lipomatosis,Entity
GPX4,Entity
Lamivudine,Entity
malignant pancreatic neoplasm,Entity
PPP2R1B,Entity
LYVE1,Entity
ARID1A,Entity
CNDP1,Entity
RFC1,Entity
L-cell glucagon-like peptide-producing neuroendocrine tumor,Entity
SLC1A2,Entity
extraosseous osteosarcoma,Entity
gallbladder leiomyoma,Entity
glycogen storage disease due to liver phosphorylase kinase deficiency,Entity
PLK1,Entity
Trimethadione,Entity
TFAP2C,Entity
bacterial gastritis,Entity
salivary duct carcinoma,Entity
megaesophagus,Entity
Shock,Entity
PDRG1,Entity
Estradiol valerate,Entity
Sporadic,Entity
OIT3,Entity
SFRP5,Entity
CCND1,Entity
Abnormality of the kidney,Entity
SLC9A3,Entity
Indapamide,Entity
CCR6,Entity
protozoal dysentery,Entity
PCSK5,Entity
CD86,Entity
thrombotic disease,Entity
ARID1B,Entity
Epstein-Barr virus infection,Entity
PAIP2,Entity
KCNQ1,Entity
intestinal perforation,Entity
RECK,Entity
Micrognathia,Entity
Clidinium,Entity
Gemcitabine,Entity
acute intestinal ischemia,Entity
UBA5,Entity
UROC1,Entity
Diltiazem,Entity
splenic disease,Entity
KMT2B,Entity
SLC2A2,Entity
MAP3K7,Entity
Guanethidine,Entity
OMA1,Entity
Wide nasal bridge,Entity
Acitretin,Entity
Impaired distal proprioception,Entity
extrahepatic bile duct adenocarcinoma,Entity
MIF,Entity
Orlistat,Entity
MDH1,Entity
Octreotide,Entity
Quinapril,Entity
adenoid cystic carcinoma,Entity
HLA-B,Entity
Decitabine,Entity
H19,Entity
Protriptyline,Entity
Antiphospholipid antibody positivity,Entity
Bardet-Biedl syndrome,Entity
hereditary chronic pancreatitis,Entity
Hepatitis,Entity
PYGL,Entity
Generalized hyperpigmentation,Entity
poisoning,Entity
Foot polydactyly,Entity
gallbladder sarcoma,Entity
SREBF1,Entity
Abnormal cellular phenotype,Entity
HMBS,Entity
Duodenal adenocarcinoma,Entity
Abnormal circulating lipid concentration,Entity
CAMKK2,Entity
SLC19A1,Entity
gastrin secretion abnormality,Entity
HTR5A,Entity
Amiodarone,Entity
Keratoconjunctivitis sicca,Entity
exercise-induced hyperinsulinism,Entity
Selegiline,Entity
maxillary sinus adenoid cystic carcinoma,Entity
ICAM1,Entity
rectum adenocarcinoma,Entity
LEPR,Entity
MIR197,Entity
Pachygyria,Entity
Chlorodiphenyl (54% Chlorine),Entity
Bumetanide,Entity
Pentazocine,Entity
Biotin,Entity
RUNX1T1,Entity
Nebivolol,Entity
autoimmune hepatitis,Entity
Alendronic acid,Entity
primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,Entity
Hamartomatous stomach polyps,Entity
Risedronic acid,Entity
DES,Entity
LTA,Entity
solitary necrotic nodule of the liver,Entity
esophageal disease,Entity
GPBAR1,Entity
Hemiplegia/hemiparesis,Entity
abetalipoproteinemia,Entity
syndromic congenital sodium diarrhea,Entity
Pyrimethamine,Entity
Metaxalone,Entity
STAT1,Entity
Meconium ileus,Entity
IgG4-related sclerosing cholangitis,Entity
CA3,Entity
colorectal lipoma,Entity
NR1H2,Entity
BAX,Entity
Sulfasalazine,Entity
Abnormality of femur morphology,Entity
leukoplakia,Entity
NTNG1,Entity
Prednisone,Entity
ASCL2,Entity
Acholic stools,Entity
CTNNB1,Entity
MTHFR,Entity
SFN,Entity
CENPU,Entity
Voriconazole,Entity
DNAJC6,Entity
MIR155,Entity
Pancytopenia,Entity
Theophylline,Entity
XAGE1A,Entity
pancreatic neuroendocrine neoplasm,Entity
NUS1,Entity
gastric gastrin-producing neuroendocrine tumor,Entity
Nandrolone,Entity
TTC37,Entity
Hemolytic-uremic syndrome,Entity
Vancomycin,Entity
meconium ileus,Entity
CYREN,Entity
telomere syndrome,Entity
BECN1,Entity
DIRAS3,Entity
Epstein-Barr virus-associated carcinoma,Entity
Lidocaine,Entity
RBM10,Entity
H1-4,Entity
NOP16,Entity
esophagus sarcoma,Entity
syndrome with a central nervous system malformation as major feature,Entity
mucinous adenocarcinoma,Entity
AKT1,Entity
porphyria due to ALA dehydratase deficiency,Entity
PDGFRA,Entity
MIR4507,Entity
Pindolol,Entity
gastric squamous cell carcinoma,Entity
Secnidazole,Entity
PKHD1,Entity
Oral ulcer,Entity
ADAMTS1,Entity
MIR192,Entity
Calcium chloride,Entity
KEAP1,Entity
PYGB,Entity
Dark yellow urine,Entity
ABCC6,Entity
Buprenorphine,Entity
RNPEPL1,Entity
Pointed chin,Entity
Atretic gallbladder,Entity
MS4A5,Entity
gastric mantle cell lymphoma,Entity
Zaleplon,Entity
TPSAB1,Entity
autoimmune disease with skin involvement,Entity
Methylmercury Compounds,Entity
colon carcinoma,Entity
NME1,Entity
Trandolapril,Entity
Small intestinal polyp,Entity
NOS2,Entity
congenital isolated hyperinsulinism,Entity
COMMD1,Entity
Hand tremor,Entity
Floxuridine,Entity
PUS1,Entity
polyp of rectum,Entity
short fifth metacarpals-insulin resistance syndrome,Entity
MUTYH,Entity
P4HTM,Entity
HRH2,Entity
Bimatoprost,Entity
Functional motor deficit,Entity
colonic neoplasm,Entity
STK36,Entity
SERPINB2,Entity
ID4,Entity
P2RY14,Entity
autosomal dominant disease,Entity
inherited digestive tract tumor,Entity
gastric liposarcoma,Entity
Increased size of the mandible,Entity
gastric adenoma,Entity
Aminoaciduria,Entity
Abnormal chorioretinal morphology,Entity
PTPRC,Entity
KIF3A,Entity
gastroenteritis,Entity
isolated agenesis of gallbladder,Entity
FOXO3,Entity
Heptachlor,Entity
neoplasm of major salivary gland,Entity
liver carcinoma in situ,Entity
TMEM117,Entity
RDH13,Entity
Functional intestinal obstruction,Entity
GSTA1,Entity
Ethoheptazine,Entity
"nephropathy, progressive tubulointerstitial, with cholestatic liver disease",Entity
HHAT,Entity
cecal neoplasm,Entity
"Heparin, bovine",Entity
Night sweats,Entity
Hydroxychloroquine,Entity
Prolonged neonatal jaundice,Entity
HIPK2,Entity
CDKN2C,Entity
pancreatic somatostatinoma,Entity
Hypernatremia,Entity
Proximal muscle weakness in upper limbs,Entity
NPPA,Entity
OLFM2,Entity
WRN,Entity
MIRLET7D,Entity
Bupropion,Entity
pancreatic lipomatosis duodenal stenosis,Entity
colon medullary carcinoma,Entity
MMP10,Entity
HPX,Entity
HLA-DPB1,Entity
gall bladder carcinoma in situ,Entity
MIR151A,Entity
Mestranol,Entity
upper digestive tract disease,Entity
signet ring cell carcinoma,Entity
FAM155A,Entity
small intestinal tubulovillous adenoma,Entity
Delayed gross motor development,Entity
IFNB1,Entity
MIR1290,Entity
C5,Entity
PRKACB,Entity
ND4L,Entity
RPS21,Entity
Abnormal muscle physiology,Entity
BCS1L,Entity
Sitagliptin,Entity
Barrett adenocarcinoma,Entity
Voglibose,Entity
Hepatic necrosis,Entity
Coloboma,Entity
TNFRSF1A,Entity
FEN1,Entity
GNA12,Entity
carcinoma of duodenum,Entity
NUF2,Entity
Chlorbenzoxamine,Entity
VRTN,Entity
Pyridoxine,Entity
Noscapine,Entity
LY96,Entity
TXNDC17,Entity
Duplicated collecting system,Entity
PMS1,Entity
Chronic fatigue,Entity
Sulfamethoxazole,Entity
Tolbutamide,Entity
parasitic infection,Entity
fibroepithelial polyp,Entity
Abnormality of the autonomic nervous system,Entity
CYP39A1,Entity
PREX2,Entity
hereditary coproporphyria,Entity
GNAZ,Entity
LAMC2,Entity
colon dysplasia,Entity
colorectal neoplasm,Entity
congenital diarrhea,Entity
intestinal helminthiasis,Entity
Domperidone,Entity
Colonic diverticula,Entity
ARRB1,Entity
Efavirenz,Entity
GCK,Entity
MIR144,Entity
AGTR1,Entity
MIRLET7C,Entity
LAMA2,Entity
Premature graying of hair,Entity
mixed neoplasm,Entity
pancreatic ductal adenocarcinoma,Entity
NUDCD3,Entity
Styrene,Entity
GKN1,Entity
CDKN2A,Entity
GYS2,Entity
congenital dyserythropoietic anemia,Entity
chemical colitis,Entity
SMARCA2,Entity
AHR,Entity
Abnormal penis morphology,Entity
MARK1,Entity
Vitamin E,Entity
benign epithelial tumor of salivary glands,Entity
Magnesium carbonate,Entity
Camostat,Entity
AASS,Entity
PRDX5,Entity
EN1,Entity
neoplasm of retromolar area,Entity
extrahepatic bile duct mucoepidermoid carcinoma,Entity
Chromium,Entity
protozoa infectious disease,Entity
extrahepatic bile duct papillary adenoma,Entity
CPT1A,Entity
TOP2A,Entity
TNF,Entity
RABL3,Entity
Bowel urgency,Entity
SULT1A1,Entity
aortic disease,Entity
PAX6,Entity
syndromic visceral malformation,Entity
TET2,Entity
Clonazepam,Entity
CAPN6,Entity
blind loop syndrome,Entity
Generalized hirsutism,Entity
LPL,Entity
polycystic liver disease,Entity
"hyperinsulinemic hypoglycemia, familial",Entity
NEK2,Entity
MIR136,Entity
Trelagliptin,Entity
Skin erosion,Entity
CYLD,Entity
ARAF,Entity
Restrictive ventilatory defect,Entity
SPRED1,Entity
carcinoma of soft palate,Entity
hereditary North American Indian childhood cirrhosis,Entity
Multicystic kidney dysplasia,Entity
Cesium,Entity
TSKS,Entity
NR1H3,Entity
SLC38A9,Entity
Ilaprazole,Entity
Cyclobenzaprine,Entity
undifferentiated carcinoma of nasopharynx,Entity
CCAT1,Entity
BTD,Entity
TCN2,Entity
pancreatic delta cell neuroendocrine tumor,Entity
MYO9B,Entity
High intestinal obstruction,Entity
SIGLEC7,Entity
NQO1,Entity
IL17REL,Entity
GATA6,Entity
UQCRC2,Entity
head and neck neoplasm,Entity
COL14A1,Entity
gastrointestinal lymphoma,Entity
MIR1307,Entity
Ramipril,Entity
Nalbuphine,Entity
Hepatic failure,Entity
USP5,Entity
DENND1B,Entity
ileocolitis,Entity
multiple congenital anomalies/dysmorphic syndrome-intellectual disability,Entity
MAP2K7,Entity
Hydroxyprogesterone caproate,Entity
glycogen storage disease,Entity
functioning endocrine neoplasm,Entity
SLC5A1,Entity
Roflumilast,Entity
GOT1,Entity
ADORA1,Entity
MIR29C,Entity
Lactitol,Entity
BPIFB2,Entity
familial colorectal cancer,Entity
genetic central nervous system and retinal vascular disease,Entity
lipodystrophy,Entity
NK-cell enteropathy,Entity
MIR130B,Entity
Hypertonic dehydration,Entity
benign neoplasm of stomach,Entity
Folate-responsive megaloblastic anemia,Entity
Glomerulopathy,Entity
ATRX,Entity
STAM,Entity
CDH5,Entity
Ischemic stroke,Entity
CDKN2D,Entity
TSPO,Entity
orofacial clefting syndrome,Entity
NEUROG3,Entity
Gliquidone,Entity
CD36,Entity
Glisoxepide,Entity
SERBP1,Entity
perfluorononanoic acid,Entity
Amrinone,Entity
type 2 diabetes mellitus,Entity
SPP1,Entity
sublingual gland carcinoma,Entity
Abnormal dermatoglyphics,Entity
RBP3,Entity
spleen angiosarcoma,Entity
quizalofop-ethyl,Entity
Ofloxacin,Entity
Hydronephrosis,Entity
Generalized non-motor (absence) seizure,Entity
Impaired vibratory sensation,Entity
Elevated serum acid phosphatase,Entity
Lynch syndrome,Entity
MAP2K1,Entity
Recurrent urinary tract infections,Entity
DEND syndrome,Entity
colon small cell neuroendocrine carcinoma,Entity
SLC13A5,Entity
Pazopanib,Entity
Anidulafungin,Entity
Abnormal gastrointestinal motility,Entity
Zinc gluconate,Entity
SLC5A5,Entity
CABYR,Entity
Carbenoxolone,Entity
ABCB1,Entity
Particulate Matter,Entity
IGBP1,Entity
Respiratory failure,Entity
NEIL3,Entity
FAT1,Entity
Thoracic aortic aneurysm,Entity
Deep venous thrombosis,Entity
IGF1R,Entity
BPNT1,Entity
Bulbous nose,Entity
Moyamoya disease with early-onset achalasia,Entity
CHRM3,Entity
BRCC3,Entity
TBXA2R,Entity
ACACB,Entity
AKR1B10,Entity
Oxyphenisatin acetate,Entity
PER1,Entity
malabsorption syndrome,Entity
Magnesium hydroxide,Entity
ZSCAN5A,Entity
parotid gland cancer,Entity
KSR2,Entity
ACTR3,Entity
oral cavity neoplasm,Entity
PDLIM5,Entity
Metformin,Entity
TMED7,Entity
PRKG2,Entity
LCT-AS1,Entity
ITGA7,Entity
UPB1,Entity
"colorectal cancer, susceptibility to",Entity
Clubbing of fingers,Entity
BMPR1A,Entity
appendix villous adenoma,Entity
Abnormality of the nervous system,Entity
Confusion,Entity
balantidiasis,Entity
GAGE1,Entity
CYP2C9,Entity
HIF1A,Entity
MIR224,Entity
PKM,Entity
Decreased LDL cholesterol concentration,Entity
PC,Entity
EPHB1,Entity
Prilocaine,Entity
Aplasia/Hypoplasia of the eyebrow,Entity
"gallbladder neuroendocrine tumor, grade 1/2",Entity
Ferrous sulfate anhydrous,Entity
CD69,Entity
VNN1,Entity
GSTM5,Entity
Mepivacaine,Entity
Abnormal abdomen morphology,Entity
CCT7,Entity
Oteracil,Entity
Abnormality of the skeletal system,Entity
DCN,Entity
Gastric diverticulum,Entity
PPARG,Entity
Aminosalicylic acid,Entity
neuronal intestinal pseudoobstruction,Entity
Flecainide,Entity
BRSK1,Entity
DDB1,Entity
PKN1,Entity
PLA2G4A,Entity
TRPM7,Entity
cribriform carcinoma,Entity
PKP1,Entity
KLF2,Entity
laryngotracheoesophageal cleft,Entity
Norfloxacin,Entity
Ophthalmoplegia,Entity
CPOX,Entity
Perindopril,Entity
NT5C,Entity
Episodic vomiting,Entity
Polyethylene glycol 3500,Entity
Metabolic acidosis,Entity
gallbladder adenoma,Entity
ABCG2,Entity
Neonatal insulin-dependent diabetes mellitus,Entity
immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Entity
Broad forehead,Entity
SETD2,Entity
intestinal type adenocarcinoma,Entity
WSCD1,Entity
Povidone K30,Entity
GALE,Entity
Berardinelli-Seip congenital lipodystrophy,Entity
malaria,Entity
Citric acid,Entity
Ozanimod,Entity
benign neoplasm of rectum,Entity
Diastomatomyelia,Entity
Hypocalcemia,Entity
PNPT1,Entity
type 1 interferonopathy,Entity
small intestinal tubular adenoma,Entity
Skeletal muscle atrophy,Entity
ALAS2,Entity
Psoriasiform dermatitis,Entity
gastric cardia adenocarcinoma,Entity
angiodysplasia,Entity
familial porphyria cutanea tarda,Entity
Phenylacetic acid,Entity
Abnormal brain FDG positron emission tomography,Entity
salivary gland basal cell adenocarcinoma,Entity
Acyclovir,Entity
isolated tracheo-esophageal fistula,Entity
Icosapent,Entity
MIR376C,Entity
COLEC10,Entity
Asenapine,Entity
TRIM28,Entity
macrotrabecular hepatoblastoma,Entity
pancreatic non-functioning delta cell tumor,Entity
SLC25A47,Entity
SLC22A4,Entity
protein-losing enteropathy (disease),Entity
SYCP1,Entity
nose and cavum anomaly,Entity
rectum malignant melanoma,Entity
PAM,Entity
ENPP1,Entity
Horseshoe kidney,Entity
FBXL18,Entity
MIR122,Entity
squamous cell bile duct carcinoma,Entity
appendiceal neoplasm,Entity
PNRC1,Entity
GLIS2,Entity
Paranoia,Entity
hereditary gastric cancer,Entity
Mendelian disease,Entity
non-neoplastic bile duct disorder,Entity
"Low-set, posteriorly rotated ears",Entity
adenoma of pancreas,Entity
TUBB4B,Entity
Imatinib,Entity
MIR421,Entity
EXOSC2,Entity
Small intestinal dysmotility,Entity
MUC2,Entity
FN1,Entity
NOP56,Entity
MALT lymphoma,Entity
gastrointestinal anthrax,Entity
Abnormal biliary tract morphology,Entity
NCOA3,Entity
ABCB10,Entity
ECE1,Entity
carcinoma of pharynx,Entity
megacolon,Entity
ketamine-induced biliary dilatation,Entity
AGTR2,Entity
DMD,Entity
Copper,Entity
CCDC62,Entity
Cholangiocarcinoma,Entity
PPM1E,Entity
gastric dilatation,Entity
Tolazamide,Entity
E2F8,Entity
KMT2D,Entity
DNMT1,Entity
Chloroform,Entity
KRTAP10-8,Entity
CFTR,Entity
COL1A2,Entity
Failure to thrive in infancy,Entity
PHOX2B,Entity
MIRLET7B,Entity
CCL7,Entity
Abnormality of small intestinal villus morphology,Entity
odontogenic neoplasm,Entity
NNMT,Entity
verrucous carcinoma,Entity
Thickened ears,Entity
carcinoma in situ of fundus of stomach,Entity
Phenobarbital,Entity
Exercise intolerance,Entity
SOAT2,Entity
DDIT3,Entity
ANAPC4,Entity
Propafenone,Entity
Avapritinib,Entity
SLC19A2,Entity
benign neoplasm of small intestine,Entity
CD74,Entity
benign neoplasm of cecum,Entity
epithelial neoplasm of rectum,Entity
BDKRB2,Entity
Abnormal renal physiology,Entity
MELK,Entity
Telecanthus,Entity
primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome,Entity
Emotional lability,Entity
Troxipide,Entity
cecum lymphoma,Entity
pancreatic large cell neuroendocrine carcinoma,Entity
RAB5C,Entity
GNB5,Entity
PKNOX1,Entity
RRM2,Entity
S100A11,Entity
solitary fibrous tumor,Entity
STK26,Entity
gastrin-producing neuroendocrine tumor,Entity
CD93,Entity
superior mesenteric artery syndrome,Entity
Ecabet,Entity
FGF7,Entity
Levofloxacin,Entity
Short nose,Entity
EGF,Entity
TIMP3,Entity
Secobarbital,Entity
Mifepristone,Entity
cirrhosis of liver,Entity
hypertension,Entity
ISYNA1,Entity
signet ring cell intrahepatic cholangiocarcinoma,Entity
Rasagiline,Entity
Loss of consciousness,Entity
NT5E,Entity
SERTAD1,Entity
PMM2,Entity
Sumatriptan,Entity
PEG3,Entity
PSMG1,Entity
RAP1GAP,Entity
GALNS,Entity
CD109,Entity
TGM2,Entity
PGK1,Entity
stomach diverticulosis,Entity
GUCY1A2,Entity
neuroendocrine neoplasm,Entity
FOXF1,Entity
INHBA,Entity
Procyclidine,Entity
Racementhol,Entity
Gait disturbance,Entity
SLC40A1,Entity
Spinal cord lesion,Entity
Amcinonide,Entity
MIR125B2,Entity
DGUOK,Entity
afferent loop syndrome,Entity
Temazepam,Entity
MIR5588,Entity
autosomal ichthyosis syndrome with prominent hair abnormalities,Entity
colorectal tubulovillous adenoma,Entity
PROM1,Entity
CORO2B,Entity
Everolimus,Entity
Villous atrophy,Entity
Tachycardia,Entity
Hyperuricemia,Entity
Levocarnitine,Entity
WNT3A,Entity
IGFBP7,Entity
genetic intestinal polyposis,Entity
Diclofenac,Entity
Abnormality of pain sensation,Entity
Rabson-Mendenhall syndrome,Entity
Sunitinib,Entity
epiglottis neoplasm,Entity
MIR151B,Entity
Norelgestromin,Entity
TWIST1,Entity
Gemifloxacin,Entity
PPP2R1A,Entity
PRKD1,Entity
Alfentanil,Entity
MPV17,Entity
IMMT,Entity
Cefotetan,Entity
Calcium gluconate,Entity
adenocarcinoma of gallbladder and extrahepatic biliary tract,Entity
ST3GAL4,Entity
Missing ribs,Entity
Recurrent enteroviral infections,Entity
MCF2L2,Entity
EEF1A2,Entity
PHLDA1,Entity
non-syndromic esophageal malformation,Entity
diffuse cavernous hemangioma of the rectum,Entity
MIR3615,Entity
gallbladder disease,Entity
CD44,Entity
Cloxacillin,Entity
Xerostomia,Entity
MTRR,Entity
maxillary sinus adenocarcinoma,Entity
disease of peritoneum,Entity
Tipranavir,Entity
Phenazopyridine,Entity
MAOA,Entity
esophageal basaloid carcinoma,Entity
C1QTNF6,Entity
CD80,Entity
Lepirudin,Entity
Argatroban,Entity
Temsirolimus,Entity
Chlorides,Entity
Abnormality of skin morphology,Entity
ATP5PD,Entity
cavernous hemangioma of colon,Entity
IL18RAP,Entity
TMEM67,Entity
Zafirlukast,Entity
myopathy and diabetes mellitus,Entity
ABCD3,Entity
enteritis,Entity
appendix goblet cell carcinoid,Entity
Aluminium phosphate,Entity
microvillus inclusion disease,Entity
Dysmetria,Entity
Ammonium chloride,Entity
Broad phalanx of the toes,Entity
drug-induced hepatitis,Entity
obstructive jaundice,Entity
Wolcott-Rallison syndrome,Entity
Generalized edema,Entity
TTN,Entity
syndromic genetic deafness,Entity
Boron,Entity
polycystic echinococcosis,Entity
Sulfisoxazole,Entity
MIR204,Entity
Adenocarcinoma of the small intestine,Entity
EZH2,Entity
Abnormality of the ureter,Entity
Respiratory insufficiency,Entity
embryonal extrahepatic bile duct rhabdomyosarcoma,Entity
CLTRN,Entity
CXCR2,Entity
PTPA,Entity
Cephalexin,Entity
Hypodontia,Entity
Pseudoephedrine,Entity
Dalteparin,Entity
LINC00221,Entity
ERI2,Entity
Auranofin,Entity
DLGAP5,Entity
INS-IGF2,Entity
Central hypothyroidism,Entity
Cabazitaxel,Entity
MIR17HG,Entity
nasopharyngeal carcinoma,Entity
Mitral regurgitation,Entity
Testosterone propionate,Entity
hepatitis C virus infection,Entity
Methotrexate,Entity
neoplasm of oropharynx,Entity
Liraglutide,Entity
ampulla of vater adenosquamous carcinoma,Entity
KRT13,Entity
small intestinal intraepithelial neoplasia,Entity
Alopecia universalis,Entity
Abdominal symptom,Entity
Nephrocalcinosis,Entity
AIFM1,Entity
Cutis marmorata,Entity
hepatoblastoma,Entity
Small hand,Entity
MIR195,Entity
eosinophilic gastroenteritis,Entity
NXN,Entity
Lactic acidosis,Entity
Prominent forehead,Entity
paranasal sinus carcinoma,Entity
ZBTB8B,Entity
Lobeglitazone,Entity
IgG4-related disease,Entity
immunodeficiency syndrome with autoimmunity,Entity
Apomorphine,Entity
colorectal leiomyoma,Entity
Thiabendazole,Entity
MIR150,Entity
gastric body carcinoma,Entity
Telbivudine,Entity
active peptic ulcer disease,Entity
Ritodrine,Entity
Sebaceous gland carcinoma,Entity
SHBG,Entity
Methazolamide,Entity
Abnormal respiratory system physiology,Entity
thoraco-abdominal enteric duplication,Entity
Elevated alpha-fetoprotein,Entity
colorectal serrated adenocarcinoma,Entity
Vedolizumab,Entity
HEBP2,Entity
CTNND2,Entity
EEF2K,Entity
Abnormal duodenum morphology,Entity
Venlafaxine,Entity
MIR10B,Entity
Bromfenac,Entity
Verapamil,Entity
achlorhydria,Entity
MIR146A,Entity
TNFRSF9,Entity
serositis,Entity
SNHG11,Entity
major salivary gland cancer,Entity
ACO2,Entity
Prucalopride,Entity
SLC10A7,Entity
FANCI,Entity
X-linked disease,Entity
esophageal duplication cyst,Entity
tuberculous peritonitis,Entity
Meperidine,Entity
Modafinil,Entity
salivary gland mucoepidermoid carcinoma,Entity
TBK1,Entity
Oxaprozin,Entity
ACADM,Entity
NAMPT,Entity
ZNF804A,Entity
anus leiomyosarcoma,Entity
GAST,Entity
COPS5,Entity
FLVCR1,Entity
submucosal invasive colon adenocarcinoma,Entity
Hemivertebrae,Entity
Losartan,Entity
FOXA2,Entity
SORT1,Entity
Oxandrolone,Entity
RAD54B,Entity
Abdominal distention,Entity
NPBWR2,Entity
Quinupristin,Entity
Pheniramine,Entity
autoimmune polyendocrine,Entity
digestive system neoplasm,Entity
POLE,Entity
RIC3,Entity
secretory diarrhea,Entity
gastrointestinal allergy,Entity
Abnormality of vision,Entity
Intracranial hemorrhage,Entity
CHRM2,Entity
PRPF19,Entity
GALNT12,Entity
Clomipramine,Entity
ALDH1L1,Entity
DTX1,Entity
PMS2,Entity
Estradiol cypionate,Entity
Ketorolac,Entity
LBP,Entity
EPHX1,Entity
GSTM3,Entity
Eltrombopag,Entity
ENG,Entity
NLRC3,Entity
Adenoma sebaceum,Entity
Nicotinamide,Entity
"polyposis syndrome, hereditary mixed",Entity
Elevated urine 4-hydroxyphenylacetic acid level,Entity
X-linked erythropoietic protoporphyria,Entity
Dasatinib,Entity
SGF29,Entity
Satoyoshi syndrome,Entity
Abnormality of the gastric mucosa,Entity
Pirbuterol,Entity
anal carcinoma,Entity
MGMT,Entity
PAX4,Entity
Paralysis,Entity
Homatropine methylbromide,Entity
MKRN3,Entity
Flurazepam,Entity
Anagliptin,Entity
Bilateral ptosis,Entity
Capecitabine,Entity
hepatic vascular disease,Entity
Respiratory tract infection,Entity
INS,Entity
MIR574,Entity
COL6A1,Entity
COX17,Entity
Glutethimide,Entity
CLEC4M,Entity
Prednisolone acetate,Entity
hepatic vein thrombosis,Entity
MIR214,Entity
ABCA3,Entity
Delayed speech and language development,Entity
HOXA2,Entity
CDX2,Entity
Peginterferon alfa-2b,Entity
NCOR1,Entity
Pruritus,Entity
CYP4A11,Entity
Hydrocephalus,Entity
MUC1,Entity
chronic intestinal pseudoobstruction,Entity
IL21-related infantile inflammatory bowel disease,Entity
ALG9,Entity
SMC1A,Entity
Gait ataxia,Entity
KIF4A,Entity
Allergy,Entity
Upslanted palpebral fissure,Entity
MIR615,Entity
Potassium gluconate,Entity
Peripheral demyelination,Entity
Thin skin,Entity
extramammary Paget disease,Entity
FGF19,Entity
Tramadol,Entity
syndrome with a cerebellar malformation as major feature,Entity
Dysphagia,Entity
NOX4,Entity
Rebamipide,Entity
CHST8,Entity
inherited Fanconi renotubular syndrome,Entity
NPL,Entity
malformation syndrome with skin/mucosae involvement,Entity
ASPM,Entity
benign neoplasm of pancreas,Entity
ulcerative colitis (disease),Entity
ST8SIA4,Entity
Growth hormone excess,Entity
systemic sclerosis,Entity
MMP11,Entity
Cortisone acetate,Entity
suppurative cholangitis,Entity
EDEM1,Entity
MIR939,Entity
MAEA,Entity
ETS1,Entity
Phenyl salicylate,Entity
atresia of small intestine,Entity
basaloid squamous cell carcinoma,Entity
MAOB,Entity
MLH3,Entity
Sufentanil,Entity
SPRTN,Entity
Testosterone enanthate,Entity
Flunisolide,Entity
SON,Entity
Fexofenadine,Entity
EDNRA,Entity
CDT1,Entity
non-infectious diarrheal disease,Entity
MBTPS1,Entity
MOGAT2,Entity
epithelial-myoepithelial carcinoma,Entity
MIR3173,Entity
Hypoplasia of dental enamel,Entity
Raynaud phenomenon,Entity
PBX4,Entity
Iloprost,Entity
hyperinsulinism due to glucokinase deficiency,Entity
Depressed nasal bridge,Entity
NDUFA2,Entity
MIR764,Entity
PTPN12,Entity
bile duct carcinoma,Entity
Lansoprazole,Entity
Famotidine,Entity
rectum neuroendocrine neoplasm,Entity
SKP2,Entity
MIR592,Entity
Dihydrocodeine,Entity
Hypoglycemia,Entity
Abnormality of vitamin metabolism,Entity
SPACA7,Entity
esophageal leukoplakia (disease),Entity
B9D1,Entity
OBSCN,Entity
delta-hexachlorocyclohexane,Entity
Mycophenolate mofetil,Entity
MIR210,Entity
ZFP36,Entity
GCGR,Entity
appendix hyperplastic polyp,Entity
Hemangioblastoma,Entity
FAT4,Entity
CLEC4G,Entity
NR3C2,Entity
REG4,Entity
Glecaprevir,Entity
bile duct mucinous cystic neoplasm with an associated invasive carcinoma,Entity
rectosigmoid carcinoma,Entity
Hyperthyroidism,Entity
cyanazine,Entity
small intestinal L-cell glucagon-like peptide producing tumor,Entity
secondary short bowel syndrome,Entity
Rabeprazole,Entity
Telmisartan,Entity
Porfimer sodium,Entity
MIR19A,Entity
Methsuximide,Entity
Mercaptopurine,Entity
Tromethamine,Entity
EREG,Entity
ABAT,Entity
congenital enterocyte heparan sulfate deficiency,Entity
Fluocinonide,Entity
Adenocarcinoma of the intestines,Entity
glucose-galactose malabsorption,Entity
CSMD1,Entity
tonsil squamous cell carcinoma,Entity
FGF9,Entity
DDR1,Entity
cystic tumor of the pancreas,Entity
Haddad syndrome,Entity
Localized skin lesion,Entity
MIR107,Entity
Cefixime,Entity
RARRES1,Entity
drug-induced liver injury,Entity
Myopathy,Entity
FLNC,Entity
"marfanoid syndrome, De Silva type",Entity
SST,Entity
CMIP,Entity
MIR134,Entity
Dieldrin,Entity
SLC17A2,Entity
liver lymphoma,Entity
MIR27A,Entity
Periventricular white matter hyperdensities,Entity
periampullary adenocarcinoma,Entity
digestive system neuroendocrine neoplasm,Entity
Dextromethorphan,Entity
undifferentiated carcinoma of liver and intrahepatic biliary tract,Entity
Homatropine,Entity
Hand polydactyly,Entity
intestinal benign neoplasm,Entity
PTPN11,Entity
MIR7704,Entity
Tachypnea,Entity
Griseofulvin,Entity
CRLF1,Entity
VCAN,Entity
Sloping forehead,Entity
Chronic noninfectious lymphadenopathy,Entity
Neoplasm of the eye,Entity
GMCL2,Entity
SCD,Entity
Tolvaptan,Entity
CLU,Entity
Proteinuria,Entity
Abnormal rapid eye movement sleep,Entity
idiopathic malabsorption due to bile acid synthesis defects,Entity
small intestine diverticulitis,Entity
MIR1468,Entity
parasitic intestinal disease,Entity
diabetes mellitus (disease),Entity
FOXH1,Entity
GATA3,Entity
Doxepin,Entity
hepatitis B virus infection,Entity
Neoplasm of the skeletal system,Entity
RND3,Entity
Ketoprofen,Entity
CCAR1,Entity
Talipes equinovarus,Entity
Ceftibuten,Entity
IFNAR2,Entity
CNTN4,Entity
Polydipsia,Entity
CORO1B,Entity
Dinoprost,Entity
immune system cancer,Entity
hereditary connective tissue disorder,Entity
PROX1,Entity
MIR203A,Entity
Estramustine,Entity
Abnormality of the small intestine,Entity
vector-borne disease,Entity
liver fibrosarcoma,Entity
intrahepatic biliary papillomatosis,Entity
ITGB4,Entity
STAT5A,Entity
Hypoxemia,Entity
Didanosine,Entity
Polyneuropathy,Entity
RAC1,Entity
INMT,Entity
Kaposi's sarcoma (disease),Entity
LIF,Entity
Pulmonary fibrosis,Entity
Oxaliplatin,Entity
cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,Entity
CANX,Entity
SFRP4,Entity
MCL1,Entity
Diphenylpyraline,Entity
Chenodeoxycholic acid,Entity
SLPI,Entity
TNFSF15,Entity
PRKD2,Entity
Antazoline,Entity
Diazinon,Entity
gallbladder biliary intraepithelial neoplasia,Entity
Zolpidem,Entity
adenocarcinoma of liver and intrahepatic biliary tract,Entity
DNMT3A,Entity
Polyethylene glycol 400,Entity
EAF2,Entity
malignant teratoma,Entity
SDHC,Entity
GCKR,Entity
Physostigmine,Entity
ATM,Entity
Sulfamerazine,Entity
VIL1,Entity
ALDH1A3,Entity
dumping syndrome,Entity
SLC6A2,Entity
Flame Retardants,Entity
"nasopharyngeal carcinoma, susceptibility to",Entity
ZNF160,Entity
monobutyl phthalate,Entity
MAPK1,Entity
gastric adenosquamous carcinoma,Entity
PLAC8,Entity
ALOX12B,Entity
TRIB3,Entity
Tipiracil,Entity
ALB,Entity
hereditary hyperbilirubinemia,Entity
CD68,Entity
Butalbital,Entity
malignant epithelial tumor of salivary glands,Entity
ROR2,Entity
MYLK,Entity
Irbesartan,Entity
inborn errors of metabolism,Entity
Bacteremia,Entity
FECH,Entity
Limb pain,Entity
HGFAC,Entity
anus cancer,Entity
Glycosuria,Entity
Erlotinib,Entity
Areflexia,Entity
SMARCA4,Entity
Ledipasvir,Entity
Phenylpropanolamine,Entity
TPM1,Entity
developmental defect of the eye,Entity
Myocarditis,Entity
Aminocaproic acid,Entity
FOXM1,Entity
Leflunomide,Entity
MIR885,Entity
Dexchlorpheniramine,Entity
GPNMB,Entity
Fluorometholone,Entity
Dicloxacillin,Entity
Reserpine,Entity
SPARC,Entity
LPA,Entity
IL7R,Entity
Corneal ulceration,Entity
Malnutrition,Entity
gastric lymphoma,Entity
PANX1,Entity
Chlorpropamide,Entity
Methantheline,Entity
Olanzapine,Entity
Episodic abdominal pain,Entity
BEX4,Entity
CCN1,Entity
LRRK2,Entity
genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability,Entity
Ethosuximide,Entity
RPL15,Entity
Valsartan,Entity
Abnormality of coagulation,Entity
Alcoholism,Entity
Progressive neurologic deterioration,Entity
Abnormality of endocrine pancreas physiology,Entity
Mucoid diarrhea,Entity
Neostigmine,Entity
Dapagliflozin,Entity
Ertugliflozin,Entity
1-hydroxypyrene-glucuronide,Entity
Recurrent gastroenteritis,Entity
Arterial thrombosis,Entity
Postaxial hand polydactyly,Entity
DCC,Entity
Hyperhidrosis,Entity
PAWR,Entity
WIF1,Entity
HOXA10,Entity
FAN1,Entity
ORMDL3,Entity
Hyperketonemia,Entity
clear cell adenocarcinoma,Entity
SNRPB,Entity
IL1RAP,Entity
Acetazolamide,Entity
Abnormal hair quantity,Entity
AKT2,Entity
Stanolone,Entity
FLCN,Entity
Nortriptyline,Entity
Insulin detemir,Entity
pharynx neoplasm,Entity
TUBA1C,Entity
BMP4,Entity
Multiple lipomas,Entity
RFLNB,Entity
Letrozole,Entity
larynx carcinoma in situ,Entity
KRT15,Entity
Polyethylene glycol 300,Entity
Intestinal malrotation,Entity
Butorphanol,Entity
ileal neoplasm,Entity
HADHB,Entity
Abnormal circulating fatty-acid concentration,Entity
ARHGEF1,Entity
inborn disorder of bile acid synthesis,Entity
CYP1A1,Entity
Propiomazine,Entity
Metoclopramide,Entity
ST6GAL1,Entity
SNAP25,Entity
Failure to thrive,Entity
Balsalazide,Entity
Hypoglycemic seizures,Entity
AZGP1,Entity
GRIN2A,Entity
gallbladder carcinoma,Entity
KIFC1,Entity
Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young,Entity
esophagus squamous cell papilloma,Entity
enterocolitis (disease),Entity
TYMP,Entity
CYP7B1,Entity
Norethisterone,Entity
Hypoplasia of the ulna,Entity
RETN,Entity
Linagliptin,Entity
Hydroxyamphetamine,Entity
Hematin,Entity
Tizanidine,Entity
Abnormality of the coagulation cascade,Entity
Imipramine,Entity
Budd-Chiari syndrome,Entity
ITGA8,Entity
GTSE1,Entity
Progressive muscle weakness,Entity
EXOSC5,Entity
PRKN,Entity
MIR346,Entity
PLPPR2,Entity
calcifying nested epithelial stromal tumor of the liver,Entity
Morphine,Entity
JAKMIP1,Entity
GPD1L,Entity
Bicornuate uterus,Entity
VASN,Entity
LEP,Entity
DLG3,Entity
HMMR,Entity
DEFA5,Entity
Semaglutide,Entity
adenocarcinoma,Entity
Azathioprine,Entity
GMNN,Entity
MIR487B,Entity
SCNN1B,Entity
Goserelin,Entity
Sulfamethazine,Entity
food protein-induced allergic proctocolitis,Entity
RTN4,Entity
"2,4,4',5-tetrachlorobiphenyl",Entity
RALGDS,Entity
Hepatic encephalopathy,Entity
Ergotamine,Entity
appendix neuroendocrine neoplasm,Entity
Nalidixic acid,Entity
Flat face,Entity
FTO,Entity
SDHB,Entity
GPR158,Entity
Bruising susceptibility,Entity
Quinestrol,Entity
Intellectual disability,Entity
appendix cancer,Entity
Bromotheophylline,Entity
Parakeratosis,Entity
Abnormality of the anus,Entity
ELOA2,Entity
Macrocephaly,Entity
colon mucinous adenocarcinoma,Entity
Dexamethasone,Entity
CASP8,Entity
DYRK2,Entity
inherited digestive cancer-predisposing syndrome,Entity
neurocristopathy,Entity
Sparse scalp hair,Entity
Fluoxetine,Entity
Tacrolimus,Entity
SERPINC1,Entity
Cafe-au-lait spot,Entity
PTPRT,Entity
CDK8,Entity
Thin upper lip vermilion,Entity
Abnormal heart morphology,Entity
BIRC3,Entity
ABCA5,Entity
Recurrent hypoglycemia,Entity
ERP29,Entity
MIR148A,Entity
Tubulointerstitial nephritis,Entity
Teduglutide,Entity
UBE2C,Entity
SHORT syndrome,Entity
HERC5,Entity
MAP3K9,Entity
EGFR,Entity
RPS19,Entity
CSF3,Entity
rectal cloacogenic carcinoma,Entity
CNTNAP4,Entity
CD81,Entity
MATK,Entity
SKA1,Entity
LTF,Entity
Chlorzoxazone,Entity
Eczematoid dermatitis,Entity
Teneligliptin,Entity
pancreatic colipase deficiency,Entity
HIGD2A,Entity
Respiratory paralysis,Entity
Elevated serum creatine kinase,Entity
UNC93B1,Entity
Hexanes,Entity
Fosfomycin,Entity
SSTR2,Entity
infectious diarrheal disease,Entity
Pantoprazole,Entity
Omarigliptin,Entity
thiamine-responsive megaloblastic anemia syndrome,Entity
KIF1B,Entity
CDC25B,Entity
SLC22A8,Entity
Topiramate,Entity
PIGO,Entity
BCHE,Entity
MLF2,Entity
Central hypoventilation,Entity
CNPPD1,Entity
HSD3B7,Entity
Necrolytic migratory erythema,Entity
Campylobacter fetus infectious disease,Entity
gingival cancer,Entity
MIR24-1,Entity
MBOAT7,Entity
Elevated serum alanine aminotransferase,Entity
PRKCZ,Entity
TBX22,Entity
Triamterene,Entity
IL6ST,Entity
Myositis,Entity
Incomplete penetrance,Entity
ectodermal dysplasia syndrome,Entity
IL11,Entity
Abnormality of the ribs,Entity
Cadmium,Entity
Nail dysplasia,Entity
Cinchocaine,Entity
Abnormality of the immune system,Entity
TAC1,Entity
pancreatic ACTH-producing neuroendocrine tumor,Entity
JPH3,Entity
SRMS,Entity
Waardenburg-Shah syndrome,Entity
ARHGAP11A,Entity
Progesterone,Entity
GPT,Entity
BMPER,Entity
Regorafenib,Entity
ASAH2,Entity
Recurrent pancreatitis,Entity
SMARCE1,Entity
perinatal necrotizing enterocolitis,Entity
intussusception,Entity
Grazoprevir,Entity
Reduced visual acuity,Entity
tubular duplication of the esophagus,Entity
PSMA4,Entity
Mitiglinide,Entity
Lopinavir,Entity
Loratadine,Entity
VSIG4,Entity
MST1R,Entity
post-viral disorder,Entity
SPRR2A,Entity
Bismuth subsalicylate,Entity
rectal prolapse (disease),Entity
Nabilone,Entity
SLC26A3,Entity
Glyburide,Entity
Hodgkin lymphoma,Entity
Erythromycin,Entity
SALL3,Entity
LCN2,Entity
cholestasis,Entity
Tapered finger,Entity
ADM,Entity
GINS2,Entity
Roxatidine acetate,Entity
Velpatasvir,Entity
ZNF292,Entity
Hydrocodone,Entity
collagenous sprue,Entity
Diclofenamide,Entity
BCL2L11,Entity
mono-benzyl phthalate,Entity
MMP7,Entity
Clubbing,Entity
GBA3,Entity
GCLC,Entity
SOD1,Entity
CFH,Entity
Rifapentine,Entity
CBR1,Entity
BLVRA,Entity
Neonatal hypoglycemia,Entity
PIK3R1,Entity
DCLK1,Entity
ampulla of vater clear cell adenocarcinoma,Entity
benign colon neoplasm,Entity
CENPA,Entity
hairy cell leukemia,Entity
Anisotropine methylbromide,Entity
pharynx carcinoma in situ,Entity
SGO1,Entity
Mitochondrial inheritance,Entity
Lixisenatide,Entity
carcinoma of floor of mouth,Entity
ID1,Entity
Developmental regression,Entity
Macrotia,Entity
Subcutaneous lipoma,Entity
Abnormality of digestive system physiology,Entity
PDGFD,Entity
Itraconazole,Entity
WDR17,Entity
Arrhythmia,Entity
KRT17,Entity
EEF2,Entity
achalasia (disease),Entity
Abnormal liver sonography,Entity
CDK14,Entity
MIR589,Entity
ERN1,Entity
PRKAA2,Entity
Nitroglycerin,Entity
Eprosartan,Entity
ACOT1,Entity
Moxifloxacin,Entity
inherited soft tissue tumor,Entity
Proximal muscle weakness in lower limbs,Entity
Alopecia,Entity
SLC24A3,Entity
CHAF1B,Entity
Lipoatrophy,Entity
Sick sinus syndrome,Entity
Etidronic acid,Entity
Apathy,Entity
Atypical pulmonary carcinoid tumor,Entity
Levorphanol,Entity
TICRR,Entity
ischemic colitis,Entity
Danazol,Entity
Oxyphenisatin,Entity
Hypoketotic hypoglycemia,Entity
Desloratadine,Entity
Congenital shortened small intestine,Entity
NAFLD1,Entity
SFRP2,Entity
Isoniazid,Entity
Coma,Entity
ileus,Entity
Palpitations,Entity
AMZ2P1,Entity
POMC,Entity
Tolterodine,Entity
TTC39A,Entity
ULBP2,Entity
Phenylbutyric acid,Entity
PRDX2,Entity
VLDLR,Entity
Celecoxib,Entity
TEDC2,Entity
colorectal adenosquamous carcinoma,Entity
Abnormal facial shape,Entity
Abnormal blood ion concentration,Entity
NR1H4,Entity
IGF2R,Entity
ESPL1,Entity
Antipyrine,Entity
DACT2,Entity
TMEM63A,Entity
Scarring alopecia of scalp,Entity
pancreatic gastrinoma,Entity
Indacaterol,Entity
Spontaneous abortion,Entity
non-Hodgkin lymphoma,Entity
DCBLD2,Entity
Gadolinium,Entity
salivary gland cancer,Entity
CHEK2,Entity
Thromboembolism,Entity
pancreatic gastrin-producing neuroendocrine tumor,Entity
NR5A2,Entity
major salivary gland mucoepidermoid carcinoma,Entity
Antimony,Entity
Vomiting,Entity
SH3KBP1,Entity
Malignant gastrointestinal tract tumors,Entity
Nephrogenic diabetes insipidus,Entity
leiomyosarcoma,Entity
SORL1,Entity
BMPR1B,Entity
liver angiosarcoma,Entity
Hepatic fibrosis,Entity
anal canal squamous cell carcinoma,Entity
Aganglionic megacolon,Entity
CXCR1,Entity
salivary gland squamous cell carcinoma,Entity
Darunavir,Entity
Insulin human,Entity
BTBD11,Entity
intestinal polyp (disease),Entity
gestational diabetes,Entity
KRAS,Entity
HSDL2,Entity
Aurothioglucose,Entity
CD163,Entity
AKAP9,Entity
SRPX,Entity
DIPK2B,Entity
carcinoma of supraglottis,Entity
Low-set ears,Entity
pancreatic exocrine neoplasm,Entity
MCRS1,Entity
UGDH,Entity
CDC42BPB,Entity
ZNRF3,Entity
GHRL,Entity
Cobalt,Entity
ANXA5,Entity
Intermittent diarrhea,Entity
duodenal ulcer (disease),Entity
Myalgia,Entity
Degarelix,Entity
Quinine,Entity
VCAM1,Entity
Chlorpyrifos,Entity
SELENOP,Entity
sublingual gland cancer,Entity
Oxazepam,Entity
IL1B,Entity
Inflammation of the large intestine,Entity
syndromic anorectal malformation,Entity
Band keratopathy,Entity
Molindone,Entity
TUFM,Entity
intrahepatic bile duct adenoma,Entity
STK32C,Entity
Benign gastrointestinal tract tumors,Entity
Adducted thumb,Entity
PRKACA,Entity
Hypothyroidism,Entity
SATB2,Entity
Apraclonidine,Entity
ASH1L,Entity
small intestine neuroendocrine neoplasm,Entity
Pseudobulbar paralysis,Entity
Joint hyperflexibility,Entity
pancreatic cystadenoma,Entity
NLRC4,Entity
Barrett esophagus,Entity
levator syndrome,Entity
Neoplasm of the gastrointestinal tract,Entity
Volvulus,Entity
PLPP1,Entity
integumentary system cancer,Entity
MPP1,Entity
Phentolamine,Entity
WNK1,Entity
Thick hair,Entity
MARK2,Entity
Reduced number of intrahepatic bile ducts,Entity
Ethionamide,Entity
Abnormality of the gastrointestinal tract,Entity
Hypopigmentation of hair,Entity
NOS3,Entity
trichohepatoenteric syndrome,Entity
SETD4,Entity
Halcinonide,Entity
Nizatidine,Entity
PGR,Entity
neonatal jaundice,Entity
immunodeficiency,Entity
C2CD6,Entity
SMO,Entity
Milnacipran,Entity
Hydroureter,Entity
Flexion contracture,Entity
ADH1A,Entity
squamous cell carcinoma,Entity
HRH1,Entity
Alprostadil,Entity
SSTR1,Entity
hepatoerythropoietic porphyria,Entity
Intestinal polyposis,Entity
LRRC47,Entity
TF,Entity
Multiple pancreatic beta-cell adenomas,Entity
CTSD,Entity
FOXA1,Entity
TRIP13,Entity
autosomal dominant hyperinsulinism due to Kir6.2 deficiency,Entity
GRK2,Entity
Amoxapine,Entity
CYP27A1,Entity
KISS1,Entity
IFNGR1,Entity
HK1,Entity
RET,Entity
steatorrhea (disease),Entity
AURKB,Entity
CAMKV,Entity
Levobupivacaine,Entity
tonsil neoplasm,Entity
Thrombocytopenia,Entity
ABCD4,Entity
EFEMP1,Entity
HMGCR,Entity
Reduced consciousness/confusion,Entity
GRIK2,Entity
CETP,Entity
Dantron,Entity
Isradipine,Entity
Alosetron,Entity
Everted lower lip vermilion,Entity
Renal insufficiency,Entity
Generalized muscle weakness,Entity
anal margin basal cell carcinoma,Entity
JAK2,Entity
KRT20,Entity
pancreatic adenosquamous carcinoma,Entity
HBA1,Entity
Bisoprolol,Entity
KLK10,Entity
Reduced coagulation factor V activity,Entity
Multiple biliary hamartomas,Entity
gastritis,Entity
HERC3,Entity
ROBO1,Entity
CAST,Entity
Cleft palate,Entity
Mental deterioration,Entity
Ramelteon,Entity
carcinoma of gallbladder and extrahepatic biliary tract,Entity
hemangiomas of small intestine,Entity
pancreatic serous cystic neoplasm,Entity
Secondary growth hormone deficiency,Entity
ATP1B2,Entity
Monopotassium phosphate,Entity
Pilocarpine,Entity
Edema,Entity
Benign genitourinary tract neoplasm,Entity
Trifluoperazine,Entity
Mecobalamin,Entity
Cysteine,Entity
PLS1,Entity
Hypotriglyceridemia,Entity
BCAS2,Entity
Methocarbamol,Entity
Chronic diarrhea,Entity
Chloroquine,Entity
colorectal medullary carcinoma,Entity
X-linked recessive inheritance,Entity
PPP1R14A,Entity
JAG2,Entity
inflammatory disease,Entity
Diethylstilbestrol,Entity
LZTS1,Entity
Exenatide,Entity
hemangioma,Entity
LPAR1,Entity
biliary cystadenocarcinoma,Entity
Iron deficiency anemia,Entity
SLC22A10,Entity
Congenital onset,Entity
HSD3B2,Entity
ZBTB11,Entity
NDUFS3,Entity
Hydrocortisone acetate,Entity
PRDX1,Entity
PPARD,Entity
Focal-onset seizure,Entity
pyloric stenosis (disease),Entity
IGF2BP2,Entity
HOMER3,Entity
Aprepitant,Entity
gallbladder small cell neuroendocrine carcinoma,Entity
Phendimetrazine,Entity
Cyclacillin,Entity
C14orf180,Entity
HAMP,Entity
MIR494,Entity
LEF1,Entity
RAD23A,Entity
Abnormality of movement,Entity
syndromic lymphedema,Entity
biliary dyskinesia,Entity
Solifenacin,Entity
Pentosan polysulfate,Entity
AKR1A1,Entity
Ampicillin,Entity
autosomal recessive hyperinsulinism due to SUR1 deficiency,Entity
CTSC,Entity
SSX1,Entity
MAPK9,Entity
PHB,Entity
KIF15,Entity
HNF1B,Entity
ADARB2,Entity
Estazolam,Entity
Praziquantel,Entity
esophagus leiomyoma,Entity
Trihexyphenidyl,Entity
TAGLN2,Entity
bromoform,Entity
Nevirapine,Entity
TNK2,Entity
Pramipexole,Entity
Cefoxitin,Entity
Abnormal circulating porphyrin concentration,Entity
TFG,Entity
appendix mucinous cystadenocarcinoma,Entity
sigmoid disease,Entity
CMTR2,Entity
LUM,Entity
Inositol nicotinate,Entity
gastric intestinal type adenocarcinoma,Entity
esophageal adenosquamous carcinoma,Entity
MAGEA6,Entity
Prolonged prothrombin time,Entity
IRF2,Entity
ADAM17,Entity
TCF7,Entity
Polyphagia,Entity
Lactose,Entity
ABCC3,Entity
Preeclampsia,Entity
bisphenol A,Entity
XPA,Entity
ELN,Entity
APOH,Entity
Stomach cancer,Entity
Rimantadine,Entity
Clavulanic acid,Entity
TTC36,Entity
Intussusception,Entity
NR4A2,Entity
CPEB3,Entity
Cardiogenic shock,Entity
Bradycardia,Entity
COL3A1,Entity
autosomal dominant hyperinsulinism due to SUR1 deficiency,Entity
Increased serum lactate,Entity
ABCG8,Entity
epithelial neoplasm,Entity
Chloral hydrate,Entity
proctitis,Entity
rectum carcinoma in situ,Entity
Elevated gamma-glutamyltransferase level,Entity
Orthokeratosis,Entity
Periportal fibrosis,Entity
Short distal phalanx of finger,Entity
renal cysts and diabetes syndrome,Entity
STING1,Entity
Jaundice,Entity
CAPN8,Entity
Lovastatin,Entity
abdominal tuberculosis,Entity
AKR1C2,Entity
Zolmitriptan,Entity
Prolonged partial thromboplastin time,Entity
PTK7,Entity
cytochrome-c oxidase deficiency disease,Entity
NCR1,Entity
ITK,Entity
mature teratoma,Entity
Splanchnic vein thrombosis,Entity
MIR345,Entity
Nepafenac,Entity
Primidone,Entity
Mesalazine,Entity
Amprenavir,Entity
Trimetrexate,Entity
functional gastric disease,Entity
polycystic liver disease 3 with or without kidney cysts,Entity
Increased serum serotonin,Entity
SDCBP2,Entity
UHRF2,Entity
Multiple gastric polyps,Entity
ORM1,Entity
Subcutaneous nodule,Entity
Spastic diplegia,Entity
gastric enterochromaffin cell serotonin-producing neuroendocrine tumor,Entity
Bisacodyl,Entity
AP1S1,Entity
Alagille syndrome due to a JAG1 point mutation,Entity
Micafungin,Entity
Arsenic trioxide,Entity
PANK4,Entity
PRSS2,Entity
Stavudine,Entity
Nitrofurantoin,Entity
salivary gland carcinoma ex pleomorphic adenoma,Entity
lymphoma,Entity
colorectal juvenile polyp,Entity
EDN3,Entity
PBK,Entity
UROS,Entity
Acetylcysteine,Entity
CFAP20,Entity
Inositol,Entity
Hypopigmentation of the fundus,Entity
cystitis,Entity
UBE2T,Entity
Abnormal bronchus morphology,Entity
Carbocisteine,Entity
Paraganglioma,Entity
PAK6,Entity
RPS6KA2,Entity
PTGS1,Entity
Increased level of L-fucose in urine,Entity
esophageal varices without bleeding,Entity
EIF2S3,Entity
CP,Entity
BMP6,Entity
BCOR,Entity
"diverticulosis, small-intestinal",Entity
ERAP2,Entity
Brachycephaly,Entity
NOTCH2,Entity
Sensory neuropathy,Entity
COL1A1,Entity
dyskinesia of esophagus,Entity
Guanabenz,Entity
GTF2B,Entity
ACKR3,Entity
Hexachlorobenzene,Entity
BAMBI,Entity
Cetuximab,Entity
MIR200C,Entity
cancer,Entity
SIX3,Entity
short bowel syndrome,Entity
RELCH,Entity
SYNE1,Entity
Mivacurium,Entity
TGFA,Entity
SERPINA1,Entity
Hematochezia,Entity
THBS1,Entity
MTHFD1L,Entity
Methionine,Entity
Increased sarcoplasmic glycogen,Entity
BDNF,Entity
"2,2',3,3',4,4',5-heptachlorobiphenyl",Entity
Clostridium difficile colitis,Entity
NKX2-3,Entity
SHC1,Entity
Ipragliflozin,Entity
squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Entity
Colorectal polyposis,Entity
autosomal recessive hyperinsulinism due to Kir6.2 deficiency,Entity
small intestine cancer,Entity
Hyponatremia,Entity
RNF43,Entity
Dystrophic fingernails,Entity
Abnormal tubulointerstitial morphology,Entity
IL15,Entity
EPHB6,Entity
WAC,Entity
ERCC6,Entity
benign endocrine neoplasm,Entity
TGFBR2,Entity
MYC,Entity
MIR377,Entity
MGA,Entity
MTSS1,Entity
SPATA21,Entity
NFIB,Entity
Asunaprevir,Entity
CCDC134,Entity
pseudomyxoma peritonei,Entity
ITPR3,Entity
Phenylephrine,Entity
neurofibroma of gallbladder,Entity
IRS4,Entity
AXL,Entity
Pioglitazone,Entity
HNRNPL,Entity
Arsenic,Entity
KCNH2,Entity
NDRG2,Entity
PPARGC1A,Entity
umbilical cord ulceration-intestinal atresia syndrome,Entity
PTK2,Entity
SLIT2,Entity
ANXA4,Entity
"hepatitis, non-human animal",Entity
NEUROD1,Entity
ADORA3,Entity
Polythiazide,Entity
Asymptomatic hyperammonemia,Entity
PDIA3,Entity
CCL3,Entity
PRDM1,Entity
colorectal neuroendocrine tumor G1,Entity
thoracic aortic aneurysm and aortic dissection,Entity
UBR5,Entity
CDC20,Entity
echinococcosis,Entity
NRK,Entity
TRMT11,Entity
PQBP1,Entity
Reactive hypoglycemia,Entity
Abnormality of cardiovascular system morphology,Entity
Trichlormethiazide,Entity
Woodhouse-Sakati syndrome,Entity
Patchy alopecia,Entity
Abnormal lymphocyte count,Entity
Aldicarb,Entity
Methanol,Entity
XRCC3,Entity
Potassium chloride,Entity
GMPR2,Entity
Sofalcone,Entity
Ketosis,Entity
Dexbrompheniramine,Entity
BNIP3,Entity
CCS,Entity
SNX10,Entity
Dichlorophen,Entity
PTCH2,Entity
RPS26,Entity
MARCO,Entity
CD226,Entity
liver hemangioma,Entity
Ascites,Entity
glycogen storage disease due to hepatic glycogen synthase deficiency,Entity
Endocardial fibrosis,Entity
Abdominal pain,Entity
Pancolitis,Entity
methyl tert-butyl ether,Entity
TACC3,Entity
HOTAIR,Entity
MIR106B,Entity
Diazoxide,Entity
SPZ1,Entity
Bronchitis,Entity
peliosis hepatis,Entity
Carteolol,Entity
Aldrin,Entity
SP110,Entity
Cerebral edema,Entity
AQP1,Entity
Primary hypothyroidism,Entity
Bifid scrotum,Entity
ETAA1,Entity
Sparse hair,Entity
Mometasone furoate,Entity
Hirschsprung disease-ganglioneuroblastoma syndrome,Entity
Stomatitis,Entity
acute disease,Entity
MIR651,Entity
Neoplasm of the thyroid gland,Entity
Bicalutamide,Entity
S100A6,Entity
Desipramine,Entity
serous cystadenoma,Entity
Gemigliptin,Entity
IL10RA,Entity
Absence of lymph node germinal center,Entity
KLF5,Entity
Urinary incontinence,Entity
Tenesmus,Entity
chronic hepatitis C virus infection,Entity
FBN2,Entity
SUFU,Entity
LGALS2,Entity
Sodium oxybate,Entity
angiodysplasia of stomach,Entity
Sepsis,Entity
"intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked",Entity
MYOT,Entity
CD34,Entity
MIA,Entity
malignant tumor of floor of mouth,Entity
Metolazone,Entity
Methyclothiazide,Entity
LRAT,Entity
liver leiomyosarcoma,Entity
MAP3K3,Entity
neuroendocrine tumor with other location,Entity
Underdeveloped nasal alae,Entity
ZDHHC7,Entity
Coumaphos,Entity
Paliperidone,Entity
Inflammatory abnormality of the skin,Entity
TH,Entity
salivary gland epithelial myoepithelial carcinoma,Entity
non-functional pancreatic neuroendocrine tumor,Entity
BTC,Entity
Candesartan cilexetil,Entity
PTPRF,Entity
TONSL,Entity
Scopolamine,Entity
HMGA2,Entity
NR4A1,Entity
BIRC2,Entity
Sulfacytine,Entity
Large for gestational age,Entity
Hypertrophic cardiomyopathy,Entity
MACIR,Entity
Hepatic cysts,Entity
MIR484,Entity
Intermittent painful muscle spasms,Entity
JMJD1C,Entity
EGR2,Entity
Magnesium,Entity
SKIV2L,Entity
CAPZA1,Entity
Cefadroxil,Entity
CEP55,Entity
IKBKG,Entity
CAVIN1,Entity
Cranial nerve paralysis,Entity
diversion colitis,Entity
malignant exocrine pancreas neoplasm,Entity
maxillary sinus carcinoma,Entity
TUBB2A,Entity
Hydroflumethiazide,Entity
Kernicterus,Entity
CENPM,Entity
endocrine tuberculosis,Entity
mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies,Entity
Small intestine carcinoid,Entity
SLC46A1,Entity
MTPN,Entity
Voxilaprevir,Entity
Carisoprodol,Entity
colorectal sessile serrated adenoma/polyp,Entity
Ureteral duplication,Entity
Duodenal diverticula,Entity
toxic megacolon,Entity
SERPING1,Entity
Buspirone,Entity
Mitomycin,Entity
extrahepatic bile duct sarcoma,Entity
GABPB1,Entity
malignant tumor of minor salivary gland,Entity
VEGFB,Entity
Chest pain,Entity
GABRA6,Entity
Asterixis,Entity
PGD,Entity
Leuprolide,Entity
Rectal abscess,Entity
TGFB2,Entity
MMP14,Entity
papillary adenoma,Entity
CSMD3,Entity
colorectal adenoma,Entity
Phenacetin,Entity
CNKSR2,Entity
MIR218-1,Entity
CENPW,Entity
Clofedanol,Entity
intestinal cancer,Entity
OCIAD1,Entity
VPS26A,Entity
KDM6B,Entity
PHIP,Entity
MAP3K6,Entity
HSPB1,Entity
ITIH4,Entity
Fever,Entity
Encephalitis,Entity
Tetralogy of Fallot,Entity
TP63,Entity
syndromic disease,Entity
Abnormal esophagus morphology,Entity
Retinopathy,Entity
MIR410,Entity
MIR183,Entity
UBE2E2,Entity
salivary gland small cell carcinoma,Entity
REN,Entity
Meclizine,Entity
WDR76,Entity
Cough,Entity
Brompheniramine,Entity
Prednisolone,Entity
IL22,Entity
gastric cancer,Entity
primary bacterial infectious disease,Entity
MAGEA3,Entity
Cyclizine,Entity
GALT,Entity
GPM6A,Entity
TCHP,Entity
White forelock,Entity
Intrahepatic cholestasis,Entity
TTR,Entity
IGF1,Entity
appendicitis,Entity
angiosarcoma (disease),Entity
Metipranolol,Entity
Zinc acetate,Entity
vascular disease,Entity
SPHK1,Entity
Tolmetin,Entity
USP48,Entity
Nicardipine,Entity
HMOX1,Entity
FBXO4,Entity
SMARCC1,Entity
SLC22A9,Entity
Pedal edema,Entity
DCLK3,Entity
Pancreatitis,Entity
Gastrointestinal infarctions,Entity
FANCC,Entity
Darifenacin,Entity
NETO2,Entity
MAX,Entity
Dulaglutide,Entity
Autosomal dominant inheritance,Entity
FGA,Entity
KIF14,Entity
Alagille syndrome,Entity
DOCK2,Entity
TST,Entity
Resorcinol,Entity
Rivastigmine,Entity
ischemic bowel disease,Entity
Nefazodone,Entity
Alfuzosin,Entity
idiopathic achalasia,Entity
Pituitary growth hormone cell adenoma,Entity
EVC2,Entity
VWF,Entity
Radioactive Fallout,Entity
YAP1,Entity
celiac disease,Entity
urea formaldehyde foam,Entity
ACOT9,Entity
GRB7,Entity
TOX3,Entity
ASCC1,Entity
Abnormal skeletal muscle morphology,Entity
STMN1,Entity
Generalized hypotonia,Entity
Abnormal autonomic nervous system physiology,Entity
PITX1,Entity
Buschke Lowenstein tumor,Entity
TNFSF10,Entity
Irinotecan,Entity
SENP2,Entity
LGALS3,Entity
Vertigo,Entity
CXCL9,Entity
CST7,Entity
epithelial tumor of the appendix,Entity
Glibornuride,Entity
SOCS2,Entity
FKTN,Entity
juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,Entity
Magnesium oxide,Entity
Colesevelam,Entity
hawkinsinuria,Entity
alpha-hexachlorocyclohexane,Entity
MAPK14,Entity
ESR1,Entity
Asbestos,Entity
Albiglutide,Entity
CCL20,Entity
Cromoglicic acid,Entity
NLGN4X,Entity
Ropinirole,Entity
Spinalarachnoid cyst,Entity
Zileuton,Entity
Zonisamide,Entity
INPPL1,Entity
ANGPTL4,Entity
ITGB6,Entity
HLA-DPA1,Entity
Lapatinib,Entity
CENPE,Entity
undifferentiated carcinoma,Entity
RPL13,Entity
Dalfopristin,Entity
MUC6,Entity
CTSH,Entity
CIITA,Entity
Clinodactyly,Entity
CELA1,Entity
PRKDC,Entity
diverticulitis,Entity
Hallucinations,Entity
Acrivastine,Entity
Dysuria,Entity
Goldberg-Shprintzen megacolon syndrome,Entity
Bacitracin,Entity
IgG4-related hepatopathy,Entity
CD14,Entity
Autosomal recessive inheritance,Entity
CACNB2,Entity
Benzoic acid,Entity
Vestibular dysfunction,Entity
DHRS7,Entity
Cardiomegaly,Entity
Elevated serum aspartate aminotransferase,Entity
SMAD9,Entity
Dexrabeprazole,Entity
Pirenzepine,Entity
Salmonella gastroenteritis,Entity
Conjugated hyperbilirubinemia,Entity
Medroxyprogesterone acetate,Entity
RNF213,Entity
neuronal intestinal dysplasia,Entity
Trihalomethanes,Entity
carbohydrate metabolism disease,Entity
anal mucinous adenocarcinoma,Entity
CCHCR1,Entity
Acute episodes of neuropathic symptoms,Entity
IFNG,Entity
TGFB1,Entity
ASAP3,Entity
Piperazine,Entity
Mesenteric venous thrombosis,Entity
Tricuspid regurgitation,Entity
FAM111B,Entity
RBP4,Entity
Raloxifene,Entity
neoplasm of thorax,Entity
chronic cholangitis,Entity
Loperamide,Entity
Ezetimibe,Entity
EIF2AK1,Entity
Chlordan,Entity
biliary tract neoplasm (disease),Entity
SRCAP,Entity
CRTC1,Entity
Hirschsprung disease-deafness-polydactyly syndrome,Entity
PTOV1,Entity
Pes cavus,Entity
Midodrine,Entity
movement disorder,Entity
FABP5,Entity
ACTA2,Entity
Amlodipine,Entity
Abnormal stomach morphology,Entity
in situ carcinoma,Entity
Whipple disease,Entity
descending colon cancer,Entity
PRG2,Entity
Strontium,Entity
Fat malabsorption,Entity
diabetic ketoacidosis,Entity
BOC,Entity
Phenoxymethylpenicillin,Entity
FGFR2,Entity
rectal disease,Entity
A2M,Entity
Terfenadine,Entity
ZBTB20,Entity
Doxapram,Entity
syndromic urogenital tract malformation,Entity
CCL5,Entity
BARD1,Entity
sporadic porphyria cutanea tarda,Entity
CASP3,Entity
Hypocholesterolemia,Entity
GNAO1,Entity
MITF,Entity
digestive system carcinoma,Entity
KLB,Entity
Serine,Entity
liver and intrahepatic bile duct neoplasm,Entity
Clofazimine,Entity
IGFBP2,Entity
Ceftazidime,Entity
Troglitazone,Entity
MAP2K6,Entity
Methyldopa,Entity
Peutz-Jeghers syndrome,Entity
MCM2,Entity
Cyproheptadine,Entity
Cefepime,Entity
NF1,Entity
IL27,Entity
Hyperglycemia,Entity
GANAB,Entity
ACACA,Entity
IRS1,Entity
CXCL12,Entity
APOE,Entity
Tioguanine,Entity
SEC63,Entity
GCGR-related hyperglucagonemia,Entity
gastroduodenitis,Entity
ANLN,Entity
Tobacco Smoke Pollution,Entity
FANCA,Entity
Toxaphene,Entity
skin carcinoma,Entity
Meprobamate,Entity
SPAG17,Entity
Unusual gastrointestinal infection,Entity
MSH5,Entity
SCTR,Entity
Phenolphthalein,Entity
anus adenocarcinoma,Entity
PTPN2,Entity
Chlordiazepoxide,Entity
Thallium,Entity
SOX2,Entity
immature gastric teratoma,Entity
Alstrom syndrome,Entity
Mepyramine,Entity
"Intellectual disability, moderate",Entity
rectal carcinoma,Entity
Pallor,Entity
Frovatriptan,Entity
hereditary folate malabsorption,Entity
ethylbenzene,Entity
Ciprofloxacin,Entity
Edrophonium,Entity
liver mesenchymal hamartoma,Entity
Urogenital fistula,Entity
Naltrexone,Entity
carcinoma in situ of gastric body,Entity
abdominal and pelvic region disorder,Entity
EPHB4,Entity
RPL6,Entity
PSMA2,Entity
PSMA5,Entity
Melatonin,Entity
ACTG2,Entity
ATP11C,Entity
DDX54,Entity
Encephalopathy,Entity
NPC1,Entity
oral/nasal cavity carcinoma,Entity
ARID2,Entity
DEPDC5,Entity
TGM3,Entity
angiomyolipoma,Entity
ATG16L1,Entity
Autoimmunity,Entity
Apnea,Entity
MAF,Entity
NEK11,Entity
RORA,Entity
Methoxsalen,Entity
tonsil carcinoma,Entity
Fosphenytoin,Entity
gallbladder melanoma,Entity
metabolic disease with intestinal involvement,Entity
Entecavir,Entity
"2,3',4,4',5-pentachlorobiphenyl",Entity
Acetohexamide,Entity
POLD1,Entity
Sofosbuvir,Entity
Caffeine,Entity
hepatorenal syndrome,Entity
Neoplasm of the stomach,Entity
maxillary sinus squamous cell carcinoma,Entity
Sevoflurane,Entity
congenital enteropathy due to enteropeptidase deficiency,Entity
Tin,Entity
Rilpivirine,Entity
Anxiety,Entity
PGA5,Entity
squamous papilloma,Entity
ERCC2,Entity
Amitriptyline,Entity
Piroxicam,Entity
Low levels of vitamin E,Entity
IGFBP1,Entity
MAPT,Entity
PIM1,Entity
NLRP3,Entity
salivary gland carcinoma,Entity
IGSF21,Entity
shigellosis,Entity
Toluene,Entity
Terbinafine,Entity
neonatal ichthyosis-sclerosing cholangitis syndrome,Entity
BLVRB,Entity
ZNF232,Entity
Glimepiride,Entity
Increased hepatitis B virus antibody level,Entity
LINC00673,Entity
SERPINB3,Entity
pancreatic small cell neuroendocrine carcinoma,Entity
GTPBP2,Entity
FZD3,Entity
LDB1,Entity
MIR217,Entity
Abnormality of the lymph nodes,Entity
Phenoxybenzamine,Entity
Carbofuran,Entity
Irregular hyperpigmentation,Entity
Treprostinil,Entity
Sorbitol,Entity
Cefamandole,Entity
CALCOCO2,Entity
Amikacin,Entity
functional diarrhea,Entity
NR1I3,Entity
HTATIP2,Entity
Low levels of vitamin D,Entity
Salivary gland neoplasm,Entity
Meclocycline,Entity
MIR181C,Entity
CHN2,Entity
Ifosfamide,Entity
MINK1,Entity
Trolnitrate,Entity
Atenolol,Entity
MORF4L1,Entity
colon Burkitt lymphoma,Entity
ZNF559,Entity
cystic fibrosis associated meconium ileus,Entity
COL5A2,Entity
PRKCB,Entity
Leukodystrophy,Entity
Cholesterol gallstones,Entity
Eszopiclone,Entity
CENPH,Entity
CYP2B6,Entity
small intestinal Burkitt lymphoma,Entity
Dorzolamide,Entity
MIR485,Entity
ODC1,Entity
Doxercalciferol,Entity
PKMYT1,Entity
squamous cell carcinoma of liver and intrahepatic biliary tract,Entity
ZNF177,Entity
"2,4-Dichlorophenoxyacetic Acid",Entity
liver inflammatory myofibroblastic tumor,Entity
Aluminum,Entity
Retinal infarction,Entity
Cirrhosis,Entity
Brodalumab,Entity
PLAT,Entity
CFLAR,Entity
HMGA1,Entity
Abnormal blistering of the skin,Entity
Prasugrel,Entity
TRAP1,Entity
cavernous hemangioma,Entity
megacystis-microcolon-intestinal hypoperistalsis syndrome,Entity
gastrointestinal mucositis,Entity
Benzoyl peroxide,Entity
CACNA2D1,Entity
GLIS3,Entity
SLC22A5,Entity
CXCL11,Entity
Motor polyneuropathy,Entity
Sirolimus,Entity
Lanthanum carbonate,Entity
FGFR4,Entity
GSE1,Entity
fibrosarcoma (disease),Entity
Hyperammonemia,Entity
Pancrelipase,Entity
Delayed puberty,Entity
GATA4,Entity
Lipoma,Entity
CCL2,Entity
SMAD4,Entity
Lomustine,Entity
CBS,Entity
extrahepatic cholestasis,Entity
IFNA1,Entity
aryepiglottic fold cancer,Entity
Mezlocillin,Entity
MIR375,Entity
Methylphenobarbital,Entity
Benzylpenicillin,Entity
Metronidazole,Entity
Furrowed tongue,Entity
Ferric oxide,Entity
congenital intestinal transport defect,Entity
NOD2,Entity
mouth disease,Entity
Somatic mutation,Entity
H1-5,Entity
Atrial septal defect,Entity
KIF20A,Entity
Amphetamine,Entity
CEBPD,Entity
HP,Entity
Metamfetamine,Entity
UTP4,Entity
SERPINE1,Entity
bile duct papillary neoplasm,Entity
T lymphocytopenia,Entity
ACTN4,Entity
PRKCE,Entity
biliary tract cancer,Entity
Abnormal vertebral morphology,Entity
ATP7A,Entity
Paroxetine,Entity
Carmustine,Entity
Patent ductus arteriosus,Entity
familial gastric type 1 neuroendocrine tumor,Entity
TBCK,Entity
MARCHF8,Entity
KRT14,Entity
KDR,Entity
CAP1,Entity
Nilutamide,Entity
Uterus didelphys,Entity
ID3,Entity
Tropicamide,Entity
MMP1,Entity
Increased factor VIII activity,Entity
Elevated hepatic transaminase,Entity
Isoflurane,Entity
Defibrotide,Entity
Neuroendocrine neoplasm,Entity
Albendazole,Entity
SLC12A5,Entity
FMO3,Entity
MIR154,Entity
erythropoietic protoporphyria,Entity
Chronic colitis,Entity
Vinblastine,Entity
Chlorpromazine,Entity
lip carcinoma in situ,Entity
BCL2L1,Entity
diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency,Entity
Duodenal polyposis,Entity
HFE,Entity
F2,Entity
ZNF23,Entity
muscular disease,Entity
Intractable diarrhea,Entity
"2,4,4'-trichlorobiphenyl",Entity
GBP5,Entity
BRD1,Entity
congenital central hypoventilation syndrome,Entity
TGFBR1,Entity
Hypopigmented skin patches,Entity
Tofogliflozin,Entity
MAGI1,Entity
Cimetidine,Entity
LRRC3B,Entity
Alogliptin,Entity
Poldine,Entity
ETFA,Entity
Agnosia,Entity
recurrent acute pancreatitis,Entity
Neonatal unconjugated hyperbilirubinemia,Entity
TBX3,Entity
MPO,Entity
Recurrent viral infections,Entity
embryonal neoplasm,Entity
Facial telangiectasia,Entity
Probenecid,Entity
THY1,Entity
CFL1,Entity
Hydromorphone,Entity
insulin-resistance syndrome,Entity
Chlorpheniramine,Entity
Atazanavir,Entity
MTUS1,Entity
annular pancreas,Entity
Cestode infectious disease,Entity
TIAM1,Entity
EPHA2,Entity
Cerebellar hypoplasia,Entity
ARFGAP2,Entity
RELN,Entity
Cetirizine,Entity
gastric neoplasm,Entity
MSH6,Entity
MTDH,Entity
ZCCHC12,Entity
PTCH1,Entity
Tacrine,Entity
CXCL1,Entity
Bezlotoxumab,Entity
DLC1,Entity
Trimipramine,Entity
peptic ulcer disease,Entity
Neonatal cholestatic liver disease,Entity
Tungsten,Entity
HMGB1,Entity
CYCS,Entity
Insulin lispro,Entity
Blindness,Entity
SESN2,Entity
Penthienate,Entity
Abnormality of the liver,Entity
Trimethoprim,Entity
Dicyclomine,Entity
RCOR1,Entity
Magnesium chloride,Entity
thiopurine immunosuppressant-induced pancreatitis,Entity
Autoimmune hemolytic anemia,Entity
TMEM70,Entity
White eyelashes,Entity
SOD2,Entity
DDC,Entity
"ileal neuroendocrine tumor, well differentiated, low or intermediate grade",Entity
Ranitidine,Entity
STAT3,Entity
Abnormality of the uterus,Entity
Azlocillin,Entity
MTR,Entity
Adalimumab,Entity
FADS1,Entity
Acarbose,Entity
CDCA8,Entity
MEN1,Entity
SLCO1B3,Entity
choledochal cyst,Entity
GC,Entity
Pain insensitivity,Entity
MRPS11,Entity
SMAD7,Entity
carcinoma of the ampulla of vater,Entity
TSC22D3,Entity
proton-pump inhibitor-responsive esophageal eosinophilia,Entity
CCKAR,Entity
IRX4,Entity
TCF7L2,Entity
CTLA4,Entity
biliary atresia intrahepatic,Entity
Zopiclone,Entity
NPM1,Entity
Paraparesis,Entity
perfluorooctanoic acid,Entity
Cholestatic liver disease,Entity
biliary atresia,Entity
Decreased circulating IgG level,Entity
Fusidic acid,Entity
TPM2,Entity
Cardiomyopathy,Entity
colorectal adenocarcinoma,Entity
MIR539,Entity
infantile multisystem neurologic-endocrine-pancreatic disease,Entity
FGF4,Entity
SLC29A3,Entity
Iron,Entity
HAT1,Entity
CDH2,Entity
diverticulitis of colon,Entity
Death in infancy,Entity
Feeding difficulties in infancy,Entity
LAMB1,Entity
PRKAB1,Entity
Mild global developmental delay,Entity
Decreased body weight,Entity
MYLK3,Entity
SNRNP200,Entity
HTR1A,Entity
alcoholic liver cirrhosis,Entity
ARHGEF39,Entity
gastric ulcer (disease),Entity
DTL,Entity
acute diarrhea,Entity
hepatocellular carcinoma,Entity
IQGAP2,Entity
Deferasirox,Entity
Elagolix,Entity
cheek mucosa cancer,Entity
Abnormality of urine homeostasis,Entity
LETM1,Entity
Paclitaxel,Entity
choriocarcinoma (disease),Entity
Sulfamethizole,Entity
Warfarin,Entity
giardiasis,Entity
CREBBP,Entity
VIPR1,Entity
primary lymphedema,Entity
RCAN1,Entity
ZIC5,Entity
IGF2BP3,Entity
MIR337,Entity
ITPR1,Entity
COX1,Entity
PYY,Entity
malignant gastric germ cell tumor,Entity
hyperinsulinism due to UCP2 deficiency,Entity
CCR4,Entity
Recurrent infections,Entity
Hyperperistalsis,Entity
FAS,Entity
Glycerin,Entity
Ethotoin,Entity
Torasemide,Entity
F3,Entity
Levodopa,Entity
FASN,Entity
GCLM,Entity
Delavirdine,Entity
Terbutaline,Entity
Acute kidney injury,Entity
RASSF1,Entity
BHMT,Entity
HLA-DQB1,Entity
bile duct cystadenoma,Entity
carcinoma of liver and intrahepatic biliary tract,Entity
ATP6V1D,Entity
Polaprezinc,Entity
aroclor 1260,Entity
Telavancin,Entity
Donohue syndrome,Entity
intestinal lymphangiectasia,Entity
OAT,Entity
Hematological neoplasm,Entity
HDC,Entity
WDR62,Entity
ZWINT,Entity
adenosquamous carcinoma,Entity
granular cell cancer,Entity
Benzthiazide,Entity
MIR200A,Entity
MIR128-1,Entity
CNPY2,Entity
Chronic pulmonary obstruction,Entity
PTPN3,Entity
LSP1,Entity
EFNB2,Entity
Carcinoma,Entity
Insecticides,Entity
MMP3,Entity
pancreatic insulin-producing neuroendocrine tumor,Entity
DDT,Entity
ZIM2,Entity
Methyltestosterone,Entity
Nitazoxanide,Entity
PAK5,Entity
CAP2,Entity
Memantine,Entity
ATP6V0D2,Entity
CABLES1,Entity
CNDP2,Entity
Labetalol,Entity
Esophageal varix,Entity
RAF1,Entity
Nisoldipine,Entity
Clomifene,Entity
TFF1,Entity
Pentoxifylline,Entity
RXRB,Entity
Renal neoplasm,Entity
SIRT7,Entity
pancreatic endocrine carcinoma,Entity
PSCA,Entity
papillary adenocarcinoma,Entity
AHCY,Entity
Barium,Entity
Osmotic diarrhea,Entity
polyp of colon,Entity
"hepatic adenomas, familial",Entity
GPR182,Entity
type 1 diabetes mellitus,Entity
Pentaerithrityl,Entity
CYP3A4,Entity
Potassium bicarbonate,Entity
Diphenoxylate,Entity
paralytic ileus (disease),Entity
REEP5,Entity
Tazobactam,Entity
Silver sulfadiazine,Entity
CCT5,Entity
Autoimmune antibody positivity,Entity
Pibrentasvir,Entity
nasopharyngeal neoplasm,Entity
Global developmental delay,Entity
intestinal motility disease,Entity
Imipenem,Entity
Triprolidine,Entity
eosinophilic esophagitis,Entity
RELA,Entity
CPT1B,Entity
TENM1,Entity
Tiludronic acid,Entity
Functional abnormality of the gastrointestinal tract,Entity
gastric cardia carcinoma,Entity
LCAT,Entity
Cyanosis,Entity
PAMR1,Entity
stomach disease,Entity
chronic mucocutaneous candidiasis (disease),Entity
pancreatitis,Entity
alcoholic hepatitis,Entity
Midclavicular hypoplasia,Entity
Intestinal bleeding,Entity
colon neuroendocrine neoplasm,Entity
juvenile polyposis of infancy,Entity
YIF1A,Entity
Neurological speech impairment,Entity
Crohn's colitis,Entity
CSTB,Entity
ACTC1,Entity
BCL2A1,Entity
OGDH,Entity
TSC2,Entity
Risperidone,Entity
ACTB,Entity
extrahepatic bile duct small cell adenocarcinoma,Entity
Abacavir,Entity
CA1,Entity
Rivaroxaban,Entity
SCARB1,Entity
congenital short bowel syndrome 1,Entity
Dinoprostone,Entity
Cholestasis,Entity
LRRC1,Entity
ABLIM2,Entity
PPP4R3C,Entity
TNFSF9,Entity
Chloramphenicol,Entity
P2RX7,Entity
Metals,Entity
pyriform sinus cancer,Entity
Anal atresia,Entity
MIR520B,Entity
Canagliflozin,Entity
Dysarthria,Entity
Doxorubicin,Entity
KIF11,Entity
KRT19,Entity
gastric linitis plastica,Entity
Amoxicillin,Entity
FZD4,Entity
Increased circulating antibody level,Entity
Synophrys,Entity
CKB,Entity
PZP,Entity
FANCG,Entity
CLPTM1,Entity
AADAT,Entity
sclerosing cholangitis,Entity
PEPD,Entity
KRT18,Entity
RCN1,Entity
Ramucirumab,Entity
HTRA1,Entity
Atovaquone,Entity
4-hydroxyphenylacetic aciduria,Entity
Excessive daytime somnolence,Entity
Cilostazol,Entity
disease of pharynx,Entity
HADHA,Entity
MAFG,Entity
exocrine pancreatic insufficiency,Entity
EPS8L3,Entity
MAFA,Entity
Tetracycline,Entity
Maternal diabetes,Entity
Biliary tract abnormality,Entity
small intestine disease,Entity
Rifamycin,Entity
ACAP1,Entity
Heterogeneous,Entity
cutaneous photosensitivity-lethal colitis syndrome,Entity
acute liver failure,Entity
Nausea and vomiting,Entity
tuberculosis,Entity
RHOA,Entity
Polycystic ovaries,Entity
SDHA,Entity
SLC51B,Entity
NCAPH,Entity
TRIM24,Entity
inherited porphyria,Entity
Indinavir,Entity
EVL,Entity
Moexipril,Entity
beta-hexachlorocyclohexane,Entity
MCM10,Entity
Liothyronine,Entity
Telithromycin,Entity
Fulvestrant,Entity
Hyoscyamine,Entity
Saxagliptin,Entity
peptic esophagitis,Entity
Fluconazole,Entity
Bethanechol,Entity
RRP9,Entity
Etretinate,Entity
generalized juvenile polyposis/juvenile polyposis coli,Entity
Elevated erythrocyte sedimentation rate,Entity
ASCL1,Entity
Mefenamic acid,Entity
digestive system disease,Entity
ITGA5,Entity
SERPINB5,Entity
KLF6,Entity
CEACAM1,Entity
dermatitis,Entity
appendix adenoma,Entity
ASPG,Entity
Zinc,Entity
Ergocalciferol,Entity
CRABP1,Entity
ANGPTL6,Entity
Generalized osteoporosis,Entity
MARCKS,Entity
Fomepizole,Entity
LRP1,Entity
AKAP12,Entity
Hypomagnesemia,Entity
ECT2,Entity
KCND3,Entity
Wheezing,Entity
hypopharynx cancer,Entity
GFI1,Entity
DEPDC1,Entity
Abnormal renal morphology,Entity
HSPA5,Entity
Procainamide,Entity
GSK3B,Entity
Tadalafil,Entity
ITIH3,Entity
HHIP,Entity
BUB1B,Entity
Sulindac,Entity
Cronkhite-Canada syndrome,Entity
GLP1R,Entity
Dextropropoxyphene,Entity
GDA,Entity
CUX1,Entity
Daclatasvir,Entity
TBL1XR1,Entity
Salicylamide,Entity
gallbladder papillary neoplasm,Entity
Coenzyme M,Entity
ANXA2,Entity
INSR,Entity
Methacholine,Entity
Fluphenazine,Entity
Rizatriptan,Entity
EDNRB,Entity
Quinidine,Entity
Maraviroc,Entity
systemic autoimmune disease,Entity
Abnormality of metabolism/homeostasis,Entity
Abnormality of the nose,Entity
Repaglinide,Entity
Dihydroergotamine,Entity
RTP3,Entity
BCL11B,Entity
Thickened skin,Entity
cholangiolocellular carcinoma,Entity
Insulin degludec,Entity
FAM180A,Entity
PAX3,Entity
ampulla of vater adenocarcinoma,Entity
gallbladder neuroendocrine neoplasm,Entity
Paraplegia,Entity
MTOR,Entity
Hematemesis,Entity
Leukocytosis,Entity
EGLN1,Entity
Papule,Entity
ZNF667-AS1,Entity
RHPN2,Entity
FCGR3A,Entity
Bexarotene,Entity
COX7B2,Entity
SEMA3D,Entity
colitis (disease),Entity
MIRLET7I,Entity
PRKCSH,Entity
Cefuroxime,Entity
CD276,Entity
CLN3,Entity
CDKN1A,Entity
salmonellosis,Entity
Skin ulcer,Entity
Bendroflumethiazide,Entity
dysentery,Entity
Polyethylene glycol,Entity
Abnormal vascular morphology,Entity
Ticlopidine,Entity
Triptorelin,Entity
CCNE1,Entity
Variable expressivity,Entity
Arthralgia,Entity
PARK7,Entity
Diabetic ketoacidosis,Entity
Mibefradil,Entity
Gout,Entity
Sleep disturbance,Entity
Titanium,Entity
Eczema,Entity
Cholangitis,Entity
"hirschsprung disease, susceptibility to",Entity
Lurasidone,Entity
Zidovudine,Entity
Burkitt lymphoma,Entity
TCF3,Entity
TNFRSF10A,Entity
Waardenburg syndrome,Entity
TK1,Entity
TRIO,Entity
CCNB2,Entity
Parathion,Entity
chronic diarrhea with villous atrophy,Entity
AXIN1,Entity
Amobarbital,Entity
Manganese,Entity
Migraine,Entity
APC2,Entity
CDC25C,Entity
BCO2,Entity
STAC3,Entity
GLI3,Entity
Chlorothiazide,Entity
MYBL2,Entity
Doripenem,Entity
JAG1,Entity
MAML3,Entity
CD5L,Entity
Low levels of vitamin K,Entity
rheumatologic disorder,Entity
Simeprevir,Entity
acetochlor,Entity
rectal villous adenoma,Entity
FOXP1,Entity
MIR29A,Entity
PBRM1,Entity
glucose intolerance,Entity
disease of genitourinary system,Entity
Cholestyramine,Entity
sarcomatoid carcinoma,Entity
ROR1,Entity
Pentamidine,Entity
gastric hemangioma,Entity
Ephedrine,Entity
Phthalic Acids,Entity
Zollinger-Ellison syndrome,Entity
Levothyroxine,Entity
Triamcinolone,Entity
S100A9,Entity
AMACR,Entity
Ertapenem,Entity
ampulla of vater small cell neuroendocrine carcinoma,Entity
Dichlorodiphenyl Dichloroethylene,Entity
Tiagabine,Entity
Cisapride,Entity
Dirithromycin,Entity
Abnormal bleeding,Entity
ANXA6,Entity
UGT1A9,Entity
Peripheral neuropathy,Entity
GDF2,Entity
Miglitol,Entity
KIF23,Entity
CHFR,Entity
CYP2E1,Entity
liver cancer,Entity
CD40,Entity
XIAP,Entity
carcinoma in situ of gastric cardia,Entity
Neoplasm of the liver,Entity
ACOX1,Entity
LY6E,Entity
Colchicine,Entity
Tramazoline,Entity
Choanal atresia,Entity
"2,2',4,4'-tetrabromodiphenyl ether",Entity
IL2,Entity
pancreatic neoplasm,Entity
Erythema,Entity
Phenelzine,Entity
UCHL1,Entity
PDGFRB,Entity
ASNS,Entity
EPHA8,Entity
Insulin aspart,Entity
Cutaneous photosensitivity,Entity
Drospirenone,Entity
PON1,Entity
ADA,Entity
Glipizide,Entity
scleroderma (disease),Entity
HMG20A,Entity
Bilateral cryptorchidism,Entity
KRT7,Entity
SCO1,Entity
XRCC1,Entity
Naproxen,Entity
Lead,Entity
IFNA2,Entity
benign neoplasm of esophagus,Entity
pancreatic adenocarcinoma,Entity
MIR369,Entity
lipoatrophic diabetes,Entity
acquired polycythemia vera,Entity
IGF2,Entity
Nephrotic syndrome,Entity
Dronedarone,Entity
Joint stiffness,Entity
intestinal neuroendocrine tumor G1,Entity
stomach carcinoma in situ,Entity
Norgestimate,Entity
HLA-DRB1,Entity
SPART,Entity
CSNK1A1L,Entity
Desirudin,Entity
"Sodium phosphate, monobasic",Entity
Malignant genitourinary tract tumor,Entity
Streptozocin,Entity
CAT,Entity
Lactulose,Entity
MDM2,Entity
NDC80,Entity
Bone pain,Entity
Hypovolemia,Entity
glycogen storage disease due to phosphorylase kinase deficiency,Entity
Urinary retention,Entity
Carboplatin,Entity
ERBB3,Entity
Difenoxin,Entity
Aluminum hydroxide,Entity
SLCO1A2,Entity
LIG3,Entity
Perazine,Entity
RASA1,Entity
WWOX,Entity
Codeine,Entity
Fenoprofen,Entity
Thiotepa,Entity
UGT1A4,Entity
Diazepam,Entity
Benzocaine,Entity
ATP7B,Entity
hepatic porphyria,Entity
IER3IP1,Entity
Nafcillin,Entity
RIPK3,Entity
head and neck cancer,Entity
IRF5,Entity
Pyrazinamide,Entity
Etravirine,Entity
AKR1C3,Entity
Fluorouracil,Entity
Isocarboxazid,Entity
Ritonavir,Entity
HMGB2,Entity
PLVAP,Entity
KIF21B,Entity
ACVR2A,Entity
Ketoconazole,Entity
Fasting hypoglycemia,Entity
Orciprenaline,Entity
Certolizumab pegol,Entity
NRSN1,Entity
NDST1,Entity
Chlorcyclizine,Entity
SLC16A2,Entity
Hirschsprung disease,Entity
DGKD,Entity
Oxytetracycline,Entity
refractory celiac disease,Entity
liver neuroendocrine carcinoma,Entity
ABCC5,Entity
Silicon dioxide,Entity
DGAT1,Entity
STK11,Entity
Empagliflozin,Entity
TPM3,Entity
PRNP,Entity
Elbasvir,Entity
DAXX,Entity
Mepenzolate,Entity
UBE2L3,Entity
Heart murmur,Entity
Lacosamide,Entity
Vertebral segmentation defect,Entity
Abnormality of the endocrine system,Entity
Isotretinoin,Entity
UTP25,Entity
HMGN5,Entity
ZNF572,Entity
PTH1R,Entity
EEF1A1,Entity
Eletriptan,Entity
ADD1,Entity
CEBPB,Entity
Fluvastatin,Entity
MAPK8IP1,Entity
RARA,Entity
CYP2C8,Entity
Vorinostat,Entity
hepatic granuloma,Entity
TFRC,Entity
Bortezomib,Entity
PRKCA,Entity
TNFRSF1B,Entity
Eosinophilia,Entity
Carbidopa,Entity
hepatic angiomyolipoma,Entity
NRP1,Entity
MYD88,Entity
Clopidogrel,Entity
Headache,Entity
BMP7,Entity
Synephrine,Entity
FCGR2A,Entity
Alimemazine,Entity
Magnesium citrate,Entity
CAV1,Entity
CYP2C19,Entity
Dimenhydrinate,Entity
Isoprenaline,Entity
Cefoperazone,Entity
TLK1,Entity
primary biliary cholangitis,Entity
Intestinal duplication,Entity
Alprazolam,Entity
AFP,Entity
VIM,Entity
Propylthiouracil,Entity
Midazolam,Entity
SCNN1G,Entity
IL17A,Entity
Azatadine,Entity
diarrheal disease,Entity
Methotrimeprazine,Entity
Dapsone,Entity
Polychlorinated Biphenyls,Entity
FLNA,Entity
Methscopolamine,Entity
CD3E,Entity
RGS2,Entity
WNT16,Entity
PRKCQ,Entity
Benzene,Entity
Epistaxis,Entity
GATA2,Entity
Xylometazoline,Entity
Mirtazapine,Entity
Decreased liver function,Entity
CRYAB,Entity
Nephrolithiasis,Entity
IRS2,Entity
Dipyridamole,Entity
cryptorchidism (disease),Entity
Methadone,Entity
Papaverine,Entity
Ethadione,Entity
Amiloride,Entity
gallbladder neoplasm,Entity
Clozapine,Entity
Flucytosine,Entity
Atomoxetine,Entity
Daunorubicin,Entity
NOTCH1,Entity
Nelfinavir,Entity
Naphazoline,Entity
BRF1,Entity
SMYD2,Entity
PAX8,Entity
KDM5B,Entity
BCL2,Entity
MT1G,Entity
CCNA1,Entity
Prostate cancer,Entity
anus neoplasm,Entity
NTHL1,Entity
AMDHD2,Entity
CACUL1,Entity
appendix adenocarcinoma,Entity
carcinoma in situ of appendix,Entity
FDFT1,Entity
SFXN1,Entity
Anal stenosis,Entity
PLXDC1,Entity
SLC16A3,Entity
ALDH4A1,Entity
FOSB,Entity
PLOD2,Entity
ZFAND3,Entity
ETV1,Entity
VHL,Entity
GDF15,Entity
SALL4,Entity
TAF15,Entity
TOMM40L,Entity
Anorexia,Entity
Membranous nephropathy,Entity
caudal duplication,Entity
isolated congenital hepatic fibrosis,Entity
duodenogastric reflux,Entity
chemically-induced disorder,Entity
Renal tubular lysine transport defect,Entity
Hyperlysinuria,Entity
SLC33A1,Entity
islet cell adenomatosis,Entity
SLC22A3,Entity
Dofetilide,Entity
FCN1,Entity
SLC23A2,Entity
Abnormality of the vasculature,Entity
"Intellectual disability, mild",Entity
Panhypogammaglobulinemia,Entity
Trichorrhexis nodosa,Entity
Uncombable hair,Entity
Increased mean platelet volume,Entity
Polycystic kidney dysplasia,Entity
Hypoplasia of the thymus,Entity
Generalized hypopigmentation,Entity
primary immunodeficiency due to a genetic defect in innate immunity,Entity
genetic parenchymatous liver disease,Entity
CDH3,Entity
HERC2,Entity
Cerebral arteriovenous malformation,Entity
Metabolic ketoacidosis,Entity
Fluoxymesterone,Entity
soft palate cancer,Entity
ARG2,Entity
multisystemic smooth muscle dysfunction syndrome,Entity
GHR,Entity
Weakness of muscles of respiration,Entity
squamous cell carcinoma of rectum,Entity
GNAS,Entity
PRL,Entity
RASL11A,Entity
MIR21,Entity
CDKN2B-AS1,Entity
endometriosis of intestine,Entity
mono-(2-ethylhexyl)phthalate,Entity
Hemiparesis,Entity
Pancreatic cysts,Entity
Intracranial cystic lesion,Entity
mucinous cystadenocarcinoma,Entity
colon adenocarcinoma,Entity
neurometabolic disease,Entity
HLA-C,Entity
ZC3HC1,Entity
CDC14A,Entity
MFN1,Entity
intestinal neoplasm,Entity
Hypoplastic fingernail,Entity
Alagille syndrome due to 20p12 microdeletion,Entity
ADIPOQ,Entity
Extrahepatic cholestasis,Entity
Hepatosplenomegaly,Entity
Ovarian carcinoma,Entity
Peritoneal abscess,Entity
SPINK1,Entity
SSTR3,Entity
SUGCT,Entity
PCWH syndrome,Entity
dyspepsia,Entity
IL10RB,Entity
CDO1,Entity
PPOX,Entity
Long nose,Entity
Triangular face,Entity
bile duct adenoma,Entity
Beta-cell dysfunction,Entity
Anorectal anomaly,Entity
Rectal atresia,Entity
IRGM,Entity
perianal Crohn disease,Entity
small bowel Crohn disease,Entity
Crohn disease of the esophagus,Entity
polycystic liver disease 4 with or without kidney cysts,Entity
Pesticides,Entity
chronic atrial and intestinal dysrhythmia,Entity
colonic disease,Entity
benign neoplasm of large intestine,Entity
colorectal Kaposi sarcoma,Entity
NAT2,Entity
ADH4,Entity
APOF,Entity
CDKN3,Entity
KCNN2,Entity
NOTCH3,Entity
ZIC2,Entity
GINS1,Entity
KBTBD11,Entity
UBD,Entity
HPSE,Entity
STAB2,Entity
NCAPG,Entity
MFSD2A,Entity
Abnormality of the thyroid gland,Entity
Increased circulating gonadotropin level,Entity
Elevated calcitonin,Entity
pancreatic vasoactive intestinal peptide producing tumor,Entity
Unconjugated hyperbilirubinemia,Entity
liver neoplasm,Entity
Papilloma,Entity
Retinal detachment,Entity
Nephropathy,Entity
DNAJC12,Entity
Eosinophilic infiltration of the esophagus,Entity
Eosinophilic microabscess formation in the esophagus,Entity
bacterial esophagitis,Entity
viral esophagitis,Entity
Increased hepatic glycogen content,Entity
diazoxide-resistant hyperinsulinism,Entity
neoplasm of minor salivary gland,Entity
Cholelithiasis,Entity
SRP72,Entity
Type I diabetes mellitus,Entity
Ventriculomegaly,Entity
Severe infection,Entity
Coombs-positive hemolytic anemia,Entity
"Reduced proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells",Entity
Nasogastric tube feeding,Entity
Inulin,Entity
Cianidanol,Entity
Chromium picolinate,Entity
Chronic constipation,Entity
Acute constipation,Entity
outlet dysfunction constipation,Entity
bowel dysfunction,Entity
SLC5A6,Entity
GGH,Entity
GNG7,Entity
SCG5,Entity
EOMES,Entity
"small intestine neuroendocrine tumor, well differentiated, low or intermediate grade",Entity
"gastric neuroendocrine tumor, well differentiated, low or intermediate grade",Entity
"neuroendocrine tumor of rectum, well differentiated, low or intermediate grade",Entity
pregnancy disorder,Entity
MIR193B,Entity
prediabetes syndrome,Entity
pancreatic serous cystadenocarcinoma,Entity
cholangitis,Entity
PGM1,Entity
CSE1L,Entity
periampullary adenoma,Entity
ampulla of vater neoplasm,Entity
duodenal neuroendocrine neoplasm,Entity
larynx cancer,Entity
Infantile onset,Entity
Decreased mucosal sucrase-isomaltase activity,Entity
Abdominal colic,Entity
intestinal disaccharidase deficiency,Entity
congenital sucrase-isomaltase deficiency with starch intolerance,Entity
congenital sucrase-isomaltase deficiency with minimal starch tolerance,Entity
congenital sucrase-isomaltase deficiency without starch intolerance,Entity
congenital sucrase-isomaltase deficiency with starch and lactose intolerance,Entity
global disaccharide intolerance,Entity
ZZZ3,Entity
ZNF593,Entity
rectum adenoma,Entity
Neurofibromas,Entity
Muir-Torre syndrome,Entity
Infantile muscular hypotonia,Entity
bile reflux,Entity
postcholecystectomy syndrome,Entity
primary intrahepatic lithiasis,Entity
idiopathic ductopenia,Entity
SEMA4A,Entity
NOX1,Entity
Anal canal squamous cell carcinoma,Entity
benign neoplasm of appendix,Entity
esophageal melanoma,Entity
CAD,Entity
perianal skin Paget disease,Entity
Type D brachydactyly,Entity
Short thumb,Entity
Short distal phalanx of the thumb,Entity
Short phalanx of hallux,Entity
HCFC1,Entity
RNF34,Entity
RPAP1,Entity
EDRF1,Entity
GUCY1A1,Entity
leukocyte disease,Entity
WDR49,Entity
GAS6,Entity
EFS,Entity
PCSK2,Entity
Large hands,Entity
C2CD3,Entity
IFT52,Entity
DISP1,Entity
mesenchymal tumor of small intestine,Entity
pancreas lymphoma,Entity
Insulin-resistant diabetes mellitus,Entity
tubular adenoma,Entity
cholecystolithiasis,Entity
Onycholysis,Entity
AMTN,Entity
Pancreatic hypoplasia,Entity
DPP10,Entity
ZNHIT6,Entity
GFER,Entity
non-syndromic visceral malformation,Entity
ADAM11,Entity
Food intolerance,Entity
Gastroschisis,Entity
Temperature instability,Entity
Abnormal glucose homeostasis,Entity
Neonatal sepsis,Entity
CRYL1,Entity
SNAI3,Entity
extrahepatic bile duct signet ring cell carcinoma,Entity
rectosigmoid junction neoplasm,Entity
polyendocrine-polyneuropathy syndrome,Entity
OSBP,Entity
xanthogranulomatous cholecystitis,Entity
acute cholecystitis,Entity
colon adenoma,Entity
SELENBP1,Entity
Aflibercept,Entity
metastatic malignant neoplasm,Entity
ARAP3,Entity
ascending colon neuroendocrine tumor G1,Entity
cecum neuroendocrine tumor G1,Entity
jejunal neuroendocrine tumor G1,Entity
GHRHR,Entity
floor of mouth mucoepidermoid carcinoma,Entity
mucoepidermoid carcinoma,Entity
Dermatological manifestations of systemic disorders,Entity
jejunal somatostatinoma,Entity
jejunal neoplasm,Entity
fibroma,Entity
STS,Entity
RAMP2,Entity
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia,Entity
SNX18,Entity
schistosomiasis,Entity
CHGA,Entity
ACIN1,Entity
LAMB3,Entity
MSX1,Entity
pancreatic intraductal papillary-mucinous neoplasm,Entity
diphtheritic peritonitis,Entity
Giant hypertrophic gastritis,Entity
Helicobacter pylori infection,Entity
TYRP1,Entity
UGT2B17,Entity
gastric tubular adenocarcinoma,Entity
mucinous cystadenoma,Entity
intestinal infectious disease,Entity
villous adenoma,Entity
GLO1,Entity
Juvenile gastrointestinal polyposis,Entity
Juvenile colonic polyposis,Entity
collagenous colitis,Entity
GRIK3,Entity
MIR127,Entity
MIR193A,Entity
MIR34B,Entity
MIR34C,Entity
MIR302D,Entity
MIR511,Entity
MIR938,Entity
gallstones,Entity
TIMP2,Entity
LDLR,Entity
Microangiopathic hemolytic anemia,Entity
Hyperlordosis,Entity
Skeletal muscle hypertrophy,Entity
HLA-DQA1,Entity
GDI2,Entity
Restlessness,Entity
GAS2,Entity
MYCBP,Entity
CNTN6,Entity
STAG3L1,Entity
EFHD1,Entity
minor salivary gland adenoid cystic carcinoma,Entity
imperforate anus,Entity
anal spasm,Entity
Mebendazole,Entity
sarcoma,Entity
rectum rhabdomyosarcoma,Entity
anus sarcoma,Entity
rectum leiomyosarcoma,Entity
bile duct sarcoma,Entity
liver extraskeletal osteosarcoma,Entity
undifferentiated (embryonal) sarcoma,Entity
XBP1,Entity
ALOX15,Entity
Ammonia,Entity
Atrazine,Entity
PCP4,Entity
EPHA1,Entity
Proximal esophageal atresia,Entity
Arroyo Garcia Cimadevilla syndrome,Entity
MIR126,Entity
Adenocarcinoma of the colon,Entity
TMEM164,Entity
ELMO1,Entity
COPS7A,Entity
intraepithelial neoplasia,Entity
Green urine,Entity
OTOP2,Entity
colonic L-cell glucagon-like peptide producing tumor,Entity
PLIN2,Entity
FGF21,Entity
MIR139,Entity
MIR17,Entity
MIR148B,Entity
MIR384,Entity
MIR503,Entity
MIR449C,Entity
B3GAT1,Entity
GJC2,Entity
SDF4,Entity
hereditary neuroendocrine tumor of small intestine,Entity
SOD3,Entity
small intestinal diffuse large B-cell lymphoma,Entity
neurofibroma of the esophagus,Entity
Uterine leiomyosarcoma,Entity
DMBT1,Entity
FZD2,Entity
HMGCS2,Entity
PTP4A3,Entity
MIR223,Entity
ADCY8,Entity
ABCD2,Entity
AMPD1,Entity
DPAGT1,Entity
DPYSL2,Entity
FOLH1,Entity
GRID2,Entity
IPP,Entity
KCNA10,Entity
NODAL,Entity
NRCAM,Entity
OVGP1,Entity
ABCE1,Entity
SNRPB2,Entity
ZNF155,Entity
CUBN,Entity
OR1E2,Entity
DCHS1,Entity
NEURL1,Entity
KCNB2,Entity
NDST3,Entity
FADS2,Entity
ZNF432,Entity
PAN2,Entity
ABCA9,Entity
ABCA8,Entity
UNC13B,Entity
AKAP3,Entity
POSTN,Entity
DIP2C,Entity
NCDN,Entity
LPIN1,Entity
VPS13A,Entity
KCNH4,Entity
NPAP1,Entity
CHD5,Entity
CPAMD8,Entity
PCDH11X,Entity
DONSON,Entity
CINP,Entity
GPR87,Entity
DNAH3,Entity
INTS13,Entity
FSTL5,Entity
DSCAML1,Entity
ZNF624,Entity
HIVEP3,Entity
SOX17,Entity
CDH22,Entity
SLC26A10,Entity
BOLL,Entity
GDAP1L1,Entity
ZNF385D,Entity
MMRN2,Entity
ZNF442,Entity
CEBPA-DT,Entity
ZKSCAN3,Entity
ZSCAN16,Entity
HPS3,Entity
FAM110B,Entity
DSEL,Entity
C8orf34,Entity
B4GALNT2,Entity
NLRP8,Entity
KDF1,Entity
CPO,Entity
FRMPD2,Entity
PHETA1,Entity
PRIMA1,Entity
ABCA13,Entity
LONRF2,Entity
ADAMTS15,Entity
VSTM4,Entity
GJD4,Entity
FERD3L,Entity
ITPRID1,Entity
TCERG1L,Entity
CCDC9B,Entity
TMEM238L,Entity
MIR1273C,Entity
colorectal lymphoma,Entity
vallecula cancer,Entity
Renal artery stenosis,Entity
pleomorphic adenoma,Entity
Serrated intestinal polyps,Entity
Extrahepatic portal hypertension,Entity
nodular regenerative hyperplasia of the liver,Entity
intractable diarrhea-choanal atresia-eye anomalies syndrome,Entity
CDS1,Entity
Abnormal platelet aggregation,Entity
gallbladder lipoma,Entity
lipoma of stomach,Entity
CST1,Entity
MLF1,Entity
THBD,Entity
FCGBP,Entity
MIR22HG,Entity
genetic gastro-esophageal disease,Entity
Sulfacetamide,Entity
autoimmune disease of gastrointestinal tract,Entity
Iodine,Entity
congenital secretory diarrhea,Entity
esophageal granular cell tumor,Entity
splenic abscess (disease),Entity
fungal gastritis,Entity
anal verrucous carcinoma,Entity
Rotavirus infection,Entity
campylobacteriosis,Entity
enterovirus infectious disease,Entity
herpes simplex virus gingivostomatitis,Entity
Ludwig's angina,Entity
pulpitis,Entity
nasopharyngeal diphtheria,Entity
vesicular stomatitis,Entity
herpes labialis,Entity
small intestinal bacterial overgrowth,Entity
sensory system cancer,Entity
non-hypoproteinemic hypertrophic gastropathy,Entity
idiopathic gastroparesis,Entity
congenital short bowel syndrome,Entity
lymphatic system cancer,Entity
Abnormality of the musculature,Entity
Atherosclerosis,Entity
SELENON,Entity
digestive duplication,Entity
common mesentery,Entity
Anemia of inadequate production,Entity
Calvarial hyperostosis,Entity
primary bone dysplasia,Entity
FAH,Entity
LOXL1,Entity
BRD3,Entity
anal fistula (disease),Entity
Triclosan,Entity
Bromodiphenhydramine,Entity
ADCY7,Entity
ulcerative proctosigmoiditis,Entity
undetermined colitis,Entity
Esophageal carcinoma,Entity
DLEC1,Entity
CYP26B1,Entity
SLC52A3,Entity
FAT3,Entity
esophagus verrucous carcinoma,Entity
Single umbilical artery,Entity
Congenital hypothyroidism,Entity
SPEG,Entity
Gastrointestinal dysmotility,Entity
Absence of stomach bubble on fetal sonography,Entity
Oral aversion,Entity
Abnormality of the urinary system,Entity
Subglottic stenosis,Entity
Aspiration,Entity
Episodic respiratory distress,Entity
Laryngotracheomalacia,Entity
Abnormality of limbs,Entity
Abnormality of the ear,Entity
Abnormal external genitalia,Entity
Pulmonary hypoplasia,Entity
Abnormality of the pinna,Entity
jejunal adenocarcinoma (disease),Entity
Small bowel diverticula,Entity
mucinous intrahepatic cholangiocarcinoma,Entity
pancreas sarcoma,Entity
small intestinal sarcoma,Entity
chronic liver failure,Entity
intestinal volvulus,Entity
ADAM8,Entity
Oropharyngeal squamous cell carcinoma,Entity
"High, narrow palate",Entity
BARX1,Entity
FCMR,Entity
HEY2,Entity
CRNN,Entity
colorectal hamartoma,Entity
gastric hamartomatous polyp,Entity
Peutz-Jeghers polyp,Entity
tonsil cancer,Entity
Increased CSF protein,Entity
Abnormal meningeal morphology,Entity
Abnormal subarachnoid space morphology,Entity
Arachnoid cyst,Entity
CSF lymphocytic pleiocytosis,Entity
Posterior fossa cyst at the fourth ventricle,Entity
Upper motor neuron dysfunction,Entity
Abnormal eye morphology,Entity
Abnormality of optic chiasm morphology,Entity
taeniasis,Entity
BDH1,Entity
XYLB,Entity
Bronchiectasis,Entity
Recurrent herpes,Entity
B lymphocytopenia,Entity
Carotid artery dilatation,Entity
Recurrent Aspergillus infections,Entity
Medial calcification of large arteries,Entity
Abnormal serum interferon-gamma level,Entity
intrahepatic bile duct cancer,Entity
gallbladder rhabdomyosarcoma,Entity
intestinal tuberculosis,Entity
esophageal tuberculosis,Entity
anus leiomyoma,Entity
Follicular hyperplasia,Entity
Mediastinal lymphadenopathy,Entity
functional pancreatic neuroendocrine tumor,Entity
DHCR7,Entity
Psychotic episodes,Entity
Motor axonal neuropathy,Entity
Dark urine,Entity
Brain imaging abnormality,Entity
Abnormality of the knee,Entity
TRMU,Entity
Abnormal paranasal sinus morphology,Entity
Chorioretinal coloboma,Entity
mixed dermis disorder,Entity
GHSR,Entity
Abnormal serum interleukin level,Entity
Bilateral tonic-clonic seizure,Entity
Inappropriate antidiuretic hormone secretion,Entity
Chronic hepatic failure,Entity
Abnormal natural killer cell count,Entity
Attention deficit hyperactivity disorder,Entity
perforation of bile duct,Entity
fibrosis of bile duct,Entity
hepatitis A virus infection,Entity
hard palate cancer,Entity
face disease,Entity
Positive Romberg sign,Entity
hypopharynx squamous cell carcinoma,Entity
ZFP57,Entity
undifferentiated pancreatic carcinoma with osteoclast-like giant cells,Entity
Annular pancreas,Entity
Abnormality of the pulmonary artery,Entity
non-syndromic gastroduodenal malformation,Entity
extrahepatic bile duct leiomyoma,Entity
Iopanoic acid,Entity
Iodamide,Entity
muscle cancer,Entity
submandibular gland adenoid cystic carcinoma,Entity
Blastocystis infectious disease,Entity
amebic dysentery,Entity
Mungan syndrome,Entity
TMEM18,Entity
carcinoma of lip,Entity
Moyamoya phenomenon,Entity
MYMY1,Entity
SLC2A10,Entity
cecum cancer,Entity
ascending colon cancer,Entity
transverse colon cancer,Entity
LIPA,Entity
PDYN,Entity
F2RL3,Entity
KANK1,Entity
HOGA1,Entity
MIR143,Entity
MIR361,Entity
MIR411,Entity
MIR875,Entity
ATP8B1,Entity
EEG with generalized epileptiform discharges,Entity
Aeromonas hydrophila infectious disease,Entity
portal vein thrombosis,Entity
Increased serum bile acid concentration,Entity
Abnormality of the digestive system,Entity
Neonatal respiratory distress,Entity
Pruritus on foot,Entity
Palmar pruritus,Entity
extragonadal germ cell cancer,Entity
gastric choriocarcinoma,Entity
Abnormal T cell count,Entity
Hoarse voice,Entity
gallbladder signet ring cell adenocarcinoma,Entity
gallbladder pleomorphic giant cell adenocarcinoma,Entity
Fasting hyperinsulinemia,Entity
Distal lower limb muscle weakness,Entity
primary bone lymphoma,Entity
benign insulitis,Entity
lymphoid system disease,Entity
Prominent metopic ridge,Entity
NKX2-2,Entity
pancreatic intraductal papillary-mucinous carcinoma,Entity
solid pseudopapillary carcinoma of pancreas,Entity
osteoclastic giant cell tumor of pancreas,Entity
chronic diarrhea due to glucoamylase deficiency,Entity
Cerebral cortical atrophy,Entity
epiglottis cancer,Entity
carcinoma in situ of hypopharynx,Entity
Visual field defect,Entity
stiff-person syndrome,Entity
ADAMTS9,Entity
minor salivary gland carcinoma,Entity
Abdominal cramps,Entity
vibrio infectious disease,Entity
Gallbladder dysfunction,Entity
Mechanical ileus,Entity
granulomatous hepatitis,Entity
fulminant viral hepatitis,Entity
idiopathic peliosis hepatis,Entity
Downslanted palpebral fissures,Entity
Craniosynostosis,Entity
Frontal bossing,Entity
Stage 5 chronic kidney disease,Entity
parotid gland acinic cell carcinoma,Entity
parotid gland adenoid cystic carcinoma,Entity
parotid gland squamous cell carcinoma,Entity
mucoepidermoid carcinoma of parotid gland,Entity
lymphocytic colitis,Entity
Abnormality of retinal pigmentation,Entity
Abnormal circulating insulin level,Entity
extrahepatic bile duct leiomyosarcoma,Entity
benign neoplasm of pharynx,Entity
respiratory system benign neoplasm,Entity
non-cutaneous melanoma,Entity
small intestinal mucosa-associated lymphoid tissue lymphoma,Entity
pancreatic neuroendocrine tumor G1,Entity
Increased circulating ACTH level,Entity
gastric small cell neuroendocrine carcinoma,Entity
adenosquamous bile duct carcinoma,Entity
chronic intestinal vascular insufficiency,Entity
Clevudine,Entity
Arachnodactyly,Entity
Anonychia,Entity
transient familial neonatal hyperbilirubinemia,Entity
ampulla of vater squamous cell carcinoma,Entity
PTPRO,Entity
fibroepithelial polyp of the anus,Entity
Ascaridida infectious disease,Entity
ATOH8,Entity
gastric fundus carcinoma,Entity
gastric pylorus carcinoma,Entity
"carcinoma of stomach, salivary gland type",Entity
bone carcinoma,Entity
angiodysplasia of intestine,Entity
postgastrectomy syndrome,Entity
neurogenic bowel,Entity
congenital enteropathy involving intestinal mucosa development,Entity
solitary rectal ulcer syndrome,Entity
cryptogenic multifocal ulcerous stenosing enteritis,Entity
retromolar area cancer,Entity
MIR145,Entity
"carcinoma of esophagus, salivary gland type",Entity
pancreatic mucinous-cystic neoplasm with an associated invasive carcinoma,Entity
Unsteady gait,Entity
External ophthalmoplegia,Entity
Macular dystrophy,Entity
TRNK,Entity
TRNL1,Entity
mitochondrial disease with eye involvement,Entity
mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA,Entity
microinvasive gastric cancer,Entity
mucinous gastric adenocarcinoma,Entity
signet ring cell gastric adenocarcinoma,Entity
Acanthocytosis,Entity
intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,Entity
Abnormality of the menstrual cycle,Entity
connective tissue cancer,Entity
metolachlor,Entity
Abnormal mitral valve morphology,Entity
eyelids malposition disorder,Entity
Mitochondrial respiratory chain defects,Entity
Macrovesicular hepatic steatosis,Entity
Microvesicular hepatic steatosis,Entity
mitochondrial disorder due to a defect in mitochondrial protein synthesis,Entity
Cerebellar agenesis,Entity
Optic nerve hypoplasia,Entity
Pectus carinatum,Entity
Convex nasal ridge,Entity
mature gastric teratoma,Entity
pancreatic steatorrhea,Entity
pancreatic mucinous ductal ectasia,Entity
disorder of lipid absorption and transport,Entity
urea cycle disorder,Entity
Femoral hernia,Entity
Short philtrum,Entity
bile duct carcinoma in situ,Entity
MIR23B,Entity
MIR191,Entity
MIR149,Entity
PCYT1A,Entity
GSTM2,Entity
Neonatal onset,Entity
Young adult onset,Entity
lower lip cancer,Entity
Povidone,Entity
Aminacrine,Entity
idiopathic copper-associated cirrhosis,Entity
hepatoportal sclerosis,Entity
primitive portal vein thrombosis,Entity
early-onset familial noncirrhotic portal hypertension,Entity
Microcystins,Entity
thoracic benign neoplasm,Entity
Cobamamide,Entity
Hepatic arteriovenous malformation,Entity
PNLIP,Entity
Increased level of propylene glycol in blood,Entity
Micronodular cirrhosis,Entity
esophageal varices,Entity
Epicanthus,Entity
Long philtrum,Entity
Wide anterior fontanel,Entity
Buphthalmos,Entity
Splenic cyst,Entity
colon mucosa-associated lymphoid tissue lymphoma,Entity
Germ cell neoplasia,Entity
Abnormality of alkaline phosphatase level,Entity
X-linked dominant inheritance,Entity
cecum villous adenoma,Entity
Abnormality of the tongue,Entity
extrahepatic bile duct rhabdomyosarcoma,Entity
JAZF1,Entity
ADCY5,Entity
carcinoma ex pleomorphic adenoma,Entity
neoplasm of jaw,Entity
mandibular cancer,Entity
abnormality of glucagon secretion,Entity
post-surgical hypoinsulinemia,Entity
pancreatic cholera,Entity
Increased hematocrit,Entity
TMPRSS15,Entity
proctocolitis,Entity
Multiple small bowel atresias,Entity
Jejunal atresia,Entity
esophagus lymphoma,Entity
thoracic cancer,Entity
malignant neoplasm of abdominal esophagus,Entity
malignant neoplasm of cervical esophagus,Entity
ALDH1L2,Entity
Abnormal thorax morphology,Entity
Midgut malrotation,Entity
Adrenocorticotropic hormone excess,Entity
Appendiceal mucinous neoplasm,Entity
classic neuroendocrine tumor of appendix,Entity
Pancreatic calcification,Entity
Elevated maternal serum alpha-fetoprotein,Entity
Hyperactive bowel sounds,Entity
Abnormal sweat electrolytes,Entity
ECHDC1,Entity
Myocardial steatosis,Entity
Neonatal death,Entity
Palmoplantar hyperhidrosis,Entity
Pheochromocytoma,Entity
Rectocele,Entity
Mucosal telangiectasiae,Entity
combined pancreatic lipase-colipase deficiency,Entity
Meglumine antimoniate,Entity
Polyvinyl alcohol,Entity
thoracic disease,Entity
Ciliophora infectious disease,Entity
Hepadnaviridae infectious disease,Entity
Herpesviridae infectious disease,Entity
infectious disease of the nervous system,Entity
gastric leiomyoma,Entity
small intestine leiomyoma,Entity
CTHRC1,Entity
papillary extrahepatic bile duct adenocarcinoma,Entity
extrahepatic bile duct clear cell adenocarcinoma,Entity
Finger syndactyly,Entity
Hypoplasia of the ovary,Entity
glyphosate,Entity
gallbladder leiomyosarcoma,Entity
CIDEA,Entity
MCCC1,Entity
Hypoplasia of the corpus callosum,Entity
Hypoplasia of the brainstem,Entity
esophageal diverticulosis,Entity
CNS demyelination,Entity
Abetalipoproteinemia,Entity
Progressive visual loss,Entity
Steppage gait,Entity
Decreased erythrocyte sedimentation rate,Entity
autosomal recessive cerebellar ataxia,Entity
hypobetalipoproteinemia,Entity
metabolic disease with pigmentary retinitis,Entity
lipoma of the rectum,Entity
esophagus leiomyosarcoma,Entity
overgrowth syndrome,Entity
rectal hyperplastic polyp,Entity
alachlor,Entity
chlorimuron ethyl,Entity
Dicamba,Entity
Fonofos,Entity
metribuzin,Entity
terbufos,Entity
Trifluralin,Entity
sublingual gland neoplasm,Entity
parotid gland neoplasm,Entity
pancreatic signet ring cell adenocarcinoma,Entity
tubulovillous adenoma,Entity
anal margin squamous cell carcinoma,Entity
Hepatocellular necrosis,Entity
Increased fecal coproporphyrin 3,Entity
Long hairs growing from helix of pinna,Entity
Facial hirsutism,Entity
colorectal gastrointestinal stromal tumor,Entity
"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Entity
"diarrhea 11, malabsorptive, congenital",Entity
mixed ductal-endocrine carcinoma of pancreas,Entity
dientamoebiasis,Entity
MIR362,Entity
neoplasm of floor of mouth,Entity
Benign neoplasm of the central nervous system,Entity
Luseogliflozin,Entity
Increased waist to hip ratio,Entity
CDKAL1,Entity
PLEKHA1,Entity
TMEM155,Entity
KCNU1,Entity
C2CD4B,Entity
MIR221,Entity
MIR339,Entity
MIR33B,Entity
MIR532,Entity
MIR628,Entity
MIR744,Entity
MIR1249,Entity
MIR1296,Entity
MIR1306,Entity
MIR1228,Entity
MIR1226,Entity
MIR1301,Entity
MIR1908,Entity
MIR2116,Entity
MIR4516,Entity
MIR4482,Entity
MIR8061,Entity
Indium,Entity
Tantalum,Entity
intermediate DEND syndrome,Entity
MIR30B,Entity
perfluorododecanoic acid,Entity
perfluoroheptanoic acid,Entity
Hyperpigmentation in sun-exposed areas,Entity
anal melanoma,Entity
gastric adenocarcinoma and proximal polyposis of the stomach,Entity
gingival neoplasm,Entity
appendix lymphoma,Entity
MIR942,Entity
hepatitis C induced liver cirrhosis,Entity
Etidocaine,Entity
SCT,Entity
SLC25A29,Entity
duplication of the esophagus,Entity
congenital esophageal diverticulum,Entity
Abnormality of the metaphysis,Entity
Abnormality of epiphysis morphology,Entity
paranasal sinus squamous cell carcinoma,Entity
Asymmetric growth,Entity
PAH,Entity
Short metacarpal,Entity
Mildly elevated creatine kinase,Entity
Pes planus,Entity
Abnormality of the humerus,Entity
Abnormal hip bone morphology,Entity
genetic alopecia,Entity
cloacogenic carcinoma,Entity
"visceral neuropathy, familial, autosomal dominant",Entity
myopathic intestinal pseudoobstruction,Entity
unclassified intestinal pseudoobstruction,Entity
distal colitis,Entity
pancolitis,Entity
anus basaloid carcinoma,Entity
Central sleep apnea,Entity
DSC2,Entity
SPIN2A,Entity
MIR1-1,Entity
MIR18A,Entity
MIR188,Entity
MIR342,Entity
MIR367,Entity
MIR505,Entity
MIR627,Entity
MIR660,Entity
MIR766,Entity
MIR877,Entity
MIR1246,Entity
MIR1291,Entity
MIR378C,Entity
MIR4448,Entity
MIR6815,Entity
Anti-Infective Agents,Entity
Clavulanic Acid,Entity
Dimethylformamide,Entity
laminopathy type Decaudain-Vigouroux,Entity
MIR194-2,Entity
MIR28,Entity
MIR365B,Entity
Decreased serum thromboxane B2,Entity
undifferentiated gallbladder carcinoma,Entity
Hyperphosphaturia,Entity
gastroesophageal junction adenocarcinoma,Entity
Abnormal pupil morphology,Entity
Abnormal anterior chamber morphology,Entity
lower gum cancer,Entity
Ineffective esophageal peristalsis,Entity
gastric leiomyosarcoma (disease),Entity
salivary gland adenosquamous carcinoma,Entity
pancreatic serous cystadenoma,Entity
squamous cell carcinoma of the oral tongue,Entity
squamous cell carcinoma of buccal mucosa,Entity
Decreased circulating cortisol level,Entity
lymphocytic gastritis,Entity
granulomatous gastritis,Entity
alcoholic gastritis,Entity
chronic erosive gastritis,Entity
collagenous gastritis,Entity
Hypoproteinemic edema,Entity
mucositis,Entity
intra-abdominal hemangioma,Entity
Sphincter of Oddi dyskinesia,Entity
Abnormal biliary tract physiology,Entity
Atretic vas deferens,Entity
Reduced sperm motility,Entity
Decreased numbers of nephrons,Entity
Absent vas deferens,Entity
peripheral nervous system cancer,Entity
liver cavernous hemangioma,Entity
non-functioning endocrine neoplasm,Entity
maxillary sinus neoplasm,Entity
malignant gastric granular cell tumor,Entity
Telangiectasia of the skin,Entity
Wide intermamillary distance,Entity
Hypoplasia of the maxilla,Entity
Sparse and thin eyebrow,Entity
Erectile dysfunction,Entity
splenic flexure cancer,Entity
anal gland adenocarcinoma,Entity
rectal sarcomatoid carcinoma,Entity
Febrile seizure (within the age range of 3 months to 6 years),Entity
Epidermal acanthosis,Entity
perinatal disease,Entity
intraductal papilloma,Entity
GADL1,Entity
Freckled genitalia,Entity
Elevated urinary carboxylic acid,Entity
Early cutaneous photosensitivity,Entity
Reduced factor X activity,Entity
postcricoid region cancer,Entity
indeterminate colitis,Entity
mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA,Entity
